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ABSTRACT 
Previous studies have proposed lipids and/or proteins to be involved in the biomineralization 
process of haemozoin formation in the malaria parasite which is a target for many 
antimalarial drugs. This study therefore investigated the biomolecules involved and 
established the role of lipids in mediating Hz formation under biomimetic conditions. 
Hz crystals were isolated from mature trophozoites obtained from saponin-lysed iRBCs. 
Trophozoites were triturated to release digestive vacuoles and subjected to freeze/thaw cycles 
to release Hz. Supernatant from SDS-washed Hz crystals and solution of dissolved crystals in 
NaOH were used for SDS PAGE and LC-MS/MS protein identification. None of the proteins 
HRPII, HDP, or those belonging to the proposed protein complex previously suggested to be 
involved in Hz formation in vivo, were identified in the proteome associated with Hz crystals. 
In addition, no ‘stand out’ proteins with expected Hz-mediating activity in the malaria 
parasite were identified. Contrastingly, putative lipoproteins and uncharacterized proteins 
with roles in lipid binding and transport were identified for the first time in the proteome 
associated with Hz crystals. Lipids consisting of MSG, MPG, DPG, DLG and DOG (NLB) 
previously reported to be associated with Hz crystals were easily identified to be associated 
with Hz crystals. Lipid was also found to be in vastly greater abundance than proteins in the 
Hz crystal. The absence, therefore, of all proteins previously suggested to be involved in Hz 
formation from the proteome associated with the Hz crystal, coupled with the identification 
of lipoproteins and the easily detected abundance of lipids with Hz-mediating activity, 
strongly suggest that lipids are the biomolecules responsible for the biomineralization of Hz 
formation in vivo.  
A solution mixture of NLB and haematin both prepared in acetone/methanol deposited on 
citrate buffer (50 mM, pH 4.8, 37
o
C), was allowed to incubate at 37
o
C for different lengths of 
time to investigate β-haematin formation. The product formed was confirmed by FT-IR to be 
β-haematin. The reaction was very fast giving yields of about 90% at 2.15 and 1.07 lipid-to-
haem mol ratios and was completed in less than 10 min. The reaction only slowed when there 
were two haem molecules to one fatty acid chain, but still gave yields of about 90% in under 
30 min. On the other hand, this slower kinetics allowed for the effects of relevant biological 
ions on the process to be investigated. Relevant biological ions at concentrations which they 
exist in RBC and/or blood are unlikely to greatly affect the lipid mediated process of Hz 
formation in vivo as only a 2.3 fold decrease in kinetics was observed in the presence of these 
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ions. β-Haematin formed over time during the reaction showed an increase in fluorescence 
measured using confocal laser microscopy. This qualitatively corresponds to that of bulk 
kinetic measurements and also demonstrates the formation of well-ordered crystals in situ in 
association with the lipid component of the emulsion. However, the β-haematin crystals 
formed seemed to have a distinct external morphology different from Hz itself and thus this 
was investigated further. 
Solutions of NLB and haematin in acetone/methanol were mixed by means of vortexing, 
ultrasonication or micromixing before being used for β-haematin formation reactions. The β-
haematin crystals formed at the emulsion layer as well as lipid droplets were characterized by 
TEM, TEM-ED and ESI/EELS and were compared to Hz. β-Haematin crystals formed from 
the vortexed mixture appeared to be smaller in size with external morphology and hkl indices 
different from Hz while ultrasonication or micromixing produced very long β-haematin 
crystals that are identical to Hz both in overall crystal habit and form. An observed difference 
in texture between the β-haematin crystals and Hz was likely due to the presence of proteins 
and lipids on the Hz crystal as shown in the proteomic and lipid studies of this work. The 
external morphology of the β-haematin formed was not affected by the NLB-to-haematin 
ratio at any given time nor by the kinetics of the crystal growth process. β-Haematin crystals 
formed at the emulsion layer were always seen to make contact with non-hollow lipid 
droplets with continuous hydrophobic interiors via their {100} faces. The lipid droplets in 
contact with crystals were found to control the length of the crystal. Growth stopped when the 
angle of contact between the lipid and crystal reached approximately 38
o
. The invariable 
observation of β-haematin crystals with their {100} face in contact with lipid droplets that 
control their sizes strongly suggests that lipids act as the nucleator, providing a favourable 
microenvironment suitable for the interaction with the propionic acid groups at the {100} 
surface of the crystal via the glycerol –OH group of the lipid.  
The proposal that lipids are the sole biomolecules responsible for Hz formation in vivo is 
strongly supported by the following findings: Firstly, all the proteins previously suggested to 
be involved in Hz formation were absent from the proteome associated with Hz. 
Interestingly, it was lipids that were found to be in relative abundance over these proteins in 
the Hz crystal. Secondly, these lipids were highly efficient in mediating β-haematin 
formation under biomimetic conditions producing crystals that were identical in overall habit 
and form to that of Hz itself. Finally, the lipid droplets invariably observed in contact with the 
crystals, controls their size and probably nucleate crystal growth via their {100} faces. 
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1. INTRODUCTION 
 
1.1 BACKGROUND REVIEW ON MALARIA 
Giovanni Maria Lancisi was the first to describe a dark pigment found in the brains of 
malaria victims observed during a fever outbreak in Rome (Lancisi, 1717). It was only in 
1847 that this pigment was again described by a German physician, H. Meckel, and later in 
1849 it was linked to malaria by the pathologist Rudolf Virchow (Virchow, 1849). In 1880, 
Charles Laveran showed clear microscopic evidence of this pigment granule in the blood 
samples of people suffering from malaria (Laveran, 1880). It was the crystalline nature of the 
pigment that led Sir Ronald Ross to later on describe the transmission of the disease by 
mosquitoes (Ross, 1897).  
Today, it is well established that malaria is caused by a parasitic protozoan belonging to the 
genus Plasmodium. There exist over 100 species of Plasmodium that cause malaria in various 
vertebrates, but of these, only P. falciparum, P. malariae, P. vivax and P. ovale are known to 
cause malaria exclusively in humans although the monkey malaria parasite P. knowlesi has 
also been reported to cause malaria in humans (Collins, 2012). Of all these species known to 
cause malaria in humans, P. falciparum is the most deadly. Infection in humans occurs from a 
bite of an infected female Anopheles mosquito in which sporozoites (the infective stage of the 
malaria parasite) are introduced into the bloodstream during the mosquito blood-feeding 
process.  
The WHO World Malaria Report in 2011 showed approximately 3.3 billion people were at 
risk of malaria with a majority of the risk population living in sub-Saharan Africa. Children 
under 5 years of age and pregnant women living in sub-Saharan Africa constitute the most 
vulnerable group at risk and account for the majority of the cases estimated at 80% and 90% 
of malaria deaths worldwide (WHO, 2012). As of 2012, there were 104 countries and 
territories in which malaria was still considered endemic due to on-going malaria 
transmission. A world map of countries affected by malaria is shown in Figure 1.1. The 
disease burden cost an estimated 1.84 billion USD in 2012 in financing and implementation 
of malaria control programmes. Malaria is strongly linked to poverty as mortality rates 
remain high in very poor countries where a majority of the population survives on less than 
1.25 USD a day. According to the WHO, the African countries of Nigeria, the Democratic 
Republic of the Congo, the United Republic of Tanzania, Uganda, Mozambique and Cote 
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d’Ivoire account for about 47% of all malaria cases in this region. India alone accounts for 
about 24 million cases per year in the South and South-East Asia region. Beside children 
under the age of five and pregnant women being the most vulnerable group to malaria 
morbidity and mortality, the recent WHO report has also classified people living with 
HIV/AIDS, non-immune migrants as well as mobile populations and travellers as belonging 
to the group of vulnerable individuals who need protection from malaria infection (WHO, 27 
June, 2013). Despite efforts by WHO and the target set by Roll Back Malaria in combating 
malaria by 2015, only about 50 countries accounting for about 3% of total malaria cases are 
on track to reduce their malaria cases by 75%. Therefore, malaria still remains one of the 
major diseases of international public health interest. 
 
Figure 1.1: Countries shown on the map have malaria in at least part of their territory. (Reprinted from 
http://microbiologyspring2010.wikispaces.com/Malaria) 
 
1.2 LIFE CYCLE OF MALARIA PARASITE 
The parasite life cycle comprises two phases, a sexual phase which occurs in the mosquito 
and an asexual phase which occurs in humans as shown in Figure 1.2. During the mosquito 
blood feeding process, sporozoites released into the blood stream by the mosquito are 
transported to the liver where they undergo schizogony. Schizogony involves cell division 
(Mikolajczak et al. 2006) producing thousands of merozoites which are released into the 
bloodstream. In P. vivax but not in P. falciparum some of the parasites lie dormant in the 
liver (hypnozoites) and only become active some years later. Merozoites released into the 
bloodstream infect red blood cells (RBCs) and develop into the trophozoite stage (most 
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metabolically active stage of the parasite) in an intraerythrocytic life cycle. Trophozoites 
mature and undergo schizogony producing more merozoites which are eventually released 
into the bloodstream upon lysis of the RBC for another round of re-infection. Some of the 
merozoites develop into the male and female gametocytes (Mikolajczak et al. 2006). The 
gametocytes are ingested by a mosquito during its blood meal. Sexual reproduction forms 
zygotes which lead to the production of sporozoites in the mosquito intestine and are then 
transported to the salivary gland of mosquito. The sporozoites in the salivary gland can again 
be injected into a human during a subsequent blood meal and this continues the cycle (Figure 
1.2). 
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Figure 1.2. The life cycle of the malaria parasite. The sexual phase of the life cycle occurs inside the mosquito 
while the asexual phase occurs in the human. The asexual reproductive phase occurs predominantly in RBCs 
causing them to rupture thereby leading to the noticeable signs and symptoms of the disease in humans. 
(Reprinted from http://microbiologyspring2010.wikispaces.com/Malaria) 
 
Parasites inside RBCs feed predominantly on RBC haemoglobin and lysis of the RBC to 
release new merozoites concurrently releases toxic parasitic waste into the bloodstream 
which sets off a wave of immunological reactions in the human body, resulting in some of the 
signs and symptoms of the disease. This therefore makes the intraerythrocytic stage of the 
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parasite life cycle a very important target in the study to develop drugs or vaccines in the 
fight against malaria. 
 
1.3 HAEMOGLOBIN DIGESTION AND HAEM METABOLISM 
Plasmodium falciparum is the most deadly species of Plasmodium. During its 
intraerythrocytic life cycle, it feeds on RBC haemoglobin to provide amino acids for its own 
protein synthesis (Rosenthal, 2004) and also to maintain osmotic stability (Lew et al. 2003). 
In this process, haemoglobin is first transported into the acidic digestive vacuole of the 
parasite through transport vesicles. The parasite in the RBC digests approximately 80% of the 
host cell haemoglobin during it intraerythrocytic life cycle (Mauritz et al. 2011 & 
Gligorijevic et al. 2006). The digestion of haemoglobin in the parasite digestive vacuole 
releases free haem which accumulates in the digestive vacuole and could result in parasite 
death through the generation of oxidative free radicals (Ziegler et al. 2001), peroxidization of 
membranes (Francis et al. 1997) and also damage to cellular metabolism through the 
inhibition of enzymes (Gluzman et al. 1994). Free haem released during the parasite feeding 
process is therefore potentially toxic to the parasite itself as it is not recycled or metabolised 
(Eckman et al. 1997). However, the parasite has developed a novel mechanism of detoxifying 
free haem by converting it into a non-toxic microcrystalline structure known as haemozoin or 
malaria pigment. Haemoglobin catabolism in the digestive vacuole is an orderly process 
which is carried out by a series of proteinases and includes aspartic proteases plasmepsin I & 
II, cysteine protease falcipains, metalloprotease falcilysin, dipeptidylaminopeptidase 
(PfDPAP1) and neutral aminopeptidases (Gorka et al. 2013) as shown in Figure 1.3. 
Plasmepsins I & II begin the enzymatic digestion of haemoglobin inside the digestive vacuole 
by cleaving the undenatured haemoglobin at the hinge region between amino acid residue 
α33Phe and α34Leu (Goldberg et al. 1991). Cleavage disrupts the tetrameric haemoglobin 
structure responsible for oxygen transport (Perutz et al. 1998) and exposes other protease 
cleavage sites. This initial cleavage of the undenatured haemoglobin also results to the release 
of its haem content (Goldberg et al. 1992). The resultant fragments from the initial 
plasmepsin digestion are further broken down into even smaller fragments by cysteine 
proteases falcipain II & III (Rosenthal, 2011) along with plasmepsin I, II & IV (Schlagenhauf 
et al. 2010 & Wyatt et al. 2002) and histo-aspartic protease, HAP (Gorka et al. 2013). These 
fragments are finally digested to 5-10 amino acid residues by a metalloprotease falcilysin by 
cleavage at polar and charged residues. A recently identified P. falciparum 
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dipeptidylaminopeptidase (PfDPAP1) in the DV (Klemba et al. 2004) which is an orthologue 
of cathepsin C lysosomal exopeptidase and is homologous to the mammalian type I 
dipeptidylaminopeptidase (DPAP1) is responsible for digesting the 5-10 residues into 
dipeptides (Klemba et al. 2004). The dipeptides are transported from the DV to the parasite 
cytoplasm by an unknown mechanism (Gorka et al. 2013) where they are then digested into 
amino acids by neutral aminopeptidase (Gavigan et al. 2001). The M1-family alanyl 
aminopeptidase (PfM1AAP) and M17-family leucyl aminopeptidase (PfM1LAP) are two 
neutral aminopeptidases described in the Plasmodium falciparum genome (Dalal et al. 2007). 
The latter is located in the cytoplasm while the former is a transmembrane protein which is 
proteolytically activated to its active form (Allary et al. 2002). The inhibition of these two 
aminopeptidases correlate with the inhibition of parasite growth (Skinner-Adams et al. 2007, 
Grembecka et al. 2003 & Gavigan et al. 2001) suggesting that the complete digestion of 
haemoglobin is required for parasite development. Incubation of purified digestive vacuole 
lysate with denatured globin at acidic pH has shown that aspartic proteases and cysteine 
proteases account for 60-80% and 20-40% of globin degrading activity in the digestive 
vacuole respectively (Francis et al. 1996, Gluzman et al. 1994 & Goldberg et al. 1990). The 
activities of these two groups of enzymes are completely blocked by a combination of 
pepstatin and E-64, which are specific inhibitors for aspartic and cysteine proteases 
respectively, thereby suggesting these two enzymes are responsible for globin degradation in 
the digestive vacuole (Gluzman et al. 1994).  
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Figure 1.3. Schematic representation of haemoglobin digestion and haemozoin formation in P. falciparum. 
 
Despite the well-known functions of protein-bound haem in biologically-important processes 
such as oxygen transport, signal transduction and respiratory photosynthesis (Ponka et al. 
1999), the presence of free haem in a biological system can contribute to alkyl and peroxyl 
radicals formation, by means of hydroperoxide decomposition mediated by haem (Davies, 
1988 and Van der Zee et al. 1996) which can cause potential damage to other biological 
structures such as interferance with membrane integrity (Schmitt et al. 1993). However, in 
most biological systems where free haem is known to be produced, the organism has evolved 
to develop unique ways of protecting itself against the adverse effect of free haem (Schacter 
et al. 1988) with haemozoin formation being the mechanism of detoxification of free haem in 
P. falciparum (Egan et al. 2002). 
 
1.4 A BRIEF OVERVIEW OF HAEMOZOIN: A HAEM DETOXIFICATION 
PRODUCT IN THE MALARIA PARASITE 
As stated above, haemozoin (malaria pigment) was described as far back as 1849 by Rudolf 
Virchow and was later shown to comprise haem which gives it its dark colour (Carbone, 1891 
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& Brown, 1911). Interest in the study of haemozoin only developed much later in the late 
1980s when Fitch et al. (1987) showed that haemozoin consists entirely of 
iron(III)protoporphyrin IX (Fe(III)PPIX) (Fitch et al. 1987). This was followed by the 
determination of its chemical composition in the early 1990s by Slater et al. (1991). 
Haemozoin crystal formation is thought to occur via a biomineralization process (Egan et al. 
2001) in the malaria parasite. The formation of this crystal has also been observed in several 
blood-feeding organisms such as R. prolixus (Oliveira et al. 1999), S. mansoni (Oliveira et al. 
2000) and H. columbae (Chen et al. 2001). Blood-feeding organisms that produce haemozoin 
obtain their nutrients by feeding on haemoglobin and in the process produce large quantities 
of free haem (Francis et al. 1997). Haemozoin formation in the digestive vacuole of the 
malaria parasite is the main haem detoxification process of the parasite as shown by electron 
spectroscopic imaging (ESI) and electron energy loss spectroscopy (EELS) of P. falciparum 
infected erythrocytes and by Mössbauer spectra of parasites accounting for at least 95% of 
ingested haem (Egan et al. 2002). Many antimalarial drugs are now known to act by 
inhibiting the haemozoin formation process (Egan et al. 1994, Tekwani et al. 2005, 
Hänscheid et al. 2007, Sandlin et al. 2011 & Combrinck et al. 2012). Great advances have 
been made so far in studying the formation of synthetic haemozoin (β-haematin) crystals both 
under physiological and non-physiological (Egan et al. 2006) conditions of temperature and 
pH in the presence of organic solvents such as pentanol and octanol (Egan et al. 2006), 
MeOH-DMSO and CHCl3 (Buller et al. 2002), polyethylene glycols (Stiebler et al. 2010b), 
lipids (Egan et al. 2006, Hoang et al. 2010 a, b, Pisciotta et al. 2007 and Jackson et al. 2004) 
and proteins (Jani et al. 2008, Sullivan et al. 1996 and Chugh et al. 2012) to better understand 
how this process occurs in vivo. However, current knowledge still does not fully explain the 
detailed biomineralization process by which haemozoin formation occurs in vivo in the 
malaria parasite. Therefore, this subject is an interesting area of current research as that could 
open up new avenues for drug discovery in malaria. 
 
1.5 CHARACTERIZATION OF HAEMOZOIN CRYSTALS 
The characteristics of the haemozoin crystal can be described in terms of its physicochemical 
properties and also its morphological and crystallographic properties. 
 
1.5.1 Physicochemical properties 
Haemozoin, described by Fitch et al. in 1987 as consisting entirely of Fe(III)PPIX, was 
shown to be chemically identical to a synthetic precipitate known as β-haematin (Table 1.1). 
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Spectroscopically, the infrared (IR) spectrum and x-ray powder diffraction pattern of β-
haematin crystals prepared by Slater et al. (1991) under acidic conditions (pH 4.5) by heating 
Cl-Fe(III)PPIX in 4.5 M acetic acid at 70
o
C showed it is identical to natural haemozoin. 
Similarly, the solubility properties of both β-haematin and haemozoin were also shown to be 
identical as they both dissolve in DMSO and aqueous alkaline solution (Slater et al. 1991).  
 
Table 1.1. Elemental compositions of haemozoin and β-haematin as determined in 1991 by Slater et al. 
Reproduced from Slater, A. F. G., Swiggard, W. J., Orton, B. R., Flitter, W. D., Goldberg, D. E., Cerami, A. & 
Henderson, G. B. An iron-carboxylate bond links the heme units of malaria pigment. Proc. Natl Acad. Sci. USA. 
1991, 88, 325-329. 
 
 Percent by weight 
Element Hemozoin β-Hematin Hematin (theory) 
Carbon 63.7 64.7 64.5 
Hydrogen 5.6 5.0 5.3 
Nitrogen 7.5 8.7 8.8 
Iron 7.5 8.3 8.8 
Chlorine <0.1 <0.3 – 
Oxygen* 15.6 13.3 12.6 
*As an accurate elemental analysis for oxygen cannot be performed in the presence of significant amounts of 
iron, the oxygen values represent the percent weight remaining. 
 
Furthermore, the chemical structures of both β-haematin and haemozoin were investigated by 
Fourier transform infrared (FT-IR) spectroscopy. Both exhibit intense peaks at 1664 and 
1211 cm
-1
, vibrational stretching frequencies corresponding to C=O and C‒O bonds typical 
of a carboxylate group coordinated to Fe(III) (Figure 1.4A). Meanwhile, the FT-IR spectrum 
of haematin was completely different from that of both haemozoin and β-haematin (Figure 
1.4B). In addition, the x-ray powder diffraction patterns of both β-haematin and haemozoin 
were identical (Figure 1.5), confirming that this synthetic counterpart of haemozoin is 
structurally identical to natural haemozoin isolated from the parasite itself. 
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Figure 1.4. FT-IR spectra of haemozoin (‒) and β-haematin (...), (A). Those of hemozoin (‒) and haematin (---) 
appeared to be completely different, (B). T is transmittance. Reprinted from A. F. G Slater, W. J. Swiggard, B. 
R Orton, W. D. Flitter, D. E. Goldberg, A. Cerami and G. B. Henderson, Proc. Natl Acad. Sci., 1991, 88, 325. 
 
 
Figure 1.5. X-ray powder diffraction pattern of haemozoin (A) is identical to that of β-haematin (B). Reprinted 
from Slater, A. F. G., Swiggard, W. J., Orton, B. R., Flitter, W. D., Goldberg, D. E., Cerami, A. & Henderson, 
G. B. An iron-carboxylate bond links the heme units of malaria pigment. Proc. Natl Acad. Sci. USA. 1991, 88, 
325-329. 
 
Bohle et al. (1997) further confirmed that the high resolution powder diffraction pattern of β-
haematin prepared by dehydrohalogenation of haemin in dry methanol was identical to that of 
freeze-dried whole parasitized RBCs as shown in Figure 1.6 (Bohle et al. 1997) and also 
showed the β-haematin crystal structure to belong to the P1¯ centrosymmetric space group. 
A
B
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This led to the proposal that the structure consisted of Fe(III)PPIX chains growing in anti-
parallel directions with the iron(III) centre on one Fe(III)PPIX coordinated to the propionate 
side chain of the next with hydrogen bonds linking the chains to one another (Bohle et al. 
1997). Later, the same group showed that it consists of cyclic dimers linked by reciprocal 
propionate to Fe(III) coordination, with neighbouring dimers linked by hydrogen bonds as 
shown in Figure 1.7 (Pagola et al. 2000). 
 
 
Figure 1.6. In panel (i), (a) and (b) represent the powder diffraction pattern of lyophilized uninfected and 
infected RBC respectively. In panel (ii), (c) is the difference between (a) and (b) in panel (i) while (d) represents 
the powder diffraction pattern of β-haematin. Reprinted from Bohle, D. S., Dinnebier, R. E., Madsen, S. K. and 
Stephens, P. W. Characterization of the products of the heme detoxification pathway in malarial late 
trophozoites by x-ray diffraction. J. Biol. Chem. 1997, 272, 713-716. 
 
12 
 
 
Figure 1.7. The β-haematin crystal structure viewed along the {001} direction showed the coordination of Fe1–
O41 bond to form dimers linked through O36 and O37 hydrogen bond to another dimer. Reprinted from Pagola, 
S., Stephens, P. W., Bohle, D. S., Kosar,A. D. & Madsen, S. K. The structure of malaria pigment (β-haematin). 
Nature. 2000, 404, 307-310. 
 
Structural determination of natural haemozoin isolated from S. mansoni and R. prolixus by 
Oliveira et al. (2005) using synchrotron x-ray powder diffraction showed it to be identical to 
that formed in the malaria parasite (Oliveira et al. 2005) as the parameters of the 
crystallographic unit cell were almost identical to that of β-haematin. Finally, solution of the 
structure of haemozoin itself from malaria parasites from the X-ray powder diffraction 
pattern using an iterative combination of the Rietveld refinement method and the maximum 
entropy method different from a simulated annealing algorithm used by Pagola et al. (2000) 
yielded an overall identical unit cell structure and virtually identical molecular structure to 
that of β-haematin (Klonis et al. 2010). The only noticeable difference was the Fe(III)‒O 
bond having a greater degree of disorder compared to that of β-haematin. However, this 
difference may arise from the lower occupancy of the oxygen site as was reported by 
Walczac et al. (2005) based on extended X-ray absorption fine structure (EXAFS) 
spectroscopy studies. A recent study reported the formation of crystalline DMSO solvate of 
β-haematin from a solution containing approximately 2 mole equivalents of CQ relative to 
Fe(III)PPIX (Gildenhuys et al. 2012). The external morphology of the β-haematin DMSO 
solvate crystal was identical to that of the haemozoin crystal itself. These authors showed 
using single crystal X-ray diffraction that the unit cell of this crystal structure belongs to the 
centrosymmetryic space group and consist of μ-propionato coordination dimers of 
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Fe(III)PPIX as shown in Figure 1.8 (Gildenhuys et al. 2012) which again is identical to 
previously reported structures of β-haematin (Pagola et al. 2000 & Klonis et al. 2010).  
 
Figure 1.8. (A) Single crystal x-ray diffraction showing the μ-propionato coordination dimers of Fe(III)PPIX in 
the β-haematin DMSO solvate. (B) The H3····O6 in (A) represents the hydrogen bond formed between the 
propionic acid group of Fe(III)PPIX and a DMSO molecule in the crystal structure. Reprinted from Gildenhuys, 
J., le Roex, T., Egan, T.J. & de Villiers, K.A. The single crystal X-ray structure of β-hematin DMSO solvate 
grown in the presence of chloroquine, a β-hematin growth-rate inhibitor. J. Am. Chem. Soc. 2013, 135, 1037-47. 
 
 Bellemare et al. (2009) reported that haemozoin and β-haematin crystals exhibit 
autoflourescence. The excitation of β-haematin is the result of a Frankel excitation from the 
lowest singlet π—π* transition in the porphyrin crystal structure which corresponds to the 
Q(0,0) band (Gouterman et al. 1978 and Bellemare et al. 2009). The fluorescence was only 
observed in the fully hydrated or the fully dehydrated crystal. The excitation and emission 
maximum was observed at 555 and 575 nm respectively. The autofluorescence of β-haematin 
and haemozoin crystals can therefore be exploited to monitor crystal formation in vivo and in 
vitro since non-crystalline Fe(III)PPIX does not fluoresce.  
 
 
A
B
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1.5.2 Morphological and crystallographic properties 
β-Haematin formed by different methods is known to exhibit external morphologies (shape) 
different from haemozoin itself although they are chemically, spectroscopically and 
crystallographically identical to one another (Pagola et al. 2000). The external morphology of 
a crystal is defined by the relative growth rate of its crystal faces (Buller et al. 2002) with the 
slowest growing face being expressed most prominently in the overall crystal morphology. 
Growth of the different faces in β-haematin crystals is determined by the attachment energy 
(Eatt) of the different crystal faces. In the case of β-haematin crystal growth, Eatt can be 
defined as the energy released per molecule when one new layer of β-haematin dimer is 
attached to the growing crystal face. Eatt of the different β-haematin crystal faces are shown in 
Table 1.2. 
 
Table 1.2. Calculated Eatt of the different crystal faces used to determine the theoretical growth form of β-
haematin. Reproduced from Buller, R., Peterson, M. L., Almarsson, O. & Leiserowitz, L. Quinoline Binding 
Site on Malaria Pigment Crystal:  A Rational Pathway for Antimalaria Drug Design. Cryst. Growth Des. 2002, 
2, 553-562. 
 
Face Eatt 
(kcal/mol) 
Face Eatt 
(kcal/mol) 
Face Eatt 
(kcal/mol) 
Face Eatt 
(kcal/mol) 
{100} –30.6  {110} –52.6  {111} –80.4 { ̅  } –106.8 
{010} –27.6  {011} –82.4 { ̅  } –92.8  {112} –112.6 
{001} –101.5 {  ̅ } –52.9 {   ̅} –112.1   
  {   ̅} –108.1     
 
The {100}, {010}, {011} and {001} faces are the most commonly observed β-haematin 
crystal faces as determined by Buller et al. (2002). The more negative the Eatt of any crystal 
face, the less important that face is in the overall crystal morphology, so therefore in order of 
importance {001}˂ {011}˂{100}˂{010} in the overall visible crystal morphology. Buller et 
al. (2002) described the morphology of β-haematin crystals as lath-like, growing fastest along 
its minor {001} face exhibiting well-formed {100} and {010} faces and a less developed 
{011} face (Figure 1.9A & B) which is similar in both habit (overall shape) and form ({hkl}) 
to that of the haemozoin crystal itself (Figure 1.9C).  
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Figure 1.9. Based on Eatt calculations, the theoretical growth form of β-haematin in A & B is similar to that of 
haemozoin crystals, C. D represents a view of the molecular dimeric structure of the β-haematin unit cell from 
the {001} face. Reprinted from Buller, R., Peterson, M. L., Almarsson, O. & Leiserowitz, L. Quinoline Binding 
Site on Malaria Pigment Crystal:  A Rational Pathway for Antimalaria Drug Design. Cryst. Growth Des. 2002, 
2, 553-562. 
 
Solomonov et al. (2007) went further to show using transmission electron microscopy (TEM) 
and TEM-electron diffraction (TEM-ED) patterns that β-haematin crystals grown in MeOH-
DMSO and CHCl3 solution predominantly lie exposing their {100} face with a few showing 
their {010} face and that their structure was consistent with that described by Buller et al. 
(2002). Most of the crystals also appeared to have a regular lath-like shape belonging to the 
P1¯ centrosymmetric space group. 
 
1.6 MECHANISM OF HAEMOZOIN FORMATION: ADVANCES MADE SO FAR 
The different approaches taken to understand the biomineralization process of haemozoin 
formation in vivo using proteins and lipids implicated in its formation as well as solvents, 
buffers and detergents used in mediating the formation of its synthetic counterpart, β-
haematin, in vitro are all discussed below. 
 
1.6.1 Proteins 
Slater and Cerami demonstrated in 1992 that under acidic conditions mimicking those in the 
parasite digestive vacuole, Fe(III)PPIX can be converted to haemozoin by P. falciparum 
trophozoite lysate. An enzyme called haem polymerase was proposed to be responsible for 
this conversion with its activity shown to be inhibited by quinoline drugs. Studies with P. 
A
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berghei lysates also showed similar activity demonstrating the conversion of Fe(III)PPIX to 
haemozoin (Chou et al. 1996). The proposed theory of a ‘haem polymerase’ involvement in 
haemozoin formation was dismissed by studies carried out by Dorn et al. (1995) which 
showed that heating the parasite extract or haemozoin crystals as well as the presence of 
proteases does not affect their β-haematin formation activity. This led to the proposal that 
haemozoin crystal formation is not an enzymatic process but a chemical process (Dorn et al. 
1995).  
 
Histidine rich protein II (HRPII) found in large quantities in the parasite digestive vacuole 
was also implicated in haemozoin formation as it has been reported to bind to Fe(III)PPIX 
and convert it to haemozoin (Sullivan et al. 1996). HPRII was later shown to be very 
inefficient in converting Fe(III)PPIX into synthetic haemozoin (β-haematin) in vitro (Pandey 
et al. 2003 and Papalexis et al. 2001). HPRIII (Histidine rich protein III) which is a 
homologue of HPRII acts in a similar manner. However, although both HPRII and HPRIII 
genes are present in clinical isolates of P. falciparum, some laboratory strains of P. 
falciparum lack one or the other of the genes. Genetic crosses of these P. falciparum strains 
lacking both genes for HPRII and HPRIII as well as P. vivax and P. berghei which do not 
possess these genes still produce haemozoin crystals as shown in Figure 1.10 (Noland et al. 
2003 and Sullivan et al. 2002), thereby suggesting that this protein is unlikely to be primarily 
responsible for haemozoin formation in vivo. 
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Figure 1.10. P. falciparum clones lacking HRPII (A) and HRPIII (B) and both HRP II & III (C) or having both 
HRP II & III (D) gene still produce haemozoin crystals in vivo. The scale bar is 300 nm for all images. 
Reprinted from Sullivan, D. J. Theories on malarial pigment formation and quinoline action. Int. J. Parasitol. 
2002, 32, 1645-53. 
 
Later, Jani et al. (2008) proposed the haem detoxification protein (HDP) as a novel malaria 
parasite protein responsible for converting free haem to haemozoin crystals in vivo. This 
study also showed using powder X-ray diffraction, scanning electron microscopy (SEM) and 
TEM that the haemozoin crystals produced with HDP were spectroscopically and 
morphologically similar to that of β-haematin and that they crystallized in the same space 
group as haemozoin. Orthologues of HDP have been identified in several other Plasmodium 
species (Carlton et al. 2002 & Protozoan genomes, 2008) while its homologues have been 
identified in the genomes of Theileria (Pain et al. 2005), Babesia (Protozoan genomes, 2008) 
and Toxoplasma gondii (Kissinger et al. 2003). The overall sequence identity of HDP was 
15% with respect to all other related HDP proteins and 60% with those of the Plasmodium 
genus. HDP was found to bind very strongly to haem (Kd = 80 nM) with 2.7 haem binding 
sites. Testing of the ability of recombinant HDP to mediate β-haematin formation showed 
that it converted about 50% of haematin to β-haematin in a concentration dependent manner, 
BA
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with most of the product formed within 20 min (Jani et al. 2008). On the other hand, HDP has 
been shown not to have any N-terminal signal sequence which normally predicts possible 
transport of proteins to their target site (Marti et al. 2004 & Hiller et al. 2004). Jani et al. 
(2008) also reported that HDP produced by P. falciparum is exported and concentrated in the 
RBC cytoplasm during the early stage of parasite infection of the RBC and is trafficked 
together with haemoglobin via cytostome derived structures to the parasite digestive vacuole 
where it becomes functional in the haemozoin formation process. Recently, a protein 
complex of about 200 kDa was proposed to be responsible for the conversion of haemoglobin 
to haemozoin in vivo (Chugh et al. 2012). This protein complex consists of falcipain 2/2′, 
plasmepsin II, plasmepsin IV, HAP, falcilysin and HDP which were all reported to be 
associated with the haemozoin crystal in vivo as represented in the schematic diagram in 
Figure 1.11A. HDP and falcipain 2 were reported to interact strongly with one another in this 
protein complex and to directly associate with the haemozoin crystal. This interaction was 
shown to be necessary for haemoglobin conversion to β-haematin as neither of them could 
mediate the conversion of haemoglobin to β-haematin alone in vitro (Chugh et al. 2012). 
HDP was reported to be thermostable (Jani et al. 2008) as heating of this protein in the 
falcipain 2/HDP complex did not affect the in vitro β-haematin formation activity of the 
complex. Chugh et al. (2012) reported HDP to be about 1000 times more efficient in 
mediating β-haematin formation than previously reported lipids (Pisciotta et al. 2007 & Fitch 
et al. 1999). However, a previous study using about 10 million sucrose purified trophozoites, 
corresponding to about 10 nmol of haemozoin for protein separation and identification on a 
12% SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis) stained with 
Coomassie brilliant blue (Figure 1.11B) (Pisciotta et al. 2007), did not identify any proteins 
associated with haemozoin crystals isolated from parasites (Pisciotta et al. 2007) calling into 
question the proposed role of the protein complex, or suggesting that it is present in only very 
small quantities. 
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Figure 1.11. A. Schematic representation of the protein complex associated with haemozoin (Hz) in vivo 
claimed to be responsible for the conversion of haemoglobin to haemozoin in the parasite digestive vacuole as 
proposed by Chugh et al. (2012). Reprinted from Chugh, M., Sundararaman, V., Kumar, S., Reddy, V.S., 
Siddiqui, W.A., Stuart, K.D. & Malhotra, P. Protein complex directs hemoglobin-to-hemozoin formation in 
Plasmodium falciparum. Proc. Natl Acad. Sci. U S A. 2013, 110, 5392-7. B. 10 nmol of Hz crystals used for 
protein separation on a 12% SDS-PAGE gel stained with Coomassie blue failed to identify any protein 
associated with Hz, while there was an abundance of proteins in the trophozoite extract (T). Reprinted from 
Pisciotta, J. M., Coppens, I., Tripathi, A. K., Scholl, P. F., Shuman, J., Bajad, S., Shulaev, V. and Sullivan, D. J. 
The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization. Biochem. J. 2007, 402, 
197-204. 
 
1.6.2 Lipids 
Dorn et al. (1995) reported β-haematin formation to be mediated by parasite extract as well as 
haemozoin crystals from parasites where they showed that heating the parasite extract or 
haemozoin crystals as well as the presence of proteases do not affect in vitro β-haematin 
formation activity. In response to this, Bendrat et al. (1995) were the first to suggest that 
lipids were responsible for the activity of the parasite extract and of haemozoin formation. 
This allowed the process of β-haematin formation by haemozoin and pre-formed β-haematin 
to be developed further, eventually even leading to high-throughput screening of compounds 
for haemozoin/β-haematin inhibition activity (Kurosawa et al. 2000 & Chong et al. 2003). 
Later on, Dorn et al. (1998) showed that the acetonitrile extracts from both trophozoite 
infected and uninfected RBCs promote β-haematin formation in vitro (Dorn et al. 1998). The 
chloroform extract from parasites recovered about 70% of β-haematin mediating activity 
thereby supporting the role of lipids in mediating this process of β-haematin formation. Fitch 
et al. (1999) then showed that mono- and dioleoylglycerols were efficient in mediating β-
haematin formation as well as some detergents too. It was reported that cholesterol and 
trioleoylglycerol as well as saturated fatty acids such as palmitic and stearic acid did not 
mediate β-haematin formation in vitro (Fitch et al. 1999). TEM studies of P. falciparum-
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infected erythrocytes (iRBC) by Pisciotta et al. (2007) showed that lipid particles were 
closely associated with haemozoin crystals in the parasite digestive vacuole (Figure 1.12A). 
These were mainly mono- and diacylglycerols and a series of mono-, di- and triacylglycerols 
which were shown to promote the formation of β-haematin in vitro under physiological 
conditions of 37°C and pH 4.8 (Pisciotta et al. 2007). Analysis by global mass spectrometry 
lipidomics of these lipids identified monopalmitic glycerol and monostearic glycerol to be 
closely associated with haemozoin, but not monooleic glycerol. The lipid structures 
associated with haemozoin crystals in the digestive vacuole were found to consist of 
monostearic glycerol (MSG), monopalmitic glycerol (MPG), dipalmitic glycerol (DPG), 
dilinoleic glycerol (DLG) and dioleic glycerol (DOG) (MSG/MPG/DPG/DLG/DOG) in the 
ratio 4:2:1:1:1 by volume which was referred to as neutral lipid blend (NLB) (Pisciotta et al. 
2007).  
 
 
Figure 1.12. TEM of iRBC stained with malachite green showed haemozoin inside the parasite DV to be 
associated with lipid structures (A) and scanning electron microscopy of sucrose purified haemozoin from 
parasites fixed with malachite green also showed lipid surrounding it (C, D & E) while delipidated Hz showed 
little or no lipid around the Hz crystal (F & G). Scale bar represents 1µm. Reprinted from Pisciotta, J. M., 
Coppens, I., Tripathi, A. K., Scholl, P. F., Shuman, J., Bajad, S., Shulaev, V. and Sullivan, D. J. The role of 
neutral lipid nanospheres in Plasmodium falciparum haem crystallization. Biochem. J. 2007, 402, 197-204. 
. 
Egan et al. (2006) and others have extensively demonstrated that neutral lipids and NLB 
efficiently mediate β-haematin formation under biomimetic conditions (Hoang et al. 2010 a, 
b & Egan et al. 2006). De Villiers et al. (2009) showed using grazing incidence synchrotron 
X-ray diffraction and X-ray reflectivity that the neutral lipid 1-myristoyl-glycerol (MMG) 
nucleates formation of β-haematin crystal which float on their {100} faces. It was proposed 
to be aided by stereospecific interactions between the OH group of MMG and the β-haematin 
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crystal nucleation face. Furthermore, Egan et al. (2006) showed MMG, monooleoylglycerol, 
1,3-dimyristoylglycerol, 1,3-dioleoylglycerol, trioleoylglycerol, 1,2-dioleoyl-glycero-3-
phosphoethanolamine, 1,2-dimyristoyl-glycero-3-phosphocholine, 1,2-dioleoyl-glycero-3-
phosphocholine, cholesterol, 1,2-dipalmitoyl-glycero-3-phosphocholine and n-octyl-b-D-
glucopyranoside to all promote β-haematin formation in vitro. The nucleation of β-haematin 
by epitaxial crystal growth on a lipid such as a phospholipid was proposed to occur as a result 
of the interaction between the carboxylic acid groups of haematin emerging from the {100} 
face and the lipid polar head groups (Egan, 2008) as shown in a schematic representation in 
Figure 1.13.  
 
 
Figure 1.13. Interaction of carboxylic acid groups of haematin with polar head groups of phospholipid proposed 
to induce nucleation of β-haematin via its {100} face. Reprinted from Egan, T. J. Recent advances in 
understanding the mechanism of hemozoin (malaria pigment) formation. J. Inorg. Biochem. 2008, 102, 1288-
1299. 
 
S. mansoni and R. prolixus are also known to produce regularly-shaped haemozoin crystals 
which crystallize in the same unit cell as that of haemozoin from P. falciparum. However, 
even though in these organisms the haemozoin crystals are produced extracellularly in the gut 
and not intracellularly as with P. falciparum, TEM imaging has also shown that haemozoin 
crystals are closely associated with hydrophobic lipid droplet-like structures or vesicles 
(Oliveira et al. 2005) as shown in Figure 1.14. Lipid droplet-like particles associated with 
haemozoin in the gut of S. mansoni appeared not to have a phospholipid bilayer membrane 
structure whereas the lipid vesicles derived from perimicrovillar membranes associated with 
haemozoin in R. prolixus are hollow and have a phospholipid bilayer membrane. 
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Figure 1.14. TEM of haemozoin crystals associated with lipid structures in the gut of S. mansoni (A, B) and R. 
prolixus (C, D). “L” marks lipid droplet structures and the arrow in (B) shows the absence of a bilayer 
membrane in the lipid structure associated with haemozoin in S. mansoni. Phospholipid bilayer membrane can 
be seen in the lipid vesicle structures associated with haemozoin in R. prolixus as shown in the insert in (D). 1, 2 
& 3 represent respectively the initial, intermediate and final developmental stages of the crystals in these 
organisms. Reprinted from Oliveira, M. F., Kycia, S., Gonzales, A., Kosar, A. D., Bohle, D. S., Hempelmann, 
E., Menezes, D., Vannier-Santos, M., Oliveira, P. L. & Ferreira, S. T. Structural and morphological 
characterization of hemozoin produced by Schistosoma mansoni and Rhodnius prolixus. FEBS Lett. 2005, 579, 
6010-6016. 
 
A recent report by Huy et al. (2013) showed phospholipids to be efficient in mediating β-
haematin formation under physiological conditions of temperature (37°C) and pH 4.8 in 50 
mM acetate buffer. Dilauroyl-phosphatidylcholine and dioleoyl-phosphatidylcholine were 
shown to be the most efficient mediators of β-haematin under these conditions with about 70-
80% conversion rate of haematin to β-haematin at low molar concentrations (Huy et al. 
2013). Dimyristoyl-phosphatidylcholine was found to have a lower β-haematin conversion 
rate with a maximum of about 30-40% at slightly higher concentrations while dipalmitoyl- 
phosphatidylcholine, distearoyl-phosphatidylcholine, dimyristoyl- phosphatidylethanolamine, 
dipalmitoyl- phosphatidylethanolamine, and dipalmitoyl- phosphatidylserine were shown not 
to have any β-haematin formation activity under these conditions (Huy et al. 2013). However, 
all the above phospholipids were shown to induce β-haematin formation to different extents 
at temperatures higher than their respective Tm (gel-to-fluid transition temperature) but not 
below their Tm. The ability of the phospholipids to induce β-haematin formation was found to 
be statistically correlated negatively with their Tm only but not with any other physical 
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properties of the phospholipids such as molecular weight, total net charge, freely rotating 
bonds, polar surface area, hydrogen bond donors, octanol-water partition coefficient, 
distribution coefficient at pH 5.5, hydrogen bond acceptors, number of anion charges and 
polarizability (Huy et al. 2013). The maximum yield of β-haematin obtained with each 
phospholipid positively correlates with the temperature of the reaction system which further 
suggests that the ability of an individual phospholipid to mediate the reaction of β-haematin 
correlates with its membrane fluidity (Huy et al. 2013). 
 
Recent TEM studies of iRBC in the Egan laboratory (unpublished) showed regular-shaped 
haemozoin crystals formed in the P. falciparum digestive vacuole which are aligned parallel 
to each other (Figure 1.15) even though no clear visible lipid droplet was seen associated with 
the haemozoin crystal despite fixing the iRBCs with malachite green. A report by 
Kapishnikov et al. (2012a) has argued that if the haemozoin crystals in the parasite digestive 
vacuole were located within NLB, it would have been difficult for them to be aligned in one 
direction in such a cluster. They went on to suggest that this alignment maybe due to face-
oriented nucleation which causes the crystals to become aligned to one another due to 
contact. With the use of 3D serial surface view microscopy, the DV of the malaria parasite 
was observed to change from a disk-like to an oval shape as the parasite matures from early 
trophozoite to schizont stages with the larger haemozoin crystals located at the centre while 
the smaller haemozoin crystals were aligned close to the inner membrane surface of the DV. 
This was clearly illustrated using cryo-x-ray tomographic (cryo-XT) reconstruction from the 
3D EM image (Figure 1.15B). The alignment of smaller haemozoin crystals on the inner 
membrane surface of the digestive vacuole was consistent with those viewed using cryo-SEM 
(Figure 1.15C) with STEM tomographic reconstructed of the DV clearly showing haemozoin 
crystals are aligned along the DV inner membrane (Figure 1.15D). This alignment was 
reported to be suggestive of some kind of nucleation at that surface (Kapishnikov et al. 2012 
b).  
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Figure 1.15. A: TEM image of iRBC stained with malachite green showed Hz crystals inside the DV aligned 
parallel to one another. B: Cryo-XT of late stage trophozoite with larger haemozoin crystals in the middle and 
smaller ones aligned along the inner DV membrane. C: Cryo-SEM of an early trophozoite with haemozoin 
crystals aligned along the DV inner membrane. D: Haemozoin crystals (yellow arrows) aligned to the DV inner 
membrane as seen using STEM tomographic reconstruction. B, C & D are reprinted from Kapishnikov, S., 
Weiner, A., Shimoni, E., Guttmann, P., Schneiderc, G., Dahan-Pasternakd, N., Dzikowski, R., Leiserowitz, L. 
and Elbaum, M. Oriented nucleation of hemozoin at the digestive vacuole membrane in Plasmodium falciparum. 
Proc. Natl Acad. Sci. USA. 2012b, 109, 11188–11193. 
 
1.6.3 Solvent, detergent and buffer systems 
Solvents have been shown to influence the relative growth rates of crystals along different 
crystallographic axes, although much is not known concerning the exact role a particular 
solvent plays in inhibiting or enhancing crystal growth (Weissbuch et al. 1995). Benema and 
others (Bennema et al. 1973 & 1992, Bourne et al. 1976 & Elwenspoek et al. 1987) proposed 
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that the interaction of solvent and solute on a specific crystal surface is favourable when it 
leads to a transition from smooth to rough interface, thereby causing the crystal to grow faster 
on that surface while on the other hand, adsorption of solvent on a crystal surface may also 
inhibit growth of that surface since additional energy is required to remove the bound solvent. 
Thus an energy barrier is created by the adsorbed solvent on the crystal surface. When Fitch 
et al. (1999) demonstrated fatty acid and lipid mediation (arachidonic, linoleic, oleic, and 
palmitoleic acids, 1-mono and di-oleoylglycerol) in β-haematin formation, they also showed 
that detergents such as Tween 80, SDS (sodium dodecyl sulfate) and n-octyl-glucopyranoside 
promote β-haematin formation at physiologically relevant temperature (37°C) after 2 h 
incubation. With regard to β-haematin formation in homogenous solvent systems, Egan et al. 
(2001) showed using IR absorbance that the crystal growth kinetics of β-haematin formation 
in this kind of system was sigmoidal and can be modelled by the Avrami equation (Equation 
1). 
 
[m/m0= exp(‒zt
n
)]........................................................... (1) 
 
m: mass of the unreacted haematin,  
mo: initial mass of haematin,  
t: reaction time,  
z: rate constant,  
n: Avrami constant which can either be 1,2,3 or 4.  
 
In this study, the Avrami constant for β-haematin formation in acetate buffer at 60oC was 
found to be four, indicating a sporadic nucleation process and three dimensional crystal 
growth (Egan et al. 2001). Results in this study were later reproduced spectrophotometrically 
using 0.05 M benzoic acid/benzoate (pH 4.5, 60 
o
C) to promote the reaction and using 5% 
pyridine to measure unreacted haematin (Egan and Tshivhase, 2006). It was suggested from 
these studies that π-π interaction between the carboxylic acid and Fe(III)PPIX at low pH 
solubilises the Fe(III)PPIX, keeping it in the dissolved state and thereby aiding its conversion 
to β-haematin. Egan et al. (2006) further showed clearly the formation of β-haematin crystals 
at pentanol-water and octanol-water interfaces (Figure 1.16E). Water miscible alcohols such 
as n-butanol, n-propanol, ethanol and methanol have also been reported to mediate the 
formation of β-haematin (Figure 1.16A-D) and it was shown that the efficiency with which 
they promote β-haematin formation was proportional to their hydrophobicity (Huy et al. 
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2007), which in this case correlated with their chain length. The hydrophobicity of the 
alcohols again helps to maintain the Fe(III)PPIX in the dissolved state so as to facilitate it 
conversion to β-haematin. 
 
 
Figure 1.16. Field emission scanning electron microscopy showed β-haematin crystals produced with methanol 
(A), ethanol (B), n-propanol (C) and n-butanol (D). Image scale bar represents 1.5µm. Reprinted from Huy, 
N.T., Maeda, A., Uyen, D.T., Trang, D.T., Sasai, M., Shiono, T., Oida. T., Harada, S. & Kamei, K. Alcohols 
induce beta-hematin formation via the dissociation of aggregated heme and reduction in interfacial tension of 
the solution. Acta Trop. 2007, 101, 130-138. SEM showed β-haematin crystals produced at the octanol-water 
interface (E) to be similar to haemozoin crystals isolated from parasites. (i) and (ii) are respectively larger and 
smaller crystals indicated with arrows. Scale bar represents 1µm. Reprinted from Egan, T.J., Chen, J.Y-J., de 
Villiers, K.A., Mabotha, T.E., Naidoo, K.J., Ncokazi, K.K., Langford, S.J., McNaughton, D., Pandiancherri, S., 
Wood, B.R. Haemozoin (β-haematin) biomineralization occurs by self-assembly near the lipid/water interface. 
FEBS Lett. 2006, 580, 5105–5110. 
 
The importance of solubilization of Fe(III)PPIX to facilitate β-haematin formation has gained 
strong support from other related studies where aqueous DMSO (dimethyl sulfoxide) and 
several polyethylene glycols (PEG 3350, PEG 6000, PEG 8000 and PEG 22 000) have been 
used to prepare β-haematin crystals (Stiebler et al. 2010b). The rate of β-formation was found 
to be proportionate to Fe(III)PPIX solubility in these systems. The formation of β-haematin 
in these systems again followed the Avrami kinetics equation with most of them having an 
Avrami constant of four. 
 
 β-Haematin has also been shown to grow on self-assembled monolayers (SAM) of the form 
HS(CH2)11X with nucleation of crystal growth induced via the {100} face when X=OH and 
via {100} or {010} face when X=CH3 although more preferably on the {010} face in the 
latter. Nucleation was induced via both {100} and {010} when X=COOH (de Villiers et al. 
2009). Unlike β-haematin formation on SAMs as reported by de Villiers et al. (2009) in a 
non-aqueous environment, a similar study of SAMs with HS(CH2)15COOH but this time in 
the presence of aqueous propionic acid over 48 h gave 100% surface coverage and was found 
to nucleate β-haematin via its {100} face (Wang et al. 2010). The nucleation by 
HS(CH2)15COOH SAM in this case was proposed to be brought about as a result of 
interaction between the COOH group of the SAM and π‒π dimers of haematin. These then 
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converted to µ-propionate dimers, therefore nucleating β-haematin crystal formation as 
illustrated in Figure 1.17. 
 
 
Figure 1.17. The interaction between the COOH group of a HS(CH2)15COOH SAM and β-haematin as proposed 
by Wang et al. (2010). Reprinted from Wang, X., Ingall, E., Lai, B. & Stack, A. G. Self-assembled monolayers 
as templates for heme crystallization. Cryst. Growth Des. 2010, 10, 798-805. 
 
Carter et al. (2010) showed that detergents such as Tween 80, Tween 20 and NP40 are 
efficient in promoting β-haematin formation giving yields of about 74%. On the other hand, 
detergents such as Triton X-100, SDS and Chaps were reported not to be efficient in 
mediating β-haematin formation as only yields of about 10% could be obtained using these 
detergents. However, Huy et al. (2007b) has shown using Tween 80 that when detergents are 
below their critical micellar concentration, they can efficiently promote β-haematin 
formation. 
 
1.7 THE HAEMOZOIN FORMATION PROCESS AS A TARGET FOR 
ANTIMALARIAL DRUGS 
Although the effects of antimalarials on haemozoin formation are not a focus of this current 
study, no discussion of haemozoin is complete without some mention of haemozoin 
inhibition by antimalarials. Therefore a brief review is provided here. 
 
As early as the 1960s, Cohen et al. (1964) showed that chloroquine forms a complex with 
haematin and its effect was demonstrated in vivo in a malaria mouse model (Macomber et al. 
1967). Later, haematin was proposed to be the target of this antimalarial drug (Chou et al. 
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1980). Since then, evidence of chloroquine inhibition of Fe(III)PPIX conversion to 
haemozoin has accumulated over the years (Egan, 2006 review, Chong et al. 2003 and Scholl 
et al. 2005) but its exact mode of action is still not fully understood. Different modes of 
interaction between the haemozoin crystal and antimalarial quinoline drugs have been 
proposed. Slater and Cerami (1992) proposed that chloroquine exhibits its antimalarial 
activity by inhibiting the supposed ‘haem polymerase’ activity of the enzyme responsible for 
haemozoin formation in vivo. Sullivan et al. however proposed that the drug acts by being 
adsorbed onto what was then believed to be a growing polymer chain thereby interfering with 
the process of haemozoin crystal growth (Sullivan et al. 1996 and 1998). Dorn et al. (1998) 
further showed that antimalarial drugs belonging to the quinoline family bind directly to the 
monomer or dimers of Fe(III)PPIX in solution. The 4-aminoquinoline nucleus of these 
compounds was confirmed to be responsible for complex formation with haematin in solution 
(Egan et al. 1997 & Dorn et al. 1998). Following the revelation of the dimeric, not polymeric 
structure of haemozoin (Pagola et al. 2000) some of the proposed mechanisms of action of 
quinoline drugs based on the formerly proposed structure, such as its ability to inhibit 
haemozoin polymerization activity in vivo (Slater et al. 1992) were therefore no longer 
considered valid and such mechanisms would need further assessment and explanation in 
terms of the new structure. Furthermore, Pagola et al. (2000) noted that haematin was by far 
in molar excess over chloroquine and it would be difficult therefore to imagine inhibition of 
the haemozoin formation process by a stoichiometric mechanism. However, Sullivan et al. 
proposed that the haematin-chloroquine complex binds to haemozoin, thereby preventing the 
crystal from growing further. This brought into question whether haematin or haemozoin is 
the target for chloroquine. Egan et al. (2000) showed the 4-amino group in chloroquine to be 
essential for both haematin binding and haemozoin inhibition but that the 7-chloro group was 
required only for haemozoin inhibition, suggesting that solution binding and inhibition are 
not directly coupled. Recently, Combrinck et al. (2012) unequivocally showed direct 
evidence of the inhibition of cellular haemozoin formation in vivo by chloroquine in a dose-
dependent fashion. Artesunate, amodiaquine, lumefantrine, mefloquine, and quinine were 
also shown to have similar but smaller effects, the importance of which remains to be fully 
investigated (Combrinck et al. 2012). Buller et al. (2002) previously reported that 
chloroquine, amodiaquine, quinine and mefloquine each protonated at the exocyclic amine 
can bind to the {001} face of the growing β-haematin crystal. The stereochemical binding of 
these quinoline derivatives to the fastest growing crystal face is through the formation of salt 
bridges between the porphyrin propionates of β-haematin and amine of quinoline while the 
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quinoline rings are sandwiched between the aromatic groups of β-haematin as clearly 
illustrated with chloroquine in Figure 1.18 (Buller et al. 2002). 
 
 
Figure 1.18. In panel I, β-haematin viewed perpendicular to the {100} face along the a-axis showed how 
chloroquine capped the fastest growing {001} face (outlined in green). Panel II showed structures of some 
antimalarial quinoline drugs. Reprinted from Buller, R., Peterson, M. L., Almarsson, O. & Leiserowitz, L. 
Quinoline Binding Site on Malaria Pigment Crystal:  A Rational Pathway for Antimalarial Drug Design. Cryst. 
Growth Des. 2002, 2, 553-562. 
 
1.8 STUDIES OF BIOMINERALIZATION PROCESS IN OTHER ORGANISMS 
Given the fact that haemozoin formation is now recognized to be a form of biomineralization, 
it is worth considering how other organisms bring about biomineralization. By so doing, it 
will help in understanding general strategies used to study other biominerals to identify 
biomolecules that are directly involved in their formation. Such strategies may also be used to 
study haemozoin in order to identify protein(s) or other biomolecules that are directly 
involved in its formation in vivo.  
Well-organized inorganic minerals formed in a biological environment in a three dimensional 
(3D) framework with an organic matrix are known as biominerals. Biomineralization 
involves the organization of this 3D structural framework by the organic material which 
provides crystal nucleation sites and compartments which contain molecules that determine 
the crystal shape and mineral polymorphism as well as crystallization inhibitors for the 
termination of crystal growth (Addadi et al. 1992, Weiner et al. 1997 and Wilt et al. 2005). 
I
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Living organisms are known to produce such well-organized 3D composite structures 
consisting of bioorganic molecules and inorganic ions ranging from nano- to macroscopic 
scale (Mann et al. 1996, Addadi et al. 1997 and Pouget et al. 2007). The haemozoin crystal, 
with its well established structure (as discussed above) is no exception and is formed via a 
complex biomineralization process in the digestive vacuole of the malaria parasite and in 
other blood-feeding organisms.  
Lipids are known to be involved in some biomineralization processes in different unrelated 
organisms. For example, in E. huxleyi algae the formation of the biocrystal coccoliths is 
known to be lipid mediated (Young et al. 1999). The cellular cytoskeletal elements found in 
the crystallization compartment are known to control the crystal shape by controlling the 
shape of the phospholipid vesicle. In vertebrates, lipid vesicles and protein aggregates are 
known to be the site of crystal growth initiation. For example, growing dentine in humans is 
known to contain a non-cellular phospholipid vesicle (matrix vesicle) which serves as the 
calcification initiation site (Anderson et al. 1995). Phospholipase enzymes, calcium-binding 
phospholipids and proteins and calcium ion channels also play a role in this biomineralization 
process. Nucleation here occurs at the inner membrane surface of the vesicle aided by 
structural and chemical complementarity between an assembly of phospholipids and protein 
of the matrix vesicle and the mineral phase. In magnetotactic bacteria, magnetite is 
encapsulated in a lipid bilayer bounded vesicle (Komeili et al. 2007). The templating effect of 
the lipid vesicle is known to have a high level of control over the crystallization process. It is 
therefore evident in all the above organisms that lipid can provide an organic phase for 
nucleation to occur aided by stereochemical and electrostatic complementarity between the 
lipid surface and growing inorganic crystal phase. 
On the other hand, proteins have also been implicated in biomineralization processes in many 
unrelated organisms. Use of SDS-PAGE and nano LC-MS/MS to study the human bone 
matrix proteome identified over 70% of the proteins expressed by osteoblasts to be present in 
the tissue that they produce. Interestingly, the ANXA2, ANXA6, and ANXA5 proteins, 
ranked amongst the twenty most abundant proteins identified in this study, have been 
reported to be highly concentrated in matrix vesicles, initiators of mineralization, where they 
function as calcium channels. Thus, the study of bone matrix proteome led to the 
identification of proteins that are functionally linked to mineralization and mineral 
metabolism in high abundance (Alves et al. 2011). Proteomic studies of sea urchin shells and 
spines using SDS-PAGE and MS/MS techniques also led to the identification of many 
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proteins including matrix metalloproteins and proteins belonging to the mesaenchyma-
specific MSP130 family implicated in biomineralization. These had been previously 
described in inhibition studies using antibodies or specific enzyme inhibitors. The proteomic 
study also showed that the matrices did not only contain previously known or supposed 
specific matrix components, but also proteins possibly involved in the regulation of mineral 
or matrix formation (Karlheinz et al. 2008). Study of the bacterial magnetic protein (BacMP) 
membrane proteome from the magnetic bacteria Magnetospirillum spp. that produces 
magnetic particles (magnetite) through a biomineralization process led to the discovery and 
identification of a novel protein named Mms6, which was characterized and found to bind to 
iron ions to initiate magnetite crystal formation and/or to regulate the morphology by 
producing a self-assembly framework structure (Arakaki et al. 2008). In another study of 
shell matrix proteome from Manila clams Venerupis philippinarum using SDS-PAGE and 
LC-MS/MS, six novel proteins that are conserved within different mollusc and cnidarian 
species were identified. Bioinformatic characterization of these proteins found them to have a 
new function in calcium carbonate formation and hence a direct involvement in the 
biomineralization process (Marie et al. 2011). Similar proteomic studies of the proteomes of 
other biomineral matrices like the radular teeth in the giant pacific chiton (Nemoto et al. 
2012) and the chicken egg shell proteome using SDS-PAGE and LC-MS techniques (Mann et 
al. 2006) have led to the identification of the proteins involved in the biomineralization 
processes. Therefore, it is evident that proteomic studies of the matrix of biominerals in many 
diverse species have invariably led to the identification of the proteins involved in the 
biomineralization process. 
The identification of the proteins involved in the biomineralization process of haemozoin in 
the DV using an ‘omics’-related approach has not been attempted. Since proteomic studies of 
biomineral matrix proteomes in other organisms where biomineralization occurs has 
invariably led to the identification of the proteins involved in the biomineralization process, 
such an approach could be of great value. The availability of the complete genomic 
sequences of both P. falciparum and H. sapiens permits the use of proteomic techniques 
combined with lipidomic techniques to study the haemozoin crystal in order to identify and 
characterize biomolecules that could be implicated in its formation. Such biomolecules could 
themselves serve as potential targets for antimalarial drug design. 
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1.9 THE Plasmodium falciparum DIGESTIVE VACUOLE PROTEOME 
The biomineralization process of Hz formation is compartmentalized to the parasite DV. So 
any proteins that are involved in mediating this process must be present in the DV. Hence, it 
is relevant to review what is known about the DV proteome. 
 
The main protein in RBC, haemoglobin, is digested in the DV by a series of enzymes present 
in the DV to provide the parasite with amino acid needed as nutrients. The ingestion of 
haemoglobin via a specialized structure called a cytostome occurs together with parasite 
plasma membrane and the parasitophorous vacuole (Slomianny et al. 1990 & Elliott et al. 
2008). The cytostome eventually fuses with the lysosome-like single membrane bound DV. 
Enzymes involved in haemoglobin digestion have been localized in the DV and these include 
the plasmepsins (PM) PMI, PMII, PMIV and HAP (Goldberg et al. 1991, Gluzman et al. 
1994, Francis et al. 1994, Banerjee et al. 2002, Dame et al. 2003). Falcipain 2 and 3 (cysteine 
proteases), falcilysin (metallo-protease) and aminopeptidases which all act downstream in the 
haemoglobin digestion process are all known DV proteins (Sijwali et al. 2004, Dahl et al. 
2005, Klemba et al. 2004, Murata et al. 2003).  
 
Lamarque et al. (2008) has extensively studied the DV using SDS-PAGE and LC-MS 
techniques to identify the full proteome of this structure. Besides the known DV proteins that 
are involved in haemoglobin digestion that were identified, other proteins involved in key 
processes in the parasite were also identified. The chloroquine resistance transporter, 
multidrug resistance transporter, V-type H
+
-ATPase, H
+
-pyrophosphatase and three other 
ATP synthases listed as putative proteins in PlasmoDB were identified together with other 
known DV proteins (Lamarque et al. 2008). ADP-Ribosylation Factor, GTPase Sar1, p24 and 
GTPases Rab1, Rab2, Rab7 and Rab11 and many others which are involved in vesicle 
trafficking, assembly, docking and fusion were identified, suggesting the existence of protein 
trafficking pathways in the parasite (Lamarque et al. 2008). Hexose transporter 1, nucleoside 
transporter 1 and aquaglyceroporin located in parasite plasma membrane and Exp1and Exp2 
localized in the parasitophorous vacuole were also identified. This suggested that proteins 
derived from these structures are trafficked with them together with haemoglobin to the DV 
(Lamarque et al. 2008). Enzymes involved in basic metabolic processes such as 
glyceraldehyde-3-phosphate dehydrogenase, fructose biphosphate aldolase, phosphoglycerate 
kinase were identified. So too were methionine and polyamine metabolism enzymes 
(adenosyl-methionine synthetase, adenosylhomocysteinase) as well as those involved in 
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purine salvage and pyrimidine base metabolism (Lamarque et al. 2008). This suggests a 
mechanism exists by which these proteins are trafficked from parasite cytoplasm into the DV. 
Chaperones such as mitochondrial HSP60, ER-resident calcium-binding protein and protein 
disulfide isomerase, three other putative proteins belonging to the HSP70 family described in 
PlamsoDB with putative roles in clathrin-dependent traffic that may play a part in cytostome 
formation and many others were identified (Lamarque et al. 2008). See Lamargue et al. 
(2008) for a complete list of proteins that consist of the DV proteome.  
  
Seemingly, amongst all the known proteins identified including putative proteins for which 
functions were assigned, it would have been expected that proteins which are likely to be 
involved in the biomineralization process of haemozoin formation inside the DV would also 
be identified. Of those proteins previously implicated in haemozoin formation in vivo only 
proteases, falcipain 2/2′, plasmepsin II, plasmepsin IV and HAP which have been implicated 
in the proposed protein complex with HDP were detected in the DV (Lamarque et al. 2008). 
However, HDP itself was not detected in the DV and nor were HRPII or HRPIII. The 
question remains as to whether small amounts of HDP may be able to be detected in 
association with haemozoin owing to an affinity to the crystal arising from involvement in its 
formation. 
 
1.10 AIMS AND OBJECTIVES 
Keeping in mind the challenges faced by many developing countries in combating malaria 
and the widespread resistance to many of the current antimalarial drugs available, elucidating 
the mechanism of haemozoin formation is of considerable interest and could eventually open 
up new avenues for drug discovery as new potential antimalarial drug targets could be 
identified. This study was therefore designed to achieve the aims and objectives stated below.  
 
1.10.1 Aims 
The three aims of this study were as follows: 
 
1. To study the proteome and lipids associated with haemozoin crystals in order to 
identify potential biomolecules that are involved in mediating the biomineralization 
process of haemozoin formation in vivo. 
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2. To systematically investigate the kinetics of synthetic haemozoin (β-haematin) 
formation mediated by the previously identified neutral lipid blend (NLB) under 
biomimetic conditions mimicking the parasite digestive vacuole (DV). 
3. To study the nucleation of β-haematin crystals at the surface of NLB for comparison 
with haemozoin and to evaluate the direct effect of chloroquine on haemozoin crystal 
growth in the malaria parasite.  
 
1.10.2 Specific objectives 
To achieve these aims, the specific objectives of this study were follows: 
 
1. To use SDS-PAGE and LC-MS to separate and identify all proteins (proteome) 
associated with haemozoin, both at the crystal surface and in the matrix to determine 
whether any potential haemozoin-mediating proteins could be identified.  
2. To use thin layer chromatography to separate and identify all lipid classes associated 
with the haemozoin crystal. 
3. To investigate the NLB and its individual constituent lipids in mediating β-haematin 
formation.  
4. To investigate the effect of lipid and haematin concentrations on the kinetics of β-
haematin formation. 
5. To investigate the effect of buffers and low molecular weight substances such as the 
ions sodium, potassium, magnesium, calcium, phosphate, carbonate, adenosine 5′-
triphosphate (ATP), reduced glutathione and 2,3-diphospho-D-glycerate (2,3-DPG) at 
concentrations at which they are present in RBC and/or serum on the kinetics of β-
haematin formation under biomimetic condition mimicking those in the parasite 
digestive vacuole  
6. To characterize β-haematin produced with MPG and NLB emulsions prepared in 
different ways as well as at the pentanol-water interface and compare them to 
haemozoin crystals isolated from malaria parasite itself using TEM and TEM-electron 
diffraction.  
7. To investigate the nucleation and location of β-haematin crystals formed with respect 
to NLB particles, the nature and structure of neutral lipid blend emulsions and also if 
there is any relationship between the size of lipid particles formed and β-haematin 
crystal growth lengths.  
8. To investigate the effect of chloroquine on haemozoin crystals in parasite cells. 
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2. MATERIALS, INSTRUMENTATION AND GENERAL METHODS 
 
2.1 MATERIALS 
All the materials used in this study were of the highest commercial grade available and no 
further purification was done before they were used. 
 
2.1.1 Solid materials (salts and powders) 
Solid materials excluding stains used in this study are listed in Table 2.1. 
 
Table 2.1. List of solid materials used in this study. 
 Material Commercial supplier 
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) Avanti Polar Lipids, 
Alabaster, USA 
rac-1-Monopalmitoylglycerol (MPG) Sigma-Aldrich 
rac-1-Monostearoylglycerol (MSG) Sigma-Aldrich 
1,3-Dipalmitoylglycerol (DPG) Sigma-Aldrich 
Citric acid monohydrate Sigma-Aldrich 
4-Morpholineethanesulfonic acid (MES) Sigma-Aldrich 
Adenosine 5′-triphosphate disodium salt (ATP) Sigma-Aldrich 
Phosporus pentoxide Sigma-Aldrich 
Porcine haemin Fluka 
Sodium hydroxide KIMIX 
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) Sigma-Aldrich 
Acetic acid, glacial Sigma-Aldrich 
L-Glutathione reduced Sigma-Aldrich 
2,3-Diphospho-D-glyceric acid pentasodium salt Sigma-Aldrich 
Ammonium persulphate Sigma-Aldrich 
Sodium dodecylsulphate (SDS) Sigma-Aldrich 
Caesium chloride ANALAR 
Chloroquine diphosphate salt Sigma-Aldrich 
Paraformaldehyde  Sigma-Aldrich 
Tanic acid Sigma-Aldrich 
Osmium tetroxide Electron Microscopy 
Sciences-USA 
Phosphate buffered saline (PBS) tablet Sigma-Aldrich 
Saponin Sigma-Aldrich 
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2.1.2 Liquid materials (solvents and suspensions) 
Liquid materials excluding stains used in this study are listed in Table 2.2. 
 
Table 2.2. List of liquid materials used in this study. 
Material Commercial supplier 
1,3-Dilinoleoylglycerol (DLG) Sigma-Aldrich 
1,3-Dioleoylglycerol (DOG)  Sigma-Aldrich 
Pyridine Sigma-Aldrich 
Acetone KIMIX 
Methanol KIMIX 
Diethylether KIMIX 
Chloroform KIMIX 
Ethanol KIMIX 
Pentanol Sigma-Aldrich 
n-Hexane KIMIX 
Nujol (mineral oil) Sigma-Aldrich 
TEMED (tetramethylethylenediamine) Merck 
2-Mercaptoethanol Merck 
Pre-stained Protein ladder Fermentas 
Acetonitrile Fluka 
DNAse I Sigma-Aldrich 
Gluteraldehyde Agar Scientific 
RBC (group O+) obtained from expired blood bank whole blood University of Cape 
Town, teaching hospital 
Spurr’s resin Agar Scientific-UK 
 
 
2.1.3 Stains 
Stains used in this study are listed in Table 2.3. 
 
Table 2.3. List of stains used in this study. 
Material Commercial supplier 
Malachite green Sigma-Aldrich 
Premuline  Sigma-Aldrich 
Silver stain kit Sigma-Aldrich 
Coomassie blue R250 Saarchem 
Lipophilic 3,3’-dioctadecyloxacarbocyanine perchlorate 
fluorescent dye (DiO) 
Molecular Probes 
Uranyl acetate Electron Microscopy 
sciences 
Giemsa azur-eosin methylene blue Merck 
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2.1.4 Accessories and devices  
Accessories and devices used in this study are listed in Table 2.4. 
 
Table 2.4. List of accessories and devices used in this study. 
Material Commercial supplier 
Schott-Duran crystallization dishes Sigma-Aldrich 
Surgical blades Lasec 
Disposable 1 mL syringes and needles  Lasec 
Carbon grids Agar Scientific 
Whatmann filter paper number 1 Lasec 
Filtration device Sigma-Aldrich 
Microscope glass slides Lasec 
Thin glass coverslips Lasec 
Cryo holders Gatan-UK 
Transparent polycarbonate Nalgene centrifuge tubes Sigma-Aldrich 
Quantifoil holey grids SPI Supplies-USA 
250 mL culture flasks Greiner 
NaCl plates PIKE Technologies 
REICHERT ultra-microtome Leica 
 
 
2.1.5 Software  
The SingleCrystal application of CrystalMaker
®
 Software Version 2.2 was used to index 
electron diffraction patterns obtained from β-haematin and haemozoin crystals 
(CrystalMaker
®
 Version 2.2, 2009, Oxford, England). Prism 3 was used to construct all 
graphs and Image J developed at the National Institutes of Health, USA, was downloaded for 
free (http://imagej.en.softonic.com/) and used to invert colours of some β-haematin crystal 
images and electron diffraction patterns taken using TEM for colour consistency. 
 
2.2 INSTRUMENTATION 
 
2.2.1 Light microscopy 
A Laborlux 12 Leitz Light microscope was used to look at thin films of malaria parasites 
prepared on glass microscope slides to determine growth stages of parasites in culture, to 
check if the parasites in culture were growing normally, to check if parasite cultures were 
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infected, to quantify parasitaemia and to count isolated haemozoin crystals on a 
haemocytometer. 
 
2.2.2 UV-Visible spectrophotometry 
UV-Vis spectrophotometry was used to quantify β-haematin formed. The absorption 
spectrum of aqueous Fe(III)PPIX exhibits a weakened and broadened Soret band relative to 
the monomer, a weaker Q band and a weak, but nonetheless prominent, charge transfer band. 
Addition of pyridine to Fe(III)PPIX solution causes the weak Soret band to become sharper 
and more intense with a red shift from 389 to about 404 nm in its absorption spectrum. This 
intense Soret band results from the formation of a low-spin coloured coordination complex of 
pyridine with the Fe(III) centre of Fe(III)PPIX (Ncokazi et al., 2004). The intensity of the 
coloured complex formed obeys the Beer-Lambert law. Thus, the absorbance of the coloured 
complex formed is proportionate to the concentration of free Fe(III)PPIX in the solution. 
Quantification of β-haematin formed for yield determination and for kinetics measurements 
was done using a Varian Cary 100 UV-Visible spectrophotometer to measure absorbance at 
405 nm of the coloured pyridine-Fe(III)PPIX complex. 
 
2.2.3 Fourier Transform Infrared (FT-IR) spectroscopy 
FT-IR spectroscopy was used to characterize β-haematin formed at lipid-water interfaces. 
The resultant absorption/transmission spectrum is unique for each bond type producing a 
molecular fingerprint for each bond type. The IR spectrum of β-haematin or haemozoin has 
peaks at 1662 cm
-1
 and 1210 cm
-1
 corresponding to its unique characteristic C=O and C‒O 
bonds in the crystal respectively. Therefore, dried β-haematin product formed with NLB and 
MPG, was finely ground using a mortar and pestle and prepared as nujol mulls and observed 
on a NaCl plate between 2000 and 1000 cm
-1
 using a Perkin–Elmer Spectrum 100 FT-IR 
spectrometer located in the Department of Chemistry, University of Cape Town. 
 
2.2.4 Water bath  
All β-haematin formation experiments were done at physiological temperature (37°C). A 
YIH DER BL-710 water bath with thermometer to measure the temperature of the water was 
heated to the required temperature before any experiment for β-haematin formation was 
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carried out. An external thermometer was also used to measure the temperature of buffer 
solution in the reaction vessel incubated in the water bath to confirm that they were actually 
heated to the required temperature before any experiment was conducted. 
 
2.2.5 Confocal laser microscopy 
This was used to characterize both β-haematin and NLB droplets formed at the lipid-water 
interface. This instrument measures the fluorescence from a sample. When the laser, which 
acts as the light source, is passed through a sample containing fluorescent molecules at a 
particular wavelength, it causes excitation of the molecules (at the excitation wavelength) 
and, as the excited electron returns to the ground state, it emits energy at a longer wavelength 
(emission wavelength) which can be measured as fluorescence arising from the molecule. β-
Haematin autoflouresces when excited at 516 nm with emission measured between 575–630 
nm. The DiO dye, which was used to stain NLB droplets, fluoresces under conditions of 488 
nm excitation with emission of 500-530 nm. A LSM510-META Zeiss confocal laser 
microscope was used to characterize the β-haematin as a function of time and NLB stained 
with DiO by measuring fluorescence emission with excitation at their respective wavelengths.  
 
2.2.6 Transmission electron microscopy (TEM) 
This was used to characterize β-haematin formed by different methods using different starting 
materials, haemozoin isolated from parasites and also within parasites, NLB droplets formed 
under different conditions and liposome preparations. TEM allows for the visualization of 
structures in the nanometre range with high resolution. The TECNAI TF20 TEM which 
operates at a high voltage of 200 kV further allows for the visualization of elements in 
materials. Thus, the TECNAI TF20 TEM was used to visualize and characterize haemozoin 
inside parasitized RBCs, isolated haemozoin, β-haematin prepared by different methods, lipid 
emulsions formed under different conditions and liposome structures. This instrument was 
also used to obtained electron diffraction patterns from β-haematin and haemozoin crystals. 
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2.2.7 Glow-discharger  
EMS 100X Glow-discharge (Electron Microscopy Sciences-UK) equipment was used to 
glow-discharge carbon-coated grids to make the surface more hydrophilic for materials in 
solution to adsorb on it for imaging using TECNAI TF20 TEM. 
 
2.2.8 pH meter 
This was used to adjust the pH of all solutions to their respective working pH values. All 
buffers used in this study were adjusted to their respective working pH using a CRISON 
Micro pH 2000 pH meter. Standard solutions at pH 4.00 ± 0.01 (Buffer, reference standard, 
B5020) and 7.00 ± 0.01 (Buffer, reference standard, B4770) were used to calibrate the pH 
meter. 
  
2.2.9 Centrifuge 
Centrifugation of all solutions, mixtures or suspensions of volumes greater than 5 mL was 
done using an Eppendorf Centrifuge 5810R while volumes less than 5 mL were centrifuged 
using an Eppendorf Centrifuge 5410.  
 
2.2.10 Weighing balance  
All salts and solid substances used in this study were weighed using an Adventurer
TM
 
OHAUS weighing balance which was regularly calibrated with mass standards. 
  
2.3 GENERAL METHODOLOGY 
 
2.3.1 Parasite culture  
 
 
 
 
41 
 
2.3.1.1 Preparation of solutions  
 
Preparation of 5 % sorbitol solution 
A 5% sorbitol solution was prepared in deionized water (50 g/L). The solution was filtered 
through a 0.22 m filter and stored at 4oC. 
 
Preparation of incomplete culture medium 
This contained 10.4 g/L RPMI 1640 with glutamine but without NaHCO3, 4 g/L glucose, 6 
g/L HEPES (buffer), 0.088 g/L hypoxanthine, 5 g/L Albumax, and 1.2 mL/L (0.05 g/L) 
gentamycin. The medium was pre-filtered with a 0.45 m filter then filter sterilized using a 
0.22 m filter. 
 
Preparation of wash medium 
Wash medium was prepared in the same way as incomplete culture medium but without any 
Albumax. 
 
Preparation of complete culture medium 
To the incomplete culture medium, 5% bicarbonate was added to make a complete culture 
medium (8.4 mL to 200 mL incomplete medium). 
 
Preparation of reaction buffer 
This contained 0.5 g MgSO4.7H2O, 7.4 g KCl, 0.58 g NaCl and 6 g HEPES dissolved in 1 L 
of deionized water and adjusted to pH 7.5 using 1 M NaOH. The solution was stored at room 
temperature. 
 
Preparation of 1 % saponin solution 
A 1% saponin solution (0.01 g/mL) was prepared in deionized water.  
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Preparation of Giemsa stain solution  
A 10% Giemsa stain solution was prepared in 1x PBS. 
 
Giemsa staining precedure 
A thin film of parasite preparation on a glass microscope slide was sprayed with methanol 
and allowed to dry in order to fix the cells. A 10% Giemsa stain was added onto the fixed 
glass slide to completely cover the thin film. This was allowed to stand for about 10 min, 
after which the Giemsa stain was washed under slow running tap water and the slide was 
allowed to dry before it was viewed under a light microscope using oil immersion. 
 
Preparation of red blood cells (RBCs) 
20 mL expired whole blood from the University of Cape Town teaching hospital blood bank 
was transferred into sterile centrifuge tubes. 30 mL wash medium was added and spun down 
at 750 rpm for 5 min. The supernatant was discarded and the process repeated. The resulting 
washed RBCs were stored at 4
o
C. 
 
Synchronization 
To the pellet of parasitized RBCs (iRBCs), 5 volumes of 5% sorbitol were added and allowed 
to stand for 10 min at 37°C in a water bath. Sorbitol lysed all stages of the parasites except 
for the ring stage and the uninfected RBCs. The solution was spun down at 750 rpm, the 
superntant discarded and the pellet put back into a 250 mL culture flask for further culturing. 
 
2.3.1.2 Experimental procedures 
Parasitized RBCs (NF54 or D10 strains) were maintained in continuous culture with 
complete culture medium according to the method described by Trager and Jensen with some 
minor modifications. Starting with the synchronized ring stage, iRBCs were diluted to 5% 
hematocrit with complete culture medium in 250 mL culture flasks. The culture flask was 
gassed with 3% O2 and 4% CO2 for about 2 min before being incubated in a CO2 incubator at 
37°C for parasite growth. After 24 h of culturing, the flask was taken out of the incubator into 
a sterile laminar flow hood. The cultured mixture was spun down at 750 rpm for 5 min. The 
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supernatant decanted and a small volume of iRBC pellet was placed on a glass microscope 
slide and spread across the slide with the aid of another microscope slide to form a thin film. 
The thin film was stained with 10% Giemsa solution before being viewed with an oil 
immersion lense on a light microscope to check if parasites in the RBCs had actually grown 
to their trophozoite stage. The remaining iRBC pellet was subcultured in a different 250 mL 
culture flask with the addition of complete culture medium and washed RBCs (group O+) to 
5% hematocrit. The flask was gassed again with with 3% O2 and 4% CO2 for about 2 min 
before being incubated at 37°C in a CO2 incubator for growth to continue. After another 24 h 
of incubation, the flask was taken out and iRBCs spun down at 750 rpm for 5 min in a sterile 
50 mL falcon tube. The supernatant was discarded and the pellet synchronized with 5% 
sorbitol solution. The synchronized iRBCs at ringe stage were then put back into culture. This 
cycle was continued until sufficient parasites were harvested at the trophozoites stage. 
 
2.3.2 Isolation of haemozoin crystals 
Parasites for haemozoin isolation were harvested at the trophozoite stage in their 
intraerythrocytic life cycle. The trophozoites were harvested from iRBCs by lysing the iRBCs 
using 1% saponin solution with 2 min incubation. The lysed iRBCs were then centrifuged at 
1500 rpm for 10 min. The supernatant was decanted leaving behind the pelleted trophozoites. 
The trophozoites were then washed twice with PBS by centrifuging at 1500 rpm for 10 min 
for each wash. The pellets were again washed further with reaction buffer by centrifuging at 
1300 rpm for 1 min. The supernatant was decanted and the pellet resuspended in deionized 
water (pH 4.6). The suspension was triturated 10 times using a 26.5 gauge needle to break 
open the trophozoites releasing the parasite digestive vacuoles (DVs) and other cytosolic 
materials into solution. The lysate was centrifuged at 1300 rpm for 1 min. The supernatant 
was decanted and the pelleted DVs resuspended in 1 mL of reaction buffer. 10 µL DNase I 
was added to the solution to digest any DNA present and the solution was incubated for 5 
min at 37°C. The incubated solution was then centrifuge at 1300 rpm for 1 min. The 
supernatant was decanted and the pelleted DVs were washed twice with reaction buffer by 
centrifuging at 1300 rpm for 1 min for each wash. Isolated DVs were further resuspended in 
deionized water, frozen and thawed at -80 
o
C to break open the DVs to release the haemozoin 
crystals. The mixture was spun down at 1300 rpm for 1 min. The supernatant was decanted 
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leaving the pelleted haemozoin crystals. This process was repeated at least three times to 
ensure all DVs were completely lysed. 
 
2.3.3 Quantification of isolated haemozoin crystals 
A 4 µL haemozoin crystal pellet was made up to 100 µL with deionized water. A suspension 
of the haemozoin crystal was placed carefully between a thin glass cover slip and placed on 
the surface of a bright light hemocytometer mounted on a Laborlux 12 Leitz light 
microscope. The setup was allowed to stand for some time for any movement in the 
suspension to completely stop. Haemozoin crystals in 5 of the 25 larger squares on the 
hemocytometer were manually counted under the light microscope.  
 
2.3.4 Preparation β-haematin from lipid and Fe(III)PPIX 
 
2.3.4.1 Preparation of solutions 
 
0.1 M NaOH 
NaOH pellets (1.0 g) were weighed out and dissolved in 250 mL of distilled water. 
 
1:9 v/v acetone/methanol mixture  
Acetone (10 cm
3
) and methanol (90 cm
3
) were both measured using a measuring cylinder and 
mixed together to give a 1:9 v/v mixture of acetone/methanol. 
 
2 mg/mL haematin solution  
Porcine haemin (2 mg) was dissolved in 400 L of 0.1 M NaOH. The solution was vortexed 
and sonicated for 3-5 min and then made up to 1 mL with 1:9 v/v acetone/methanol. 
 
50 mM citric acid buffer, pH 4.8  
Citric acid (10.507 mg) was dissolved in 1 L of distilled water to give a concentration of 50 
mM. The pH was adjusted to 4.8 with NaOH slurry. 
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3.31 mM MSG solution 
MSG powder (11.86 mg) was dissolved in 10 mL of 1:9 acetone/methanol mixture. 
 
3.31 mM MPG solution 
MPG powder (10.98 mg) was dissolved in 10 mL of 1:9 acetone/methanol mixture. 
 
3.31 mM DPG solution 
 DPG powder (18.56 mg) was dissolved in 10 mL of 1:9 acetone/methanol mixture. 
 
3.31 mM DLG solution 
From the liquid DLG stock, 22.2 L was pipetted out and made up to 10 mL with 1:9 
acetone/methanol mixture.  
 
3.31 mM DOG solution 
From the liquid DOG stock, 21.84 L was pipetted out and made up to 10 mL with 1:9 
acetone/methanol mixture  
 3.31 mM neutral lipid blend (NLB) solution 
The constituent lipids prepared in 1:9 v/v acetone/methanol were made up in the ratio MSG, 
MPG, DPG, DLG, DOG (4:2:1:1:1 v/v) to give a total concentration of 3.31 mM.  
 
5% pyridine solution (100 mL) 
To 5 mL pyridine solution, 50 mL acetone, 10 mL HEPES (0.2 M, pH 7.5) and 35 mL of 
distilled water were added and thoroughly mixed together. 
 
Extrusion of liposomes and micromixing of lipid or lipid mixed with Fe(III)PPIX solution 
Liposomes or solutions of neutral lipids (NLB or MPG) or neutral lipids mixed with 
Fe(III)PPIX at different concentrations were extruded or micromixed by passing them several 
times through a 10 m pore filter using an Avanti® Mini-Extruder. 
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2.3.4.2 Experimental procedures 
β-Haematin was prepared using a method previously described by Hoang et al. (2010a & b) 
with some slight modifications as follows: 50 mL citric acid buffer (50 mM, pH 4.8) in a 
Schott-Duran crystallization dish with internal diameter of 9 cm was pre-incubated for 30 
min at 37°C in a water bath. 1 mL of 3.31 mM MPG or NLB solution was mixed with 500 μL 
of 2 mg/mL Fe(III)PPIX solution to give a total volume of 1.5 mL of the mixture. The 
solution was layered carefully on the surface of the pre-incubated citric acid buffer using a 1 
mL syringe and this was incubated further at 37°C for either 30 min or at different lengths of 
time to monitor β-haematin formation. A control reaction mixture for β-haematin preparation 
was set up exactly as described above but without lipid.  
 
2.3.5 Collection and processing of β-haematin crystals for TEM imaging and TEM-ED 
pattern acquisition 
 
Samples where carefully taken from the milky emulsion layer and placed on a glow-
discharged carbon-coated grid. Excess solution was blotted on Whatmann filter paper number 
1 and the grid was immediately stained with a negative stain (uranyl acetate) by carefully 
placing the grid on a drop of the uranyl acetate solution and it was allowed to stand for about 
3-5 min. Excess stain on the grid was blotted on Whatmann filter paper number 1 and the grid 
was allowed to dry at room temperature. A TECNAI TF20 TEM operating at 200 kV located 
at the Electron Microscope Unit, University of Cape Town, was used for normal imaging of 
crystalline materials on the grid and also for acquisition of diffractions pattern from the 
imaged crystalline structures. 
 
2.3.6 Indexing of diffraction patterns 
The SingleCrystal
TM
 application of CrystalMaker
®
 Software Version 2.2 was used to index 
the diffraction patterns obtained from β-haematin crystals (CrystalMaker, Oxford, 2009). The 
calculated structural data for β-haematin described by Pagola et al. (2000) was used to build a 
structural model of the β-haematin crystal using CrystalMaker®. The single crystal diffraction 
software was then used to predict a simulated diffraction pattern based on this structure. The 
Grid tool in SingleCrystal
TM
 was used to index the diffraction pattern obtained from β-
haematin crystals as follows; The observed electron diffraction pattern obtained from the β-
haematin crystals was opened using the single crystal window of the software. In the same 
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window, the CrystalMaker
®
 file for the reported β-haematin crystal structure was loaded. The 
Grid tool was superimposed on the observed diffraction pattern, making sure that all observed 
diffraction spots coincided. The grid was adjusted such that all grid points lay directly over 
the observed points. The software was then used to match the simulated pattern with the 
observed pattern, with the strongest reflections being indexed in this manner.  
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3. THE PROTEOME AND LIPIDS ASSOCIATED WITH HAEMOZOIN CRYSTALS  
 
3.1 INTRODUCTION 
As discussed in Chapter 1, the Hz crystal, with its well-known structure (Pagola et al. 2000), 
is formed via a complex biomineralization process in the malaria parasite and other blood-
feeding organisms such as S. mansoni (Oliveira et al. 2000), H. columbae (Chen et al. 2001) 
and R. prolixus (Oliveira et al. 1999). Proteins belonging to the P. falciparum proteome such 
as HRP II (Sullivan et al., 1996), HDP (Jani et al. 2008) and lipids (Fitch et al. 1999 & 
Pisciotta et al. 2007) isolated from P. falciparum have been shown to efficiently promote β-
haematin formation in vitro. 
The involvement of lipids in biomineralization processes has been described in different, 
unrelated organisms such as the formation of coccoliths in E. huxleyi algae (Young et al. 
1992) and the growth of dentine in humans (Anderson et al. 1995) which are known to be 
lipid-mediated processes. Lipid involvement in crystal growth is therefore evident as it 
provides an organic phase for nucleation to occur. 
Alternatively, proteomic studies of biomineral matrix proteins in different unrelated 
organisms such as human bone matrix (Alves et al. 2011), shell matrix from Manila clams 
(Marie et al. 2011), sea urchin shell and spine (Mann et al. 2008), radular teeth in the giant 
pacific chiton (Nemoto et al. 2012), chicken egg shell (Mann et al. 2006) and the bacterial 
magnetic protein (BacMP) membrane from magnetite producing bacteria (Alves et al. 2011) 
using SDS-PAGE and LC-MS techniques have all led to the identification of the proteins 
involved in these biomineralization processes.  
The question of which bioorganic molecules (lipids and/or proteins) are involved in the 
biomineralization of Hz in vivo has been a subject of intense debate. Given that proteomic 
studies of biomineral matrix proteomes in other organisms have invariably led to the 
identification of the protein(s) involved in biomineralization process, it was decided to use 
SDS-PAGE and LC-MS/MS to study the proteome related to the Hz crystal so as to identify 
proteins associated with Hz to determine whether any potential Hz-mediating proteins could 
be identified. At the same time, the lipids associated with the Hz crystal surface were also 
investigated and will be discussed in this chapter. 
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3.2 METHODS 
 
3.2.1 Parasite culture, isolation, quantification and TEM of Hz crystals 
Parasitized RBCs (P. falciparum NF54 strain) were maintained in continuous culture with 
complete culture medium according to the method described by Trager & Jensen with some 
minor modifications as described in Section 2.3.1.2 of Chapter 2. Trophozoite stage iRBCs 
were harvested and Hz crystals isolated and quantified as described in Section 2.3.2 in 
Chapter 2. Isolated Hz crystals in deionized water were placed on a carbon-coated grid. 
Excess aqueous solution was blotted with Whatmann filter paper number 1 and the grid was 
allowed to dry at room temperature before visualizing using a TECNAI TF20 TEM operating 
at 200 kV for normal imaging.  
 
3.2.2 Casting and running of 15% SDS-PAGE gel 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used to 
separate proteins associated with haemozoin crystals. SDS-PAGE is a technique that uses a 
potential difference to separate proteins according to their molecular weight based on their 
differential mobility in the polyacrylamide gel. Higher gel percentages separate proteins of 
smaller molecular weight with better resolutions. A 15% SDS-PAGE was used to separate all 
the proteins found on the surface and in the matrix of haemozoin crystals isolated from P. 
falciparum based on their molecular weight before subsequent identification using LC-MS. 
 
3.2.2.1 Sample preparation 
 
Preparation of resolving buffer 
A solution of 0.185 g/mL of Tris and 0.004 g/mL SDS was prepared in distilled water and the 
pH adjusted to 8.8. 
 
Preparation of stacking buffer 
A solution of 0.0605 g/mL Tris and 0.004 g/mL SDS was prepared in distilled water and the 
pH adjusted to 6.8. 
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Preparation of 5× running buffer 
A solution containing 15.1 g Tris, 72 g glycine and 5 g SDS water was prepared in 1 L of 
distilled water (pH was between 8.3-8.5). 
 
Preparation of 4× sample buffer 
This contained 10 mL stacking buffer, 8 ml glycerol, 0.8 g SDS, 0.8 mL of 2-mercapto-
ethanol, 0.2 mg bromophenol blue and 1.2 mL distilled water. 
 
Preparation of 15% resolving gel (10 mL) 
This contained 3.55 mL distilled water, 3.75 mL of 40% acrylamide, 2.60 mL resolving 
buffer, 0.100 mL of 10% ammonium persulphate (APS) and 0.006 mL TEMED 
(tetramethylethylenediamine). 
 
Preparation of 5% stacking gel (10 mL) 
This contained 1.480 mL distilled water, 0.250 mL of 40% acrylamide, 0.270 mL stacking 
buffer, 0.020 mL of 10% APS and 0.004 mL TEMED. In all cases TEMED was added last 
prior to pouring the gel solution into the casting device. 
 
3.2.2.2 Experimental procedures 
Resolving gel solution was poured carefully into the gel casting device (BIO-RAD Mini-
PROTEAN® 3 Cell system) to avoid the formation of air bubbles. The gel solution was 
allowed to solidify. The stacking gel solution was carefully poured on top of the solidified 
resolving gel. Combs were fitted into the stacking gel solution and the latter was allowed to 
solidify. After solidification of the stacking gel, the comb was removed forming wells in the 
gel. Hz sample preparation for protein separation by SDS-PAGE was as illustrated in Figure 
3.1. 
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Samples (4% SDS-washed extract from Hz crystal surface, PBS-rinsed solution from washed 
Hz crystals and dissolved Hz crystals) were mixed with 4× sample buffer in the ratio 3:1. The 
samples were heated in boiled water for about 5 min. 20 μL of each sample was then loaded 
into an appropriate well on the 15% SDS-PAGE gel mounted in a BIO-RAD Mini-
PROTEAN® 3 Cell system. The gel was run at constant current of 30 mA for 75 min. The 
molecular weight marker used was PageRuler
TM
 Plus, Prestained protein ladder (Fermentas). 
 
 
Figure 3.1. Schematic representation of the Hz isolation process to sample preparation for SDS-PAGE protein 
separation. “Troph” represent trophozoites. 
 
3.2.3 Staining and destaining of gels 
 
3.2.3.1 Sample preparation 
 
Lysing of  iRBC with 1 % saponin, 
centrifuge and wash troph pellet with PBS
Triturate trophs using 26.5 gauge needle, 
wash with DNAse I, centrifuge and wash DV 
pellet with reaction buffer
Freeze-thaw DV in deionized water at ‒80 oC
at least 3 , centrifuge and collect pellet of Hz
Vigorously vortex Hz in 50 µL 4% 
SDS, centrifuge and collect supernatant
Both supernatants combined 
is referred to as sample Hs
(contains proteins from Hz 
surface as well DV 
membrane)Vigorously vortex Hz in 50 µL PBS, 
centrifuge and collect supernatant
15 µL of supernatant 
run on 15% SDS PAGE 
15 µL of supernatant run 
on 15% SDS PAGE 
Dissolve Hz in 50 µL 0.1 M NaOH
15 µL of supernatant run 
on 15% SDS PAGE 
Referred to as sample Hd
(contains proteins trapped in 
the Hz crystal and possibly 
those very firmly bound to the 
Hz surface)
iRBC
Troph
DV
Hz
Hz
Hz
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Preparation of Coomasie Blue stain solution 
A 0.25% Coomassie Blue R250 solution was prepared by first disolving the Coomassie Blue 
R250 in methanol (450 mL) before adding 450 mL water and 100 mL acetic acid to it. 
 
Preparation of destaining solution 
This contained 600 mL water, 300 mL methanol and 100 mL acetic acid. 
 
3.2.3.2 Experimental procedures 
Gels containing extracts from Hz surface and dissolved Hz crystals were placed in a solution 
of Coomassie Blue stain overnight with continuous shaking on a shaker device (FINEPCR 
orbital shaker SH30). The overnight stained gel was destained with a destaining solution 
while shaking until the gel was clear leaving behind only stained protein bands. 
ProteoSilver
TM
 Plus Silver Stain Kit (SIGMA) was used to stain and destain the gel 
containing PBS-rinsed solution from washed Hz crystals according to the procedure 
described in the kit manual. Pictures of stained gels were taken using a ChemiDOC
TM
 XRS+ 
with image lab
TM
 software located at the Molecular and Cellular Biology Department at the 
University of Cape Town. Gel pieces were carefully cut out from different protein bands and 
gel portions using surgical blades. Each gel piece was placed in a labelled Eppendorf tube 
containing 50 µL acetonitrile to dehydrate the gel pieces for 15 min. The dehydrated gel 
pieces were sent to the Center for Proteomic and Genomic Research at the University of Cape 
Town for protein identifcation by LC-MS/MS. 
 
3.2.4 LC-MS/MS protein identifcation from gel pieces 
 
3.2.4.1 In-gel digestion 
Gel slices were destained in an Eppendorf 1.5 mL tube with 200 mM NH4HCO3:acetonitrile 
50:50 (Burdick & Jackson; Sigma) until clear. The gel pieces were further dehydrated and 
desiccated. They were then washed with 25 mM NH4HCO3 followed by another dehydration 
step. Proteins were digested by rehydrating gel pieces in 20 ng/µL trypsin (Promega) solution 
and incubating overnight at 37°C. Peptides were extracted from the gel pieces with 50 L of 
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0.1% trifluoroacetic acid (TFA) (Sigma), 2% acetonitrile (ACN) followed by a second 
extraction with 50% acetonitrile/H2O containing 0.1% trifluoroacetic acid (TFA). The 
samples were dried down and 200 L water added and dried down again to remove residual 
NH4HCO3. 
   
3.2.4.2 Chromatography 
Nano-RP-LC chromatography was performed on a Dionex Ultimate 3000 nano-HPLC 
system. The solvent system employed was solvent A, 2% ACN/water; 0.15% TFA and 
solvent B 80% ACN/water; 0.12% TFA. The gradient was generated at 300 nL/min as 
follows; 0-10 min 5-12.5% B, 10-120 min 15-40% B, 120-140 min 40-55% B, 140-150 min 
90% B and 150-165 min 5% B. The gradient from 5-55% B used for sample analysis was 
generated using a combination of a linear and Chromeleon non-linear gradient 6 gradients. 
Fraction collection commenced after 20 min with 120 min duration. The eluted peptides were 
spotted onto a MALDI target plate using a Probot (LC packings) robotic spotter. MALDI 
matrix (7.5 mg/mL CHCA, 10 mM monobasic ammonium phosphate; calibration mixture in 
solvent B) was added at 1:2 ratios to the column outflow (600 µL/min) through a micro-T 
connector. Final matrix concentration was 5 mg/mL. Spots were collected at 15 s intervals. 
 
3.2.4.3 Mass spectrometry 
Mass spectrometry of collected fractions was performed as follows. The laser was set at 4400 
arbitrary units, 500 laser shots/spectrum, and grid voltage at 16 kV. All spots were internally 
calibrated using a 5 point calibration mixture with minimum of 1 point to match with mass 
tolerance of m/z = 0.1, maximum outlier error of 10 ppm. The interpretation method used for 
ion selection was: minimum signal/noise ratio = 35, excluded adducts = 22.99, global 
exclusion lists were generated from the calibration spectra with m/z tolerance equal to 0.1. In 
addition, all precursors within 150 FWHM (full width half maximum) resolution were 
excluded. Tandem mass spectrometry acquisition parameters were: laser set at 4800 arbitrary 
units, a maximum of 5000 laser shots/spectrum, grid voltage at 16 kV. Stop conditions were 
set to cease acquisition once the following criteria were met: 8 peaks with signal to noise 
ratio equal or greater than S/N = 100. 
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3.2.4.4 Data analysis 
Database interrogation was performed with the Mascot algorithm using the Swissprot 
database on a GPS workstation. Search parameters were set as in Table 3.1.  
Table 3.1. Specification for search parameters used to perform MASCOT analysis for protein identification.  
Parameters Specification 
Species Plasmodium falciparum and Homo sapiens 
Enzyme Trypsin 
Maximum number of missed cleavages 1 
Fixed modifications Carbamidomethyl 
Variable modifications Oxidation and deamination  
Precursor tolerance 0.1 da 
Fragment tolerance 0.2 da 
Minimum peptide confidence interval 95% 
 
3.2.5 Lipid TLC 
 
3.2.5.1 Sample preparation 
 
Preparation of premuline stain 
A 0.05 mg/mL solution of premuline stain was prepared in acetone:water (80:20). 
 
3.2.5.2 Experimental procedures 
The 4% SDS washed extracts from Hz crystals were mixed with chloroform:methanol (2:1) 
solvent so as to facilitate the extraction of lipids from the solution. About 2-4 µL of the 
mixture was spotted on a silica gel TLC plate using a thin capillary glass tube. Control lipids 
of individual MSG, MPG, DPG, DLG, DOG (2.5 mg/300 µL each) were prepared in 
chloroform:methanol (2:1) solvent and about 2-4 µL of each spotted on the TLC plate. The 
bottom of the plate was immersed in solvent I (chloroform:methanol:water at 50:20:3 v/v) in 
a closed system allowing the different classes of lipid to be separated along the TLC plate as 
the solvent moved up the plate by capillary action. Using a soft pencil, a line was drawn 
across the TLC plate at the maximum height reached by solvent I. The TLC plate was 
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removed from solvent system I and placed in another closed system of solvent II 
(hexane:diethyether:acetic acid at 16:10:1 v/v) for further separation of lipid on the TLC plate 
as the solvent moved further up the plate by capillary action. Another line was drawn on the 
TLC plate where movement of solvent II was stopped. Premuline stain was sprayed on the 
TLC plate and it was then visualized under ultravoilet (UV) light. 
 
3.3 RESULTS AND DISCUSSION 
 
3.3.1 TEM of isolated Hz crystals 
Hz crystals isolated from P. falciparum for proteomic study were viewed using TEM as 
shown on Figure 3.2. This showed Hz crystals were successfully isolated from the parasite 
and confirmed the starting material used for proteomic study indeed consisted of intact Hz 
crystals.  
 
Figure 3.2. TEM imaging of isolated Hz crystals used for proteomic study. 
 
3.3.2 Possible origins of some proteins likely to be identified with isolated Hz crystals 
Haemoglobin is transported from the RBC cytoplasm to the parasite by invagination of a 
specialized cytostome structure together with parasite plasma membrane and the PV 
membrane which eventually fuse together to form one single membrane-bound DV (Elliot et 
al. 2008) as illustrated in a schematic diagram in Figure 3.3. Proteins coming from some of 
these parasite structures engulfed together with haemoglobin would likely be identified in this 
study too. Some RBC proteins are likely to be ingested together with haemoglobin and 
transported to the DV during the parasite feeding process. The lysing of iRBC to isolate 
trophozoites, followed by the DV and finally the Hz crystals, also causes some membranous 
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structures in the parasite cytoplasm to break open releasing their contents (membranes and 
soluble proteins) which are likely to be present with Hz crystal preparations. So therefore, it 
would be expected that some proteins coming from nuclear envelope, ER, Golgi bodies, 
plastid, lysosomes and parasite cytosol would be likely to be carried over as contaminants. 
The isolated Hz crystals are expected not to have large quantities of RBC and parasite 
membrane since they were isolated from DVs, but since lipid material was not removed from 
isolated crystals, the 4% SDS washed extracts would not only have proteins present on the 
surface of Hz crystals but also DV membranes. This fraction is hereafter referred to as sample 
Hs. The dissolved Hz crystals would be expected to contain proteins incorporated into the 
crystal matrix as well as any proteins that might be so strongly adsorbed on the crystal 
surface that were not dislodged by SDS. This fraction is hereafter referred to as sample Hd. 
 
 
Figure 3.3. Schematic representation of invagination and transportation process of haemoglobin together with 
other RBC cytoplasmic proteins to the parasite DV via specialized cytostome structures. Hb; haemoglobin, Hz; 
haemozoin crystal, DV; digestive vacuole, PV; parasitophorous vacuole, PVM; PV membrane, Nu; nucleus, ER; 
endoplasmic reticulum, possible protein trafficking route, labels,  RBC cytoplasmic proteins,  
possible plasma protein or RBC membrane protein,  parasite proteins,     process of interest under 
investigation.  
 
RBC membrane
Hb
PVM
PV
RBC 
cytoplasm
ER
Parasite cytoplasm
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Parasite membrane
Hz
Hb
DV
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DV membrane
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P. falciparum infection of human RBC is known to cause several changes and modifications 
of the proteome in both the parasite itself and it host cell, such as the incorporation of 
exported parasite proteins in the erythrocyte membrane cytoskeleton (Pei et al. 2005, Waller 
et al. 2007 and Pei et al. 2007) which results in an increase in iRBC plasma membrane 
permeability and rigidity (Glenister et al. 2002). Other related studies have also identified 
several RBC cytoplasmic proteins to be modified by the presence of P. falciparum in it 
(Fontaine et al. 2012). Moreover, the PVM is known to contain proteins derived from RBC 
plasma membrane (Murphy et al. 2007). Proteins trafficked via the PVM or cytostome 
derived structures from the PVM are therefore most likely to contain both cytoplasmic and 
membrane-derived RBC proteins.  
 
3.3.3 A 15% SDS-PAGE of 4% SDS washed Hz extract and dissolved Hz crystal (Hz 
matrix) 
SDS-PAGE is the most widely and extensively used proteomic technique in separating 
proteins according to their molecular weights. It was first used to separate the different 
proteins present in samples Hs and Hd before identification by LC-MS/MS. A 15 µl extract 
(supernatant) obtained from approximately 2.06  109 Hz crystals isolated and washed 
thoroughly with 50 µL of 4% SDS (sample Hs) was used to run a 15% SDS-PAGE and 
developed with coomassie blue R250 stain as shown in Figure 3.4A. The 15 µL extract used 
in lane 2 translates to material obtained from approximately 0.618  109 Hz crystals. The 
washed Hz crystals were then rinsed by a second wash with 50 µL PBS buffer, of which 15 
µL of the supernatant was used to run another 15% SDS-PAGE and developed using silver 
stain kit (Sigma-Aldrich) as shown on lane 1 in Figure 3.4B. The washed Hz crystals were 
then dissolved in 50 µL of 0.1 M NaOH. Of the 2.06  109 completely dissolved Hz crystals, 
15 µL was used for loading on lane 1 (sample Hd) in Figure 3.4A.  
The average length of a Hz crystal is measured to be 500 nm as in Section 5.3.1 and the 
length to width ratio is 3.4, giving an average width of 147 nm for Hz crystals. Buller et al. 
(2002) measured the average width to thickness of haemozoin crystals to be 1.3 which gives 
an average thickness of 113 nm for Hz crystals. An average Hz crystal thus has a volume of 
500 nm  147 nm  113 nm (8.3  106 nm3). The Hz crystal unit cell dimension is 1.2 nm  
1.4 nm  0.8 nm (1.344 nm3). This implies there is an average of 6.175  106 unit cells per 
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Hz crystal. Considering there are 2 haem molecules per unit cell, there is an average of 12.35 
 106 haem molecules per crystal. Since material from approximately 0.618 x 109 Hz crystals 
was used per lane, this corresponds to material associated with about 7.63 x 10
15
 haem 
molecules per lane. This translates to material from about 12 nmol of haem per lane on the 
gel. The instrument used for LC-MS/MS protein identification has a detection limit of around 
5 to 10 fmol (measured for pure BSA). This corresponds to 1.3-2.5  106 haem molecules per 
protein molecule at the detection limit, corresponding to 5-10 protein molecules per Hz 
crystal at the detection limit of the instrument. 
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Figure 3.4. 15% SDS-PAGE of Hz crystal sample. A: Dissolved Hz crystals in lane 1 showed no distinct protein 
bands while the extract washed from the surface of Hz crystals with 4% SDS in lane 2 showed several distinct 
bands with coomassie blue stain. B: Silver-stained gel of material obtained from the surface of 4% SDS washed 
Hz crystals also showed distinct protein bands. 
 
Protein Marker (kDa)
Lane 1
Lane 2
170
130
100
70
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40
35
25
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C1
C2
C3
C4
C25k
C5
C7
CHz
Dissolved haem (area below was 
completely brown & wasn’t 
stained by coomassie blue)
A 
B 
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3.3.4 LC-MS/MS protein identification from gel sections 
The different sections of both gels labelled from C1 through C7, C25k (gel section at 25 
kDa), CHz (Figure 3.4A) and S1, S2, S4 & S5 (Figure 3.4B) were cut out for LC-MS/MS 
analysis for protein identification. Peptide fragments generated from LC-MS/MS were used 
for MASCOT analysis to interrogate both the P. falciparum and H. sapiens protein data bank. 
MASCOT is a probabilistic scoring algorithm that incorporates the MOWSE (Molecular 
Weight Search ) scoring algorithm used for peptide mass fingerprinting (Pappin et al. 1993), 
fragment ion series, mass accuracy, and peptide length. The results from MASCOT are 
reported as a probability-based “Ions Score” (Kapp et al. 2005). This led to the identification 
of 71 unique P. falciparum proteins and 73 unique H. sapiens proteins (a complete list of all 
proteins identified from the respective gel sections is found in Appendix 1). Some of the 
identified proteins appeared not to be separated on the 15% SDS-PAGE according to their 
molecular weights calculated from their amino acid sequences. Proteins identified from bands 
at molecular weight lower than their predicted mass might be as a result of digestion by 
proteases in the DV, or released from lysed DVs during the Hz isolation process. Some 
proteins were also identified from bands at molecular weights higher than their predicted 
mass. This phenomenon of irregular migration of proteins on gels is not surprising as SDS-
PAGE gel mobility studies of the proteomes of some organisms have shown that more than 
40% of the proteins do not migrate within 10% of the predicted position calculated from their 
amino acid sequences (Shirai et al. 2008). This therefore indicates that it is difficult to predict 
the absolute molecular weight of proteins based on their mobility in SDS-PAGE solely from 
their amino acid sequences. Hydrophobicity, denoted by a GRAVYscore (Kyte et al. 1982), 
is one of the factors which is known to greatly affect the mobility of proteins on gels as 
hydrophilic proteins tends to exhibit slower migration. This is so because SDS preferentially 
binds to the hydrophobic regions of proteins in an approximate ratio of one SDS molecule to 
two amino acid residues (Shirai et al. 2008). Subcellular localization of proteins is also 
known to affect their mobility on gels as nuclear proteins tend to migrate slower such as 
P38545 (GTP-binding nuclear protein Ran) and P40282 (Histone H2A) identified in this 
study. Whereas proteins from mitochondria, ER and Golgi bodies tend to migrate faster 
compared to their predicted/calculated molecular weight e.g P34940 (Chaperonin CPN60, 
mitochondrial precursor), although it is difficult to distinguish amongst them those that are 
caused by degradation or digestion by proteases. Post-translational modification of proteins 
such as phosphorylation, glycosylation, ubiquitination etc. causes them to migrate slowly on 
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gels (Cook et al. 2003, Poly et al. 1997 & Zhu et al. 2002). On the other hand, cytosolic 
proteins are expected to migrate normally as predicted from their amino acid sequence. In 
this study, the majority of proteins were identified from gel bands at lower molecular weight 
than their respective predicted masses. This was expected since the proteins came from the 
DV which contains many proteases. Moreover, parasite proteins have also been shown to 
degrade host proteins (Dua et al. 2001 and Hanspal et al. 2002) and this may be the case with 
some of the human proteins identified in this study at gel bands below their expected 
molecular weight, such as P02730 (band 3 anion transport protein), P11678 (eosinophil 
peroxidase precursor), O14830 (serine/threonine protein phosphatase with EF-hands-2), etc.  
Of the 71 unique P. falciparum proteins identified, 68 were from sample Hs and 24 from 
sample Hd respectively. P. falciparum is known to spend most of it life cycle in the human 
host inside the RBC. For this reason, all 73 unique H. sapiens proteins identified were 
interrogated against the human RBC proteome which is freely available on the Internet 
(http://proteome.biochem.mpg.de/rbc/_rbcsearch.jsp?flag=listall) (Pasini et al. 2006). Of the 
73 unique H. sapiens proteins identified (Appendix 2), 37 belonged to the human RBC 
proteome. RBC proteins identified were found to be present associated with both the Hz 
crystal surface and matrix irrespective their supposed function there. Although the remaining 
36 human proteins were not found in the human RBC proteome available on the Internet 
(Pasini et al. 2006), searches of the UNIPROTKB site with the protein accession number, 
identified them to have come from other human cells or cells from specific body tissues. 
These may be contaminants, although interestingly the RBC proteome available on the web 
also contains proteins that originate from cells in the brain, liver, bones, B cells, eosinophils, 
serum, etc. thus making it seemingly possible that some of the identified known non-RBC 
proteins might have entered the iRBC cytoplasm from the blood via the permeable iRBC cell 
membrane and were further engulfed together with haemoglobin and transported to the DV 
where haemoglobin digestion and Hz formation takes place. All 73 unique H. sapiens 
proteins identified were present on the surface of the Hz crystal while 19 were found in the 
Hz crystal matrix. Since it is possible that these proteins could merely be contaminants, for 
this study only the 37 proteins found in the RBC proteome available on the web together with 
the 71 unique P. falciparum proteins as indicated in Table 3.2 were considered for further 
discussion. 
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Table 3.2. Total number of identified P. falciparum and H. sapiens proteins considered in this study. 
 Sample Hs Sample Hd 
 P. falciparum 
protein 
H. sapiens 
protein 
P. falciparum 
protein 
H. sapiens 
protein 
Total proteins identified 68 73 24 19 
No. of human proteins 
found in RBC proteome 
 37 (51%)  17 (89%) 
Total protein considered 
for analysis 
68 37 24 17 
No. of proteins 
previously reported in 
DV 
21 (31%)  10 (42%)  
 
A second algorithm known as X!Tandem was also used to interrogate the P. falciparum 
protein database using all peptide fragments generated from LC-MS/MS. X!Tandem is a 
heuristic algorithm for MS/MS protein identification that uses information of intensity 
patterns associated with particular amino acid residues to generate theoretical spectra for the 
peptide sequences  which are then correlated with the experimental data using a dot product 
from which an expectation value is calculated (Kapp et al. 2005). So therefore, besides 
looking at how it compares to protein identification by MASCOT analysis, this was used to 
widen the spectrum of proteins identified by using both algorithms and, more importantly, to 
increase the chances of identifying proteins that have been suggested to be associated with Hz 
crystal formation inside the DV. A total of 91 unique proteins were identified using the 
X!Tandem algorithm (Appendix 3) of which only eight were also identified using MASCOT. 
Despite the differences in these two algorithms used for MS/MS protein identification, 
differences in software versions used has also been shown to account for the difference in the 
numbers and types of protein identified using these two algorithms from the same biological 
sample (Kapp et al. 2005). This may also be the reason why only eight proteins were 
identified by both algorithms. This gives a grand total of 154 unique proteins identified using 
the MASCOT and X!Tandem algorithms as shown in the Venn diagram in Figure 3.5. There 
were 10 putative uncharacterized P. falciparum proteins identified using the X!Tandem 
algorithm. Blastp (basic local alignment search tool for proteins only genome) search 
together with a Pfam (protein family) and/or Interpro (inter-protein domain) search found on 
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the UNIPROTKB site was used to assign some functions to these 10 putative proteins. None 
of these proteins seem to have known functions related to nucleation and/or initiation of the 
biomineralization process of Hz formation as summarized in Table 3.3.  
On the contrary, two of the putative uncharacterized proteins, Q8IEJ0_PLAF7 and 
Q8ILM8_PLAF7 appear to be involved in lipid transport or binding. Furthermore, a putative 
phospholipid scramblase 1(Q8IJH8_PLAF7) presumably involved in the redistribution of 
phospholipid after cell activation or injury and also in the translocation of lipids from one 
monolayer to the other in a lipid bilayer cell membrane, and a putative long chain 
polyunsaturated fatty acid elongation enzyme (C6KSQ7_PLAF7) involved in the elongation 
of long chain polyunsaturated fatty acid, were also identified using the X!Tandem algorithm. 
Putative phospholipid scramblase 1 may be located in the DV membrane while putative long 
chain polyunsaturated fatty acid elongation enzyme presumed to be located on the surface of 
ER and in other organisms such as yeast is known to affect plasma membrane H
+
-ATPase 
activity and might have been trafficked via the formation of Golgi-like transport vesicle to the 
DV membrane for lipid biosynthesis. 
 
 
Figure 3.5. Using MASCOT and X!Tandem algorithm to interrogate P. falciparum genome respectively 
identified 71 and 91 unique proteins with 8 proteins common to both analysis. 
 
 
 
 
 
 
 
MASCOT,
71
X!Tandem,
91
8
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Table 3.3. Assigned function of putative P. falciparum proteins identified using the X!Tandem algorithm based 
on either a Blastp search for proteins with known function having similar sequence or Pfam or interpro. 
 Blastp identification Pfam and/or 
interpro 
Assigned function 
Q8IEJ0_PLAF7 F0V7J3_NEOCL Lipocalin-
like protein, related 
(Neospora caninum), e-value 
7.0×10
-4
 
http://pfam.sange
r.ac.uk/family/P
F08212 
Transport of small 
hydrophobic 
molecules such as 
steroids and lipids 
Q8ILE3_PLAF7  http://pfam.sange
r.ac.uk/family/P
F01459 
Family of porin ion 
channel located on 
mitochondria outer 
membrane  
Q8ILM8_PLAF7  http://pfam.sange
r.ac.uk/family/P
F13639 
Zinc finger protein 
motif that binds, RNA, 
DNA, proteins and/or 
lipids 
Q8ILY8_PLAF7 Q8IFP4_PLAF7 putative 
Erythrocyte membrane-
associated antigen, e-value 
3.0×10
-4
 
  
Q8IJR6_PLAF7   WD40-repeat proteins, 
helps in assembly of 
multi-protein 
complexes 
Q8IM26_PLAF7 No closely related proteins   
Q8IE80_PLAF7 No closely related proteins   
Q8I490_PLAF7 B3L0F6_PLAKH. Liver 
stage antigen 3, putative, e-
value 2.7×10
-1
  
  
Q8IAU7_PLAF7 Q8WSK5_PLAFA CCAAT-
box DNA binding protein 
subunit B, e-value 7.0×10
-27
 
http://pfam.sange
r.ac.uk/family/P
F00808 
Involved in protein-
protein interactions 
Q8I2Q0_PLAF7 Q8IES7_PLAF7 Peptidase, 
putative, e-value 4.3 
http://www.ebi.a
c.uk/interpro/entr
y/IPR011009 
 
 
MASCOT and X!Tandem has been shown to have the highest specificity and therefore ability 
to calculate low-ranking scores for random matches in MS/MS identification of protein 
compared to other algorithms such as SEQUEST and Spectrum Mill and using trypsin digest 
in the search parameter, it was also shown that MASCOT perform better than X!Tandem 
(Kapp et al. 2005). For this reason proteins identified by MASCOT analysis from both P. 
falciparum and H. sapiens are discussed in detail and also because protein identification by 
MASCOT analysis of peptide fragments generated by LC-MS/MS is the most widely used in 
proteomic studies. 
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3.3.5 Proteins identified in sample Hs 
A total of 105 proteins originating from both Plasmodium falciparum and the human RBC 
proteome were identified with material isolated from the surface of the Hz crystals, of which 
68 (65%) were from P. falciparum, while 37 (35%) were from the human RBC proteome as 
indicated in the pie chart in Figure 3.6.  
 
Figure 3.6. Pie chart distribution of protein found associated with the surface of Hz crystals showed 65% and 
35% of the proteins originated from P. falciparum and human RBC proteome respectively. 
 
Of the 68 P. falciparum proteins found associated with the Hz crystal surface which are listed 
in Table 3.4, 21 (25%) have previously been found in the DV (Lamarque et al. 2008). The 
remainder of the proteins are known to be located in different compartments inside the 
parasite and their distribution in different subcellular locations is shown in the pie chart in 
Figure 3.7A & B. Some of the proteins have been described in more than one subcellular 
compartment within the parasite. Of the 37 human RBC proteins identified (Table 3.5) from 
sample Hs, 14 (38%) are located on the RBC cell membrane and 24 (62%) in the cytoplasm 
as shown in a pie chart distribution in Figure 3.8. 
Human RBC 
proteome 
37, 35% 
P. falciparum 
proteome 
68, 65% 
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Figure 3.7. Pie chart showing the distribution of P. falciparum proteins identified associated with the surface of 
the Hz crystal, listed by cellular compartment (A) and subcellular location (B). 
 
Figure 3.8. Distribution of RBC proteins found associated with the surface of Hz crystals based on location of 
origin. 
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Table 3.4. List of all P. falciparum proteins found associated with the surface of Hz crystals.  
Protein name 
(P13830) Ring-infected erythrocyte surface antigen precursor  
(P13819) Merozoite surface protein 1 precursor  
(P04932) Merozoite surface protein 1 precursor  
(P22621) Apical membrane antigen 1 precursor  
(P13568) Multidrug resistance protein  
(Q8I3H7) T-cell immunomodulatory protein homolog precursor  
(P50489) Apical membrane antigen 1 precursor  
(P68875) Transmission-blocking target antigen S230 precursor  
(Q04956) Probable cation-transporting ATPase 1  
(Q08853) Calcium-transporting ATPase (EC 3.6.3.8)  
Q9UAR6) Myosin A (PfM-A)  
(P22620) 101 kDa malaria antigen (P101)  
(P19214) Erythrocyte-binding antigen EBA-175  
(P13814) Circumsporozoite protein precursor (CS)   
(P02895) Glycophorin-binding protein (GBP-130)  
(P05691) Circumsporozoite protein (CS) (Fragment)  
(P62343) Calcium-dependent protein kinase 1 (EC 2.7.1.37)  
(Q02595) Probable serine/threonine-protein kinase 2 (EC 2.7.1.37)  
(P16405) Octapeptide-repeat antigen (ORA) (Fragment) 
(P22620) 101 kDa malaria antigen (P101)  
(P09593) S-antigen protein precursor  
(P04928) S-antigen protein precursor  
(Q03400) S-antigen protein precursor  
(Q8I4V5) Probable U3 small nucleolar RNA-associated protein 11  
(P40282) Histone H2A  
(P30315) DNA polymerase delta catalytic subunit (EC 2.7.7.7)  
(P27625) DNA-directed RNA polymerase III largest subunit  
(P41001) DNA topoisomerase II (EC 5.99.1.3)  
(P38545) GTP-binding nuclear protein Ran  
(P14248) DNA-directed RNA polymerase II largest subunit  
(P13825) Aspartic acid-rich protein precursor  
(Q25998) DNA primase small subunit (EC 2.7.7.)  
(O96935) M1-family aminopeptidase (EC 3.4.11.)  
(P61076) Thioredoxinreductase (EC 1.8.1.9) (TrxR)  
(Q00080) Elongation factor 1-alpha (EF-1-alpha)  
(Q07805) Ornithine aminotransferase (EC 2.6.1.13)  
(P20147) Heat shock 90 kDa protein homolog (Fragment)  
(Q07785) Cell division control protein 2 homolog (EC 2.7.1.37)  
(Q27727) Enolase (EC 4.2.1.11)  
(Q05866) 78 kDa glucose-regulated protein homolog precursor  
(P33948) ER lumen protein retaining receptor  
(P14643) Tubulin beta chain (Beta tubulin)  
(P34787) Tubulin gamma chain 
(P10988) Actin I  
(P14883) Actin II  
(P46468) Putative cell division cycle ATPase  
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(Q94650) ADP-ribosylation factor  
(O97231) 60S ribosomal protein L44  
(Q94660) 60S acidic ribosomal protein P0  
(P34940) Chaperonin CPN60, mitochondrial precursor  
(Q08210) Dihydroorotate dehydrogenase homolog 
(O15865) Calcium-dependent protein kinase 2 (EC 2.7.1.37) 
(P21422) DNA-directed RNA polymerase beta' chain (EC 2.7.7.6)  
(P12078) Heat shock 70 kDa protein PPF203 (Fragment)    
(P24044) Calmodulin (CaM)  
(P39898) Plasmepsin 1 precursor  
(Q27743) L-lactate dehydrogenase 
(P69193) Serine-repeat antigen protein precursor  
(P11144) Heat shock 70 kDa protein (HSP70)  
(P38545) GTP-binding nuclear protein Ran  
(Q8IBS5) Calcium-dependent protein kinase 4  
(Q9NJU9) Calcium-dependent protein kinase 3 (EC 2.7.1.37)  
(P13922) Bifunctional dihydrofolate  
(P13824) Clustered-asparagine-rich protein  
(P25407) Hypothetical protein in calmodulin 5' region (Fragment) 
(P50647) Ribonucleoside-diphosphatereductase large chain  
(P25805) Trophozoite cysteine proteinase precursor (EC 3.4.22.)  
(Q02155) Hexokinase (EC 2.7.1.1)  
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Table 3.5. List of Human RBC proteins identified associated with the surface of Hz crystals. 
Protein name 
(P11166) Solute carrier family 2, facilitated glucose transporter, member 1  
(P02730) Band 3 anion transport protein (Anion exchange protein 1  
(Q99569) Plakophilin 4   
(P27105) Erythrocyte band 7 integral membrane protein (Stomatin) 
(O75131) Copine III  
(Q13683) Integrin alpha-7 precursor   
(Q02094) Rhesus blood group-associated glycoprotein  
(O94973) Adapter-related protein complex 2 alpha 2 subunit  
(Q8WUD1) Ras-related protein Rab-2B  
(P59190) Ras-related protein Rab-15  
(Q15907) Ras-related protein Rab-11B (GTP-binding protein YPT3) 
(P02768) Serum albumin precursor  
(P08311) Cathepsin G precursor (EC 3.4.21.20 
(P51956) Serine/threonine-protein kinase Nek3 (EC 2.7.1.37)  
(P68871) Haemoglobin beta chain  
(P69905) Haemoglobin alpha chain  
(Q9H293) Interleukin-17E precursor (IL-17E)  
(P14778) Interleukin-1 receptor, type I precursor  
(P42330) Aldo-ketoreductase family 1 member C3  
(P27105) Erythrocyte band 7 integral membrane protein (Stomatin)  
(P04406) Glyceraldehyde-3-phosphate dehydrogenase, liver (EC 1.2.1.12)  
(P08107) Heat shock 70 kDa protein 1 (HSP70.1)  
(P62988) Ubiquitin (P0CG47,P0CG48,P62979,P62987) 
(P02261) Histone H2A.c/d/i/n/p (H2A.1) (H2A/c) (H2A/d) (H2A/i) (H2A/n) (H2A/p) 
(H2A.1b) H2AC_HUMAN; Demerged into P0C0S8 (H2A1_HUMAN) 
(P62805) Histone H4  
(Q01543) Friend leukemia integration 1 transcription factor  
(P62826) GTP-binding nuclear protein Ran (GTPase Ran) (Ras-like protein TC4)  
(O14830) Serine/threonine protein phosphatase with EF-hands-2 (EC 3.1.3.16)  
(Q9Y6X8) Zinc fingers and homeoboxes protein 2  
(Q99569) Plakophilin 4 
(Q8WUD1) Ras-related protein Rab-2B  
(Q9H082) Ras-related protein Rab-33B  
(Q9NRW1) Ras-related protein Rab-6B  
(P61106) Ras-related protein Rab-14  
(Q9NP58) ATP-binding cassette, sub-family B, member 6, mitochondrial precursor  
(P11171) Protein 4.1 (Band 4.1) (P4.1) (EPB4.1) 
 
 
 
3.3.6 Proteins identified from sample Hd 
A total of 41 proteins originating from both P. falciparum and the RBC proteome were 
identified from dissolved Hz crystals, of which 24 (59%) were P. falciparum proteins and 17 
(41%) were human RBC proteins as illustrated in a pie chart distribution diagram in Figure 
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3.9A. Of the 24 parasite proteins coming from the Hz crystal matrix listed in Table 3.6, only 
3 of the proteins (shaded in violet in Table 3.6) were not identified on the Hz crystal surface. 
Different subcellular location and functions have previously been asigned to these 3 proteins. 
The protein P50250 (adenosylhomocysteinase), involved in methionine and polyamine 
metabolism, is also known to be located in the cytoplasm and DV; P16893 (thrombospondin 
related anonymous protein) is known to be located in the parasite membrane, while P25408 
(hypothetical protein in calmodulin 3' region, fragment) has an unknown location. None of 
the 24 parasite proteins is known or suspected to be involved in the biomineralization process 
of Hz crystal formation in the DV. The distribution of parasite proteins by subcellular 
location showed 10 (31%) of the 24 proteins, were already known to be present in the DV 
(Figure 3.9B). Interestingly, the same number of proteins (10, 31%) were also known to come 
from the cytoplasm. The presence of these cytoplasmic proteins in sample Hd could only be 
considered as contaminants if they bound so strongly to the Hz surface that they could not be 
dislodged even after washing thoroughly with 4% SDS and rinsed with PBS. This seems very 
unlikely as only very few of these proteins would have been expected to still be present on 
Hz surface. Moreover, the proportion of cytoplasmic and DV proteins found on the Hz crystal 
surface (Figure 3.7A) to that in the matrix (Figure 3.9B) are almost similar. This, together 
with the equal number of DV and cytoplasmic proteins present in the Hz crystal matrix, 
strongly suggests that these cytoplasmic proteins trapped in the crystal matrix are actually 
present in the DV and as a result some were incorporated into the crystal matrix during Hz 
formation. In addition, the similarity in the proportions of cytoplasmic and DV proteins 
present in the Hz surface to that in the matrix also showed that the use of 4% SDS efficiently 
washed off proteins on the surface of the Hz crystal. Some of these proteins have also been 
identified in more than one subcellular location in the parasite as shown in Appendix 4 
(which also includes the number of unique peptide fragements from each protein identified). 
All 17 human RBC proteins identified in sample Hd listed in Table 3.7 were also identified in 
sample Hs. None of these proteins has a known function related to Hz formation. It is worth 
mentioning that none of the expected proteins belonging to the protein complex proposed to 
convert haemoglobin to haemozoin (Chugh et al. 2012) (falcipain 2/2′, plasmepsin II, 
plasmepsin IV, histo aspartic protease (HAP), and haem detoxification Protein) were 
identified in the Hz crystal matrix with MASCOT analysis.  
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Figure 3.9. Distribution of the origin of proteins constituting the Hz matrix proteome showed the majority to be 
P. falciparum proteins (A) and further analysis of the P. falciparum proteins by subcellular location showed that 
the majority come from the DV and cytoplasm (B).  
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Table 3.6. List of all P. falciparum proteins found in sample Hd. 
(P25408) Hypothetical protein in calmodulin 3'region (fragment)  
(P16893) Thrombospondin related anonymous protein 
(P50250) Adenosylhomocysteinase (EC 3.3.1.1)  
(Q8I3H7) T-cell immunomodulatory protein homolog precursor  
(Q00080) Elongation factor 1-alpha (EF-1-alpha)  
(P11144) Heat shock 70 kDa protein (HSP70)  
(P39898) Plasmepsin 1 precursor (EC 3.4.23.38)  
(P04932) Merozoite surface protein 1 (P195)   
(P38545) GTP-binding nuclear protein Ran (GTPase Ran)  
(Q07805) Ornithine aminotransferase (EC 2.6.1.13)  
(P10988) Actin I  
(P14643) Tubulin beta chain (Beta tubulin) 
(Q04956) Probable cation-transporting ATPase 1 (EC 3.6.3.-)   
(P40282) Histone H2A  
(P50647) Ribonucleoside-diphosphatereductase large chain (EC 1.17.4.1)  
(P13830) Ring-infected erythrocyte surface antigen  
(P14883) Actin II  
(P13922) Bifunctionaldihydrofolatereductase-thymidylate synthase  
(P34787) Tubulin gamma chain (Gamma tubulin) 
(P25805) Trophozoite cysteine proteinase precursor (EC 3.4.22.-)  
(Q8I3H7) T-cell immunomodulatory protein homolog precursor  
(Q9UAR6) Myosin A (PfM-A)  
(P16405) Octapeptide-repeat antigen (ORA) (Fragment)  
(Q08210) Dihydroorotate dehydrogenase homolog, mitochondrial precursor  
 
Table 3.7. List of all human RBC proteins found in sample Hd. 
(P13727) Eosinophil granule major basic protein precursor  
(P61106) Ras-related protein Rab-14  
(P68871) Haemoglobin beta chain  
(P27105) Erythrocyte band 7 integral membrane protein (Stomatin)  
(P62805) Histone H4  
(P02768) Serum albumin precursor  
(P11166) Solute carrier family 2, facilitated glucose transporter,  
(P69905) Haemoglobin alpha chain  
(P02730) Band 3 anion transport protein  
(Q9Y6X8) Zinc fingers and homeoboxes protein 2  
(P62988) Ubiquitin (P0CG47 (UBB_HUMAN), P0CG48(UBC_HUMAN), P62979 
(RS27A_HUMAN), P62987 (RL40_HUMAN) 
(P08107) Heat shock 70 kDa protein 1 (HSP70.1) (HSP70-1/HSP70-2) 
(P59190) Ras-related protein Rab-15  
(Q9H082) Ras-related protein Rab-33B  
(Q9NRW1) Ras-related protein Rab-6B  
(P08311) Cathepsin G precursor (EC 3.4.21.20) (CG) CATG_HUMAN 
(P02261) Histone H2A.c/d/i/n/p (H2A.1)(H2A/c)(H2A/d)(H2A/i)(H2A/n)(H2A/p) 
(H2A.1b)  
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3.3.7 Proteins previously implicated in Hz crystal formation in the DV 
In view of recent reports, surprisingly, using MASCOT analysis with peptide identification 
set at 95% confidence level, none of the proteins belonging to the proposed protein complex 
(falcipain 2/2′, plasmepsin II, plasmepsin IV, HAP, or haem detoxification protein) suggested 
as being required for haemoglobin degradation and Hz formation was identified (Chugh et al. 
2012). On the other hand, plasmepsin I (PMI), which begins the digestion of haemoglobin 
and is thought to be the most abundant and important aspartic protease, was found both on 
the Hz crystal surface and in the matrix. This protein has also been found to be abundant in 
the DV (Lamarque et al. 2008) and has been shown with immunoelectron microscopy study 
of trophozoites using anti-PM I antibodies to colocalize with haemozoin in the DV (Banerjee 
et al. 2002). Another protein known to convert haem to -haematin, HRPII, previously 
thought to be responsible for Hz formation (Sullivan et al. 1996), was not detected either on 
the Hz crystal surface or in the matrix proteome. HRPII is known to be located mainly in the 
erythrocyte periphery, although it has been suggested that about 3% of can be trafficked into 
the DV (Lamarque et al. 2008). This also implies that it is possible for other erythrocyte 
proteins to be trafficked into the parasite DV as illustrated in Figure 3.2. Indeed, many such 
proteins were readily identified. 
 
For curiosity purposes, MASCOT analysis was also set at a peptide confidence interval of 
80% to determine if any of the proteins belonging to the proposed haemozoin-forming 
complex could be identified, but again none were found (data not shown). A second analysis 
with the X!Tandem algorithm could only identify one protein, HAP (Q8IM15_PLAF7), 
belonging to the proposed protein complex. Haem detoxification protein (HDP) (PlasmoDB # 
PF14_0446) is the most important protein in this complex for haemozoin formation and has 
been reported to be approximately 1000-fold more efficient in converting haem to haemozoin 
in vitro (Jani et al . 2012). HDP is thought to have 2.7 haem binding sites and binds strongly 
to haem with a binding constant (Kd) of 80 nM (Jani et al. 2008), yet HDP was not present 
either on the Hz surface or in the matrix proteome in any of the analyses using either the 
X!Tandem algorithm or MASCOT set at the 95% or 80% peptide confidence level. Study by 
Lamarque et al. (2008) of DV proteome identified amongst other proteins HAP, plasmepsin 
II, plasmepsin IV, and falcipain 2 belonging to the proposed protein complex, therefore they 
are certainly detectable in the DV, but appear to show no affinity for Hz. HDP was not 
reported to be present in the DV proteome by these authors. Indeed, HDP is known to be 
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produced in the parasite cytoplasm and is supposed to be trafficked into the DV. The absence 
of it in the DV proteome and, most especially, on the Hz crystal surface or in the matrix 
cannot completely exclude its presence in the DV. The study of proteomes of various crystal 
matrices in a variety of biominerals in different organisms has invariably led to the 
identification of those protein(s) involved in the nucleation and/or initiation of crystal growth 
(Alves et al. 2011, Mann et al. 2008, Arakaki et al. 2008, Marie et al. 2011, Nemoto et al. 
2012 and Mann et al. 2006). The absence of HDP in the proteome associated with either the 
Hz crystal surface or the matrix therefore tends to suggest that it is unlikely to be involved in 
the Hz formation in the DV. The high affinity binding of HDP to haem as determined by Jani 
et al. (2008) may mean HDP is more likely to function as either a haem transporter (haem 
transport protein) from the site of haemoglobin digestion where haem is released to the inner 
walls of the DV where crystal growth is said to take place (Kapishnikov et al. 2012) or HDP 
is temporarily recruited into the DV to bind free haem in stressful conditions in the parasite 
when more haem is released than can be efficiently sequestered into Hz due to interference, 
e.g. treatment with drug, or is involved in protection from haem outside the DV or has some 
other function. 
 
3.3.8 Some known proteins identified associated with the Hz crystal surface and matrix  
The identification of human proteins in parasite structures is in line with other studies which 
have found mature parasite-infected erythrocyte surface antigen to be associated with protein 
4.1 (Waller et al. 2003), a human RBC protein also identified on the surface of Hz crystals in 
this study as well as parasite surface proteins such as P04932 (merozoite surface protein 1 
(P190)), P50489 (apical membrane antigen 1 precursor) and P13819 (merozoite surface 
protein 1 precursor). The merozoite surface proteins and other surface proteins expressed in 
mature schizonts or in merozoites and found to be present in this study could arise from 
enrichment of mature trophozoite stage iRBCs of which some might have already advanced 
into schizonts expressing these proteins. Proteins such as Q00080 (elongation factor 1-alpha 
protein) and others involved in cell protein translational machinery are known to always be 
present in 1D gels as classical contaminants due to their high abundance in the parasite (Le 
Roch et al. 2003). ADP-ribosylation factor (Q94650) identified associated with the surface of 
the Hz crystal is a key protein required for protein trafficking in the parasite as it assembles 
proteins that coat transport vesicles. This protein has also been previously indentified in the 
DV (Lamarque et al. 2008). This study showed that an active trafficking route exists for 
proteins produced in some cytoplasmic organelles to be trafficked or diverted into the DV to 
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carry out certain functions. DV membrane proteins such as P13568 (multidrug resistance 
protein) identified on the Hz crystal surface could come from the lysed DV membrane. This 
was expected since nothing was done to remove such components from sample Hs since a 
conservative washing protocol was deliberately employed. Enzymes involved in basic 
metabolism such as (Q02155) hexokinase and (Q27727) enolase identified on the surface of 
the Hz crystal are highly abundant in cells and therefore may be cytosolic contaminants. 
Glycophorin-binding protein (P02895), elongation factor 1 alpha (Q00080) and the heat 
shock 70 kDa protein (P11144) identified on the Hz surface have also been found to be 
differentially up- and down-regulated by greater than five-fold between RBC and iRBC 
membranes (Fontaine et al. 2012), which again highlights the fact that protein produced in the 
parasite cytoplasm or cytoplasmic vesicles can either be trafficked or diverted into the host 
cell cytoplasm or membrane and/or into the DV. Thioredoxinreductase (P61076), also found 
to belong to the DV proteome, is known to play a role in various cellular functions such as in 
antioxidant defence, redox-sensitive signal transduction, transcriptional activation of stress-
response genes etc (Nickel et al. 2006).  
 
Actin I (P10988), actin II (P14883), tubulin beta-chain (P14643) and tubulin gamma chain 
(P34787) are some of the cytoskeletal proteins found in Hz crystal matrix proteome. Another 
organism known to form biocrystals (magnetite) through a biomineralization process is the 
magnetotactic bacteria. The magnetite surrounded by lipid bilayer membrane has a dedicated 
cytoskeleton which organizes it into chains (Komeili et al. 2007). Lipid-mediated formation 
of Coccolith biocrystals in Emiliania huxleyi algae also has cellular cytoskeletal elements 
which control the crystal shape. However, the cytoskeletal proteins identified in dissolved Hz 
crystal may just be involved in the DV cytoskeleton as they have not been shown to play a 
similar role in Hz crystal growth shape. 
Heat shock 70 KDa protein (HSP 70) (P11144) and heat shock 70 KDa protein1 (P08107) 
from the parasite and RBC proteome respectively are some of the chaperones found present 
in the Hz crystal matrix. The heat shock 70 KDa protein and heat shock 90 KDa protein 
(HSP90) are among the most widely-studied molecular chaperones whose function is to 
facilitate the folding of other proteins both under normal and stressful conditions and in the 
case of malaria parasite they are known to play an important role in parasite development 
(Shonhai et al. 2005 and 2007). The malaria parasite experiences a heat shock during 
transmission from about 25
o
C in the insect vector to about 37°C in humans (Bayoh et al. 
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2003) although it is not known if the parasite heat shock proteins play an important role in its 
adaption to such drastic change in temperature. HSP70 and HSP90 are known to be 
associated with Fe(III)PPIX (Famin and Ginsburg, 2003) and have therefore been earmarked 
as potential targets for antimalarial drug development (Pesce et al. 2010 and Shonhai, 2010). 
For example, some pyrimidinone compounds are known to exhibit their antimalarial activity 
by binding to the EEVD motif of Hsp70 while geldanamycin (benzoquinone ansamycin class 
of drugs) is said to exhibit its antimalarial activity by inhibiting HSP90 chaperone activity 
(Stebbins et al. 1997) which results in the inhibition of parasite growth although its exact 
mechanism of action is not known. This therefore highlights the importance of HSP70 and 
HSP90 in parasite development and survival. In effect, the presence of some of these proteins 
(both from parasite and RBC) in the matrix therefore makes it seem likely that these proteins 
were incorporated into the intracrystalline matrix because they are present in the 
crystallization compartment at the time when the Hz crystal growth started in the DV. 
 
Since only about 60% of the P. falciparum genome has been annotated, it might have been 
expected that uncharacterized proteins belonging to the parasite genome which play a role in 
the nucleation of Hz crystal growth would also be identified in the Hz crystal matrix. But 
none of these putative uncharacterized proteins belonging to the parasite genome was 
identified using MASCOT analysis set at 95% peptide confidence level. Alternatively, one or 
more proteins constituting the proteome of the Hz crystal matrix could play an alternative or 
secondary role in Hz crystal growth besides their known function in the parasite. However, 
this seems somewhat unlikely as haem sequestration into Hz is a major process and would be 
expected to required proteins or other bioorganic molecules dedicated for that process. Based 
on the proteins identified, constituting the proteomes associated with both the Hz crystal 
surface and matrix, it would seem likely that bioorganic molecules other than proteins may be 
actively responsible for Hz crystal growth in the DV. 
 
3.3.9 Protein versus lipid in mediated Hz formation 
Since HDP was not detected either associated with the Hz crystal surface or in the matrix 
using an LC-MS instrument sensitive enough to detect 5-10 protein molecules per Hz crystal 
using the quantities of material utilized in this study, this suggests that if HDP is present in 
association with Hz, it is present in extraordinarily low abundance. 
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On the other hand, Pisciotta et al. (2007) showed neutral lipids to be present at a ratio of 15 
per 100 haem molecules. This corresponds to a NLB amount of 1.8 nmol in a sample 
corresponding to a lane in the present study. Thus, at the reported protein detection limit of 5-
10 fmol there would be 180 000-360 000 times more lipid than HDP. Thus, notwithstanding 
the reported 1000-fold greater efficiency of conversion of haem to Hz by HDP, at the 
amounts present in association with Hz lipids are still likely to bring about the conversion 
200 times faster and play the dominant role in Hz formation.  
 
This calculation, coupled with the absence of proteins belonging to the protein complex 
proposed to be involved in Hz formation from the proteome associated with the Hz surface or 
matrix, raises the question of any involvement of these proteins in the biomineralization 
process of Hz formation. If any proteins are involved, those found in the Hz matrix proteome 
are more likely candidates and could be investigated further to see whether, besides their 
known function, they do play an alternative role in the biomineralization process of Hz 
formation. The absence of any evidence of HDP or members of its putative protein complex 
in Hz matrix together with the identification of known lipoproteins responsible for lipid 
transport/biosynthesis and other uncharacterized proteins with assigned function mainly to 
transport hydrophobic molecules such as lipids across the membrane seems to further 
strengthen the proposed involvement of lipids in the biomineralization process of Hz 
formation in the DV. 
 
3.3.10 Lipid TLC of Hz crystal 
Separation of chloroform/methanol (2:1) washed extracts from Hz crystals isolated from 
malaria parasites on a TLC plate in two different solvent systems gave several spots upon UV 
visualization of the premuline stained TLC plate. The Rf of TLC separations of known 
individual lipids constituting the NLB identified by Pisciotta et al. (2007) in the same solvent 
system was used as a control to identify the different lipid spots coming from the Hz crystal 
surface as shown in Figure 3.10. 
 
Based on the Rf of the reference lipids, all the NLB lipid constituents were found associated 
with the Hz sample, confirming that this lipid blend is indeed associated with the surface. The 
lipid spot at the top of the TLC plate (which could ether be triacylglycerol or non-esterified 
fatty acid) and another spot below that of MSG and MPG (which could also be either 
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phosphatidylcholine or phosphatidylethanolamine) was also previously shown to be present 
on the Hz crystal surface by Pisciotta et al. (2007). 
 
 
Figure 3.10. Lipid TLC of chloroform/methanol washed Hz crystals showed the presence of MSG, MPG, DPG, 
DLG and DOG on its surface. 
 
3.4 CONCLUDING REMARKS 
The availability of the complete genomic sequence of both P. falciparum and its host RBC 
presented a good starting point to use proteomic tools to study the proteome of the Hz surface 
and matrix in order to identify protein(s) that may be responsible for Hz formation and which 
could potentially serve as new antimalarial targets. This study led to the identification of 
more than a hundred proteins of both parasite and RBC origin. Some of the proteins 
identified were already described in locations other than the DV and some may be 
contaminants arising from the Hz isolation process. Proteins found in DV not identified in 
this study are most likely not bound to the surface or incorporated into the matrix of Hz 
crystal. Seemingly, this is the first ever comprehensive study of the proteome of the Hz 
surface and matrix and also showed the presence of RBC proteins on the surface and in the 
matrix of Hz. This study also produced the first comprehensive list of the proteome 
associated with the Hz crystal in the DV. Finally, the idea of Hz crystal growth in the DV 
being nucleated and/or initiated by any of the proteins previously implicated in the process 
2nd front 
(hexane:diethylether:
acetic acid) 16:10:1 
1st front 
(CCl4:MeOH:H2O) 
50:20:3
MSG MPG DPG DLG DOG
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seem very unlikely as none were found to be bound to the crystal surface let alone 
incorporated into Hz crystal matrix. So far, proteomic studies of the Hz crystal did not 
identify any “stand-out” protein and/or previously described proteins that could be implicated 
solely in mediating this process of Hz formation in the malaria parasite. On the contrary, in 
this study, lipids stood out as the most likely bioorganic molecules actively involved in 
mediating the process based on their vastly greater abundance over proteins implicated in 
mediating this process. In addition, for the first time, putative lipoproteins and 
uncharacterised proteins with roles in lipid binding and transport were identified as part of the 
Hz crystal associated proteome.  
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4. KINETIC STUDIES OF LIPID MEDIATED BETA-HAEMATIN FORMATION  
 
4.1 INTRODUCTION  
From proteomic and lipodomic studies of the Hz crystal in the previous chapter, none of the 
proteins previously implicated in Hz formation such as HDP and HRP II or any unknown 
“stand-out” proteins that could be implicated in Hz formation in vivo were identified. In 
contrast, lipid constituting MPG/MSG/DPG/DOG/DLG was confirmed to be associated with 
the Hz crystal surface and lipids were proposed to be the most likely biomolecules 
responsible for Hz formation in vivo based on their vastly greater abundance over putative 
haemozoin-forming proteins associated with the Hz crystal. Previous TEM studies of P. 
falciparum iRBC by Pisciotta et al. (2007) had shown evidence of Hz in the DV associated 
with MPG/MSG/DPG/DOG/DLG in the ratio 2:4:1:1:1 by mass, which will be referred to as 
neutral lipid blend (NLB) (Pisciotta et al. 2007).  
As described in Chapter 1, the involvement of lipids in Hz formation was suggested by 
Bendrat et al. (1995) where they showed that acetonitrile extracts from haemozoin contains 
lipids which promote β-haematin formation. Fluorescence microscopic studies of Nile Red-
stained iRBC has also shown neutral lipid bodies to be associated with parasite DV which 
was confirmed by TEM studies of iRBCs (Jackson et al. 2004). Furthermore, previous studies 
have clearly shown some of the individual constituent lipids of NLB as well as NLB itself to 
be very efficient in mediating β-haematin formation in vitro (Picsiotta et al. 2007, Egan et al. 
2006, Hoang et al. 2010a and Hoang et al. 2010b). However, detailed kinetic information on 
effects of lipid concentration, lipid-to-Fe(III)PPIX ratio and biologically relevant ions on β-
haematin formation in the presence of NLB and its constituent lipids is still lacking. 
In this chapter, therefore, the kinetics of β-haematin formation with respect to the effects of 
NLB and its individual constituent lipids were further investigated. The effect of lipid and 
Fe(III)PPIX concentration on the kinetic of β-haematin formation and finally the influence of 
buffers and low molecular weight ions such as sodium, potassium, magnesium, calcium, 
phosphate, carbonate, ATP, reduced glutathione and 2,3-diphospho-D-glycerate (2,3-DPG) at 
concentrations at which they are present in RBC and/or serum on the kinetics of β-haematin 
formation under biomimetic conditions mimicking that in the DV was also investigated. 
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4.2 METHODS 
 
4.2.1 Determination of yield of β-haematin formation with lipid 
 
4.2.1.1 Experimental procedures 
β-Haematin was prepared using a method previously described (Hoang et al. 2010a) with 
some slight modifications as follows: 50 mL citric acid buffer (50 mM, pH 4.8) in a Schott-
Duran crystallization dish with internal diameter of 9 cm was pre-incubated for 30 min at 
37°C in a water bath. 1 mL of 3.31 mM lipid solution (NLB or an individual constituent 
lipid) was mixed with 500 μL of 2 mg/mL Fe(III)PPIX solution (2.15 lipid/ Fe(III)PPIX mol 
ratio) to give a total volume of 1.5 mL. Keeping the concentration of Fe(III)PPIX constant 
(3.07 mM), that of the lipid (NLB or an individual constituent lipid) was varied to give lower 
lipid/Fe(III)PPIX (L/H) mol ratios of 1.07, 0.54, 0.27, 0.13 and 0.067, each with a total 
volume of 1.5 mL. The control experiment which had no lipid consisted of 500 μL of 2 
mg/mL Fe(III)PPIX and 1 mL of 1:9 v/v of acetone/methanol. The above mixtures of lipid 
and Fe(III)PPIX at different mol ratios and that of the control were layered carefully on the 
surface of the pre-incubated citric acid buffer using a 1 mL syringe and this was incubated 
further at 37°C for 30 min for β-haematin formation. Each experiment was repeated at least 
three times.  
 
4.2.1.2 Quantification of β-haematin formed 
 
After 30 min incubation, the bulk reaction mixture in the Schott-Duran crystallization dish 
was completely transferred into a 50 mL transparent polycarbonate Nalgene centrifuge tube 
and centrifuged at 10 000 rpm for 15 min using an Eppendorf 5810 R centrifuge. The 
supernatant was discarded and the pellet used to quantify the amount of β-haematin (yield) 
formed using a reliable method previously described by Ncokazi et al. (2004). In this method 
the pellet was washed with 1 mL of 5% pyridine (pyridine does not dissolve β-haematin but 
will dissolve all the free Fe(III)PPIX in solution by forming a low-spin coloured complex 
with the Fe(III) centre of Fe(III)PPIX which has an absorption maximum at 405 nm). The 1 
mL of washed pellet was centrifuged at 14 000 rpm for 10 min in a small plastic 1.5 mL 
Eppendorf tube using an Eppendorf 5410 centrifuge. 50 μL of the coloured supernatant was 
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diluted with 1 mL of deionised water (1:20 dilution) and the absorbance was measured at 405 
nm using a Varian Cary 100 UV-Visible spectrophotometer. The yield was then calculated 
using equation 2. 
 
 
4.2.2 Effect of lipid identity and concentration on the kinetics of β-haematin formation  
 
4.2.2.1 Experimental procedures 
Kinetic studies were done for NLB and its indidvidual constituent lipids (MSG, MPG, DPG, 
DLG and DOG) at lipid/Fe(III)PPIX ratios of 2.15, 1.07 and 0.54. β-Haematin was prepared 
as described above in Section 4.2.2.1. In this case, incubation of the lipid and Fe(III)PPIX 
mixture for β-haematin formation was allowed to go on for varying lengths of time for the 
different L/H mol ratios. Each experiment was repeated at least three times for each time 
point. At the end of each incubation time, β-haematin formed was quantified as described in 
Section 4.2.1.2. The yield values obtained at different incubation times for a particular L/H 
mol ratio were used to generate a kinetic plot for that particular L/H mol ratio. 
 
4.2.3 Effect of Fe(III)PPIX concentration on yield of β-haematin formation 
 
4.2.3.1 Experimental procedures 
Keeping the concentration of MPG constant (16.1 M), which is the concentration of lipid at 
a 0.54 L/H mol ratio, the Fe(III)PPIX concentration used for β-haematin preparation as 
described in Section 4.2.2.1 was varied starting with a lower Fe(III)PPIX concentration of 
7.44 M (0.5 mg/mL) to a higher concentration of 4.1 mg/mL. The yield of β-haematin 
formed at each Fe(III)PPIX concentration was determined as described in Section 4.2.1.2. 
 
 
 
% Yield of β-haematin formed  =
Absorbance at 405 nm of test experiment
Absorbance at 405 nm of control experiment
1 ‒  100 .............(2)
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4.2.4 Kinetic study of β-haematin formation at Fe(III)PPIX concentrations greater than 
2 mg/mL  
 
4.2.4.1 Experimental procedures 
Fe(III)PPIX concentrations of 2.3 and 3.0 mg/mL corresponding to 0.47 and 0.36 L/H mol 
ratios respectively were used to generate kinetic data for β-haematin formation as described 
in Section 4.2.3.1. Yield values of β-haematin formed at different incubation time were 
determined as described in Section 4.2.1.2 and used to generate a kinetic plot. All kinetic 
experiments were repeated at least three times.  
 
4.2.5 FT-IR characterization of product formed with Fe(III)PPIX and lipid  
 
4.2.5.1 Experimental procedures  
Products formed from β-haematin formation kinetic experiments with NLB at 2 min and with 
MPG at 30 min incubation times, as described in Section 4.2.3.1, were harvested by 
centrifugation at 10 000 rpm for 15 min using an Eppendorf 5810 R centrifuge. The 
supernatant was discarded and the pellets dried in a dessicator over phosporous pentoxide for 
3-5 days. The dried product was ground to fine powder using a morter and pestle and then 
suspended in Nujol to form a nujol mull. The IR spectrum of the nujol mull was recorded 
using a Perkin-Elmer Spectrum 100 FT-IR spectrophotometer.  
 
4.2.6 Characterization of product formed with Fe(III)PPIX and lipid using TEM and 
TEM-ED  
 
4.2.6.1 Experimental procedures  
Samples containing product formed with Fe(III)PPIX and lipid were carefully taken from the 
reaction mixture using a micropipette and placed on a glow-discharged carbon-coated grid. 
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Excess solution was blotted on Whatman filter paper number 1 and the grid was immediately 
stained with a negative stain (uranyl acetate) for 3-5 min. Excess stain was blotted on 
Whatman filter paper number 1 and the grid was allowed to dry at room temperature. The 
TECNAI TF20 TEM operating at 200 kV located at the Electron Microscope Unit, University 
of Cape Town, was used for imaging the grid and also for acquisition of the electron 
diffraction pattern from imaged crystals. 
 
4.2.7 Confocal laser microscopy study of product formed with Fe(III)PPIX and lipid  
 
4.2.7.1 Experimental procedures  
From the reaction mixture of the kinetic study of β-haematin formation with MPG at 0.54 
L/H mol ratio, 2 μL of the suspension was taken from the reaction mixture at 10, 20, 30 and 
60 min incubation time and placed on different glass microscope slides. A thin glass cover 
slip was placed on top of each solution carefully to avoid air bubble formation in the liquid 
between the glass slide and cover slip. The glass microscope slides were carefully inverted 
and mounted in the LSM510-META Zeiss confocal microscope sample chamber located at 
the Confocal and Light Microscope Imaging facility at the University of Cape Town. The 
samples were viewed with water immersion. Continuous z-stacked images of 
autoflourescence arising from the product formed at different incubation times were acquired 
under the following conditions; pin hole diameter of 444 μm, excitation laser at 488 nm, 20% 
transmission power out, detection band pass 500-530 nm (emission) and LD C-Apochromat 
40x/1.1 W objective. 
  
4.2.8 Effect of dish diameter on the kinetics of β-haematin formation 
 
 4.2.8.1 Experimental procedures  
The kinetics experiment using MPG at 0.54 L/H mol ratio was repeated as described above in 
Section 4.2.3.1, except that a 100 mL beaker with an internal diameter of 5 cm was used 
instead of the usual 9 cm Schott-Duran crystallization dish. 
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 4.2.9 Effect of Buffers on the kinetics of β-haematin formation 
 
 4.2.9.1 Sample preparation  
50 mM MES (4-morpholineethanesulfonic acid) buffer, pH 4.8:  
4-Morpholineethanesulfonic acid (9.76 g) was dissolved in 1 L deionised water. The pH was 
adjusted to 4.8 with NaOH slurry.  
 
50 mM Sodium acetate buffer, pH 4.8: 
Sodium acetate anhydrous (4.102 g) was dissolved in 1 L deionised water. The pH was 
adjusted to 4.8 with perchloric acid.  
 
4.2.9.2 Experimental procedures 
Kinetic experiments for β-haematin formation with MPG at 0.54 L/H were done as 
previously described in Section 4.2.3.1. In this case, MES and sodium acetate buffers were 
used instead of the usual citric acid buffer. Quantification of β-haematin yields for kinetic 
plots were determined as described in Section 4.2.2.2.  
 
4.2.10 Effect of physiologically relevant ions and other low molecular weight bio-
molecules on kinetics of β-haematin formation 
 
4.2.10.1 Sample preparation 
 
RBC concentration of low molecular weight bio-molecules: 
 
8.0 mM sodium ions: 
NaCl (0.4675 g) was dissolved in 1 L of 50 mM citric acid buffer (pH 4.8) and minor pH 
adjustments to 4.8 were made with NaOH slurry. 
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150 mM potassium ions: 
KCl (11.184 g) was dissolved in 1 L of 50 mM citric acid buffer (pH 4.8) and minor pH 
adjustments to 4.8 were made with NaOH slurry. 
 
 1.75 mM Magnesium ions: 
MgCl2.6H2O (0.3558 g) was dissolved in 1 L of 50 mM acetate/acetic acid buffer (pH 4.8) 
and minor pH adjustments to 4.8 were made with NaOH slurry.  
 
1 mM phosphate ions: 
Na2HPO4 (0.14196 g) was dissolved in 1 L of 50 mM citric acid buffer (pH 4.8) and minor 
pH adjustments to 4.8 were made with NaOH slurry.  
 
15 mM hydrogen carbonate ions: 
NaHCO3 (1.26015 g) was dissolved in 1 L of 50 mM citric acid buffer (pH 4.8) and minor pH 
adjustments to 4.8 were made with NaOH slurry. This leads to the formation of sodium 
citrate and CO2 at this pH. 
 
1.5 mM ATP: 
Adenosine 5′-triphosphate disodium salt (0.82671 g) was dissolved in 1 L of 50 mM citric 
acid buffer (pH 4.8) and minor pH adjustments to 4.8 were made with NaOH slurry. 
 
2.48 mM Glutathione: 
L-glutathione reduced powder (0.76210 g) was dissolved in 1 L of 50 mM citric acid buffer 
(pH 4.8) and minor pH adjustments to 4.8 were made with NaOH slurry under argon. 
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4.5 mM of 2,3-diphospho-D-glyceric acid pentasodium salt: 
 
2,3-DPG salt (0.3382g) was dissolved in 200 mL 50 mM citric acid buffer (pH 4.8) and 
minor pH adjustments to 4.8 were made with NaOH slurry. 
 
Ions at RBC concentration combined: 
A solution of 8.0 mM Na
+
, 150 mM K
+
, 1.75 mM Mg
2+
, 1 mM H2PO4

, 15 mM HCO3

 and 
1.5 mM ATP was prepared in 1 L of 50 mM citric acid buffer (pH 4.8) and minor pH 
adjustments to 4.8 were made with NaOH slurry. 
 
Plasma concentration of low molecular weight bio-molecules: 
 
150 mM sodium ions: 
NaCl (8.766 g) was dissolved in 1 L of 50 mM citric acid buffer (pH 4.8) and minor pH 
adjustments to 4.8 were made with NaOH slurry. 
 
1.5 mM Magnesium ions: 
MgCl2.6H2O (0.30495 g) was dissolved in 1 L of 50 mM citric acid buffer (pH 4.8) and 
minor pH adjustments to 4.8 were made with NaOH slurry. 
 
3.0 mM calcium ions: 
CaCl2.2H2O (0.44106 g) was dissolved in 1 L of 50 mM acetate/acetic acid buffer (pH 4.8) 
and minor pH adjustments to 4.8 were made with NaOH slurry. 
 
Ions at serum concentration combined: 
A solution of 150 mM Na
+
, 1.75 mM Mg
2+
 and 3 mM Ca
2+
 was prepared in 1 L of 50 mM 
citric acid buffer (pH 4.8) and minor pH adjustments to 4.8 were made with NaOH slurry. 
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4.2.10.2 Experimental procedures 
Kinetic experiments for β-haematin formation with MPG at 0.54 L/H were done as 
previously described in Section 4.2.3.1, but in the presence of all the above bio-molecules 
dissolved in citric acid buffer individually and in combination at their respective 
concentrations at which they are present in RBC or plasma. Determination of β-haematin 
yields for preparing the kinetic plots was done as described in Section 4.2.1.2. 
 
4.3 RESULTS AND DISCUSSION 
 
4.3.1 Infrared characterisation of crystalline product mediated by NLB and MPG 
FT-IR was used to characterise the crystalline products formed with NLB and MPG after 2 
and 30 min incubation respectively. This was done because quantification of β-haematin 
formed was done indirectly by measuring the amount of unreacted Fe(III)PPIX and this alone 
does not prove that the remaining product formed is β-haematin. Therefore the products 
formed with these lipids were dried over P2O5 in a desiccator and FT-IR spectra of the dried 
products prepared as Nujol mulls were obtained using a Perkin-Elmer Spectrum 100 FT-IR 
spectrophotometer. The spectrum showed characteristic peaks at 1661 and 1210 cm
-1
 arising 
from C=O and C−O stretching vibrations of β-haematin. This β-haematin spectrum is 
identical to those of Slater et al. (1991) obtained from β-haematin and Hz crystals. Peaks at 
1550 and 1320 cm
-1
 are from nujol (Figure 4.1).  
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Figure 4.1: FT-IR spectra of dried product formed with NLB or MPG and Fe(III)PPIX. Products formed with 
NLB and Fe(III)PPIX (thick line) or MPG and and Fe(III)PPIX (thin line) showed characteristic β-haematin 
peaks at 1662 cm
-1
 and 1210 cm
-1
 (arrows). Thus confirming β-haematin is formed with both lipids. Peaks 
marked as () and (*) arising from nujol and lipid respectively. Reaction conditions: 2.15 L/H ratio (64.3 M 
total lipid), citric buffer (50 mM, pH 4.8), 37C, 2 min and 30 min incubation for NLB and MPG respectively. 
 
 
 
4.3.2 TEM and electron diffraction characterisation of β-haematin  
Besides FT-IR characterization of products formed with lipids, β-haematin is well known to 
be crystalline in nature and based on this criterion further characterization of the product was 
done using TEM. TEM imaging of the wet product formed with MPG within 30 min of 
incubation showed β-haematin formed during this reaction process to be crystalline in nature 
with a corresponding diffraction pattern exhibiting strong diffraction spots which 
unequivocally confirmed β-haematin crystals formed during this process (Figure 4.2). The 
indexed TEM-ED shows that the crystal lies at an arbitrary orientation of {972} exposing 
randomly selected diffraction planes to the electron beam as seen from diffraction spots 
arising from higher order Miller indices, with none of the principal crystallographic axes seen 
even with a double tilt goniometer stage. The β-haematin crystals are smaller than natural Hz 
in size and also exhibit a distinct external morphology. These differences in size and external 
morphology of β-haematin may account for the difference in the crystal {hkl} plane seen 
with TEM-ED to that of Hz (Solomonov et al. 2007) although this needs to be investigated 
further. 
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Figure 4.2: (A) TEM imaging of product formed with lipid and Fe(III)PPIX at the end of a typical kinetic 
reaction run showed they are crystalline in nature and (B) the electron diffraction pattern obtained from these 
structures gave bright spots of higher Miller indices from randomly selected diffraction planes which 
unequivocally demonstrated that β-haematin is formed during the reaction. Scale bar in A = 20 nm. 
 
 
 
4.3.3 Yields of β-haematin formation as a function of lipid concentration 
Starting with 64.27 M NLB (2.15 L/H mole ratio) an initial high yield of about 90% β-
haematin was obtained. When Fe(III)PPIX concentration was kept constant and the 
concentration of NLB was decreased, the yield remained relatively constant over a range of 
concentrations. This yield started to decrease below a mol ratio of 0.54 L/H and levelled out 
with a low yield at lower concentrations (Figure 4.3). Looking at the yield pattern of β-
haematin formed with the different lipid constituents of the NLB, a similar pattern was 
obtained with monopalmitic glycerol (MPG) as shown in Figure 4.4A. Monostearic glycerol 
(MSG) and dipalmitic glycerol (DPG) with observed precipitation in the assay gave relatively 
lower yields of about 40% at the highest concentration of the lipid (64.27 M) used in this 
study (Figure 4.4B & C) which was similar to yields obtained with NLB at lower lipid 
cencentrations. The lower yields at higher lipid concentration might be due lower solubilty of 
these two lipids since precipitated lipid was evident with DPG in solution. Dilinoleic glycerol 
(DLG) and dioleic glycerol (DOG) gave higher yields of about 80-90% β-haematin similar to 
that of NLB and MPG at higher lipid concentrations. DLG had a yield of about 40% at 0.27 
L/H mol ratio (Figure 4.4D) and DOG appears to be even more effecient as it gave a much 
higher yield of β-haematin of about 80% even at a much lower lipid concentration of 0.27 
L/H mol ratio (Figure 4.4E) and only started to decrease below this concentration. The L/H 
mol ratio at which the sharp decrease in yield was observed is hereafter refered to as the cut-
A B
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off point in this study. In the case of NLB and MPG this corresponds to an approximate mol 
ratio of 0.54 L/H. Pisciotta et al. reported that the extracted NLB from Hz crystals exists in 
the proportion of 15 lipid to 100 Fe(III)PPIX molecules. β-Haematin yield formed by NLB 
under relevant physiological conditions in this study showed this ratio to lie below the cut-off 
point where poor conversion of Fe(III)PPIX to β-haematin occurred. Other studies have also 
suggested that precipation of Fe(III)PPIX slows its conversion to β-haematin, if it is finally 
converted to β-haematin at all (Egan et al. 2001 & 2006). This is because the rate of 
conversion of Fe(III)PPIX to β-haematin is controlled by dissolution rather than 
crystallization, therefore, the drop in yields at higher Fe(III)PPIX concentrations (below 0.54 
L/H) coupled with the difficulty in obtaining a 100% yield with any of these lipids despite the 
longer incubation time at the highest concentration tested may be as a result of precipitation 
of fraction of the Fe(III)PPIX before it could be partitioned into lipid droplets. The 
precipitation of Fe(III)PPIX is likely not to occur in the parasite DV as Fe(III)PPIX is 
released at the rate at which haemoglobin is digested, meaning all the Fe(III)PPIX is not 
introduced into the crystallization compartment where Hz formation takes place at once in 
contrast to what was done at the beginning of the reaction in this study.  
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Figure 4.3: Yields of β-haematin formed with NLB. NLB gave a high yields of about 80-90% β-haematin at 
higher lipid/Fe(III)PPIX mol ratios staying relatively constant from 2.15 L/H (64.3 M total lipid) to 0.54 L/H 
after which it suddenly drops to a value of about 10 % below 0.067 L/H. Reaction conditions: Citric buffer (50 
mM, pH 4.8), 37C, 30 min incubation. Error bars represent SEM (L/H = 2.15 and 1.07, n = 6; L/H = 0.54 and 
0.27, n = 8; L/H = 0.13 and 0.067, n = 4; L/H = 0.033, n = 2). 
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Figure 4.4: Yields of β-haematin formed with individual constituent lipids of NLB. MPG gave high yields of 
about 80-90% at L/H ratios from 2.15 to 0.54 which decreased to about 10-20% at 0.27 L/H (A). MSG and DPG 
gave lower yields of about 40% at 2.15 L/H which decreased sharply to about 10-20% at L/H ratios of 0.54 and 
1.07 (B and C respectively). DLG gave high yields around 80-90% at higher mol ratios (2.15-0.54) which 
decreased sharply to about 30-40% at 0.27 L/H mol ratio and dropped further to about 10% and lower at 0.13 
L/H (D). DOG appears to be the most efficient lipid with a high yield of almost 90% between 2.15 L/H and 0.27 
L/H before decreasing sharply between 0.27 and 0.13 L/H (E). Reaction conditions: Citric buffer (50 mM, pH 4.8), 
37°C, incubated for 30 min. Constant total Fe(III)PPIX concentration of 30 μM. Error bars represent SEM (A, n=3; B, n=4; 
C – E, n=3).  
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4.3.4 Yields of β-haematin formation with DPG at non-physiological temperature of 
60
o
C 
As a result of the low yield of β-haematin observed in the reaction mediated by DPG at 37°C, 
the β-haematin yield was also determined at a much higher temperature of 60oC. This was 
done to check if the low β-haematin yield obtained was as a result of lower temperature 
causing the lipid to precipitate in solution or whether this lipid is just not as efficient as the 
other lipids in mediating β-haematin formation. β-Haematin yield obtained at 60oC with DPG 
increased tremendously (Figure 4.5) from about 40% at 37°C to about 90% at 60
o
C (64.3 M 
total lipid), with no observed precipitation of lipid in the reaction mixture. DPG has saturated 
hydrocarbon chains and had been shown to have a higher melting point (Tm) and activation 
energy compared to the other lipids with unsaturated hydrocarbon chains such as DLG and 
DOG (Hoang et al. 2010b), which may explain why it did not completely dissolved at 37°C. 
Meanwhile at a much higher temperature of 60
o
C, it dissolved completely. The complete 
dissolution of DPG at 60
o
C therefore increases the amount of lipid droplets in solution which 
helps to maintain much of the Fe(III)PPIX in the dissolved state and also to nucleate β-
haematin crystal formation which translates into increased yield at this elevated temperature. 
The yield trend obtained at 60
o
C with DPG was similar to that of DLG (Figure 4.4D).  
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Figure 4.5: Yields of β-haematin formed with DPG at 60oC. The yield of β-haematin formed increased greatly to 
about 90% at 2.15 L/H mol ratio (64.3 M total lipid) and stayed relatively constant through 0.54 L/H before 
gradually dropping to about 60% at 0.27 L/H, down to 20% at 0.13 L/H. Reaction conditions: Citric buffer (50 
mM, pH 4.8), 37C, 30 min incubation. Error bars represent SEM (n=4). 
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4.3.5 Kinetics of β-haematin formation with NLB and the effects of lipid identity and 
concentration on the kinetics of β-hematin formation 
The kinetics of β-haematin formation with NLB was very fast at mol ratios of 2.15 L/H and 
1.07 L/H (64.3 and 32.2 μM total lipid respectively). These reactions were completed within 
10 min with yields of above 80%. This is in accordance with previous studies (Hoang et al. 
2010a & Pisciotta et al. 2007) which showed NLB to be very efficient in mediating β-
haematin formation. The kinetics at 0.54 L/H mol ratio was slower but the reaction also gave 
a similar yield of about 80% when allowed to go to completion, which occurred within about 
1 hour (Figure 4.6). The above kinetics of β-haematin formation were modelled with the 
Avrami equation given in Chapter 1 as described previously by Egan et al. (2001). The 
kinetic process fitted well to the Avrami model with an Avrami constant n = 1 describing a 
solid-state process of nucleation and growth which conformed to pseudo first-order kinetics. 
Of the constituent lipids of the NLB, MPG showed the most similar kinetics. The reaction 
was very fast at 2.15 L/H and 1.07 L/H mol ratios reaching completion within less than 10 
min. The slow kinetics at 0.54 L/H mol ratio (Figure 4.7A) is comparable to the NLB at the 
same mol ratio. The kinetic plot started to level off after 30 min of incubation time which 
means the reaction effectively reached completion within 30 min. Thus, the drop in yield 
below the 0.54 L/H may be as result of the decrease in the rate of β-haematin formation. 
MSG at 2.15 L/H mol ratio mediated relatively slow kinetics (Figure 4.7B) with a lower yield 
of about 35% after 45 min compared to NLB and MPG at a much lower mol ratio of 0.54 
L/H. The kinetics mediated by DLG at 1.07 and 0.54 L/H mol ratios were relatively faster 
(Figure 7C) than NLB and MPG at the same 0.54 L/H mol ratio, indicating this lipid on its 
own promotes β-haematin formation faster than the NLB at same concentration. DOG, which 
has been shown above to be very efficient in forming β-haematin also exhibits the fastest 
kinetics at all the different L/H mol ratios studied (Figure 4.7D). The relatively slow kinetics 
of β-haematin formation with DOG at 0.27 L/H mol ratio can be compared to NLB and MPG 
at 0.54 L/H mol ratio. This study showed the unsaturated lipids (DLG and DOG) or the 
diaglycerides DLG, DOG and DPG (as seen at a much higher temperature of 60
o
C) are more 
efficient in mediating the formation of β-haematin than their monoglyceride counterparts 
(MPG and MSG). The efficiency with which these lipids mediate β-haematin formation 
remains high and only starts to drop significantly when there is one lipid molecule to two 
Fe(III)PPIX. Moreover, DOG and DLG which are liquid at room temperature are known to 
have lower activation energy (Hoang et al. 2010b) with respect to β-haematin formation at 
37°C since their Tm is below this temperature. The monoglycerides MPG and MSG are 
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known to form two crystalline polymorphs termed α and sub-α. The conversion of the α to 
the sub-α occurs at temperatures below 37°C for MPG (Hoang et al. 2010b), thus, this may 
account for its greater efficiency in mediating β-haematin formation than MSG at 37°C. The 
similarity in kinetic data at 0.54 L/H mol ratio for both the NLB and MPG (Figure 4.6 and 
4.7A) with almost the same rate constants, k, suggest that MPG is a good lipid model of the 
NLB to study the effect of other substances on the kinetics of β-haematin formation. It is also 
much cheaper than some of the other constituent lipids of the NLB. Furthermore, the very 
fast rate of β-haematin formation by NLB and MPG could be decreased to an appreciably 
slower rate without any significant change in the overall yield obtained by decreasing the 
lipid to Fe(III)PPIX ratio to about 0.54. This allowed the effect of other low molecular weight 
ions on the kinetics of β-haematin formation to be conveniently investigated. 
 
 
 
 
 
 
 
 
Figure 4.6: Kinetics of β-haematin formation with NLB. NLB showed fast kinetics at higher mol ratios of 2.15 
(■) and 1.07 L/H (▲) with the reactions completed within 10 min giving yields of about 80 %. The kinetic 
curve conformed to the Avrami equation with Avrami n = 1 describing pseudo first-order kinetics. The rate 
constants obtained were 1.9 ± 0.2 and 1.6 ± 0.1 min
1 respectively. 0.54 L/H (●) gave relatively slower kinetics 
with k = 0.082 ± 0.006 min
1
. Reaction conditions: incubation at different times, citric buffer (50 mM, pH 4.8), 
37 C. 
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 Figure 4.7: Kinetics of β-haematin formation with individual lipid constituent of NLB. MPG showed fast 
kinetics at 2.15 L/H (■) and 1.07 L/H mol ratio (▲) with k = 0.61 ± 0.07 and 0.40 ± 0.03 min1 respectively, 
which slowed down at 0.54 L/H mol ratio (●) with k = 0.085 ± 0.006 min1, similar to that of NLB (A). MSG at 
the highest lipid concentration (2.15 L/H) showed slower kinetics than NLB and MPG at 0.54 L/H mol ratio, 
with k = 0.044 ± 0.007 min
1
 (B). DLG at 1.07 L/H (▲) and 0.54 L/H (●) appeared to give relatively faster 
kinetics than that of NLB at same mol ratio with k = 1.2 ± 0.2 and 0.27 ± 0.02 min
1
 respectively, while at 0.27 
L/H mol ratio (□) the reaction was relatively slower with k = 0.058 ± 0.009 min1 (C). The kinetics with DOG 
were exceptionally fast at 1.07 L/H (▲) and 0.54 L/H mol ratio (●) with k = 2.4 ± 0.2 and 0.69 ± 0.08 min1 
respectively while at 0.27 L/H (□) the kinetics were slower with k = 0.094 ± 0.008 min1, comparable to NLB 
and MPG at mol ratio of 0.54 L/H (D). Reaction conditions: Citric buffer (50 mM, pH 4.8), 37°C. Constant total 
Fe(III)PPIX concentration of 30 μM. Error bars represent SEM (n = 4, except D for which n = 3).  
 
4.3.6 Effect of Fe(III)PPIX concentration on yields of β-haematin formed 
The concentration of MPG corresponding to the cut-off L/H mol ratio (16.06 M) in the 
experiments described above was used to study the effect of varying Fe(III)PPIX 
concentration on the yield of β-haematin formed. Starting at 7.44 M (0.5 mg/ml) of 
Fe(III)PPIX the yield of β-haematin formed stayed relatively constant through 30 M (2.0 
mg/mL), after which it started to decline before levelling off at 45 M (3.0 mg/ml) with a 
yield of about 10 % (Figure 4.8). The cut-off ratio here is identical to that obtained by 
decreasing lipid concentration while keeping Fe(III)PPIX constant.  
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Figure 4.8: Effect of Fe(III)PPIX concentration on yields of β-haematin formed. About 80% yields of β-
haematin were obtained with 0.5 mg/ml (2.15 L/H) to 2.0 mg/mL (0.54 L/H) Fe(III)PPIX and 16.1 M MPG 
which started to decline from 2.3 mg/mL (0.46 L/H) to 2.5 mg/mL Fe(III)PPIX to about 30-50% and levelled 
out to a lower yield of about 10% at 3.0 mg/mL (0.36 L/H) and 4.1 mg/mL (0.27 L/H). Reaction conditions: 
Incubation time was 30 min at 37 C, citric buffer (50 mM, pH 4.8). Error bars represent SEM, (n = 3). 
 
4.3.7 Kinetic studies of β-haematin formation at Fe(III)PPIX concentrations higher than 
2 mg/mL and MPG at 16 µM (below cut-off concentration of lipid/Fe(III)PPIX ratio) 
Looking at the differences in the yield of β-haematin formed above and below the 0.54 L/H 
cut-off mol ratio, an experiment was performed to investigate if the difference in β-haematin 
yield arose from slower kinetics or a decrease in the extent to which the reaction occurred. 
Starting at 2.3 mg/mL (0.46 L/H) through 3.0 mg/mL (0.36 L/H) Fe(III)PPIX concentration, 
the rates of β-haematin formation were relatively constant (Figure 4.9) compared to that at 
0.54 L/H. This therefore suggests that the decrease in β-haematin yield below the cut-off ratio 
is not due to the rate at which β-haematin is formed but the extent to which it is formed. The 
observed general decrease in yield below this cut-off point of 0.5 L/H might be as result of 
the precipitation of Fe(III)PPIX in solution, which slows down its dissolution and partitioning 
into lipid droplets in solution thereby decreasing its conversion to β-haematin as previously 
described by Egan et al. (2001 & 2006). Also important is that fact below the cut-off the 
number of Fe(III)PPIX molecules is high compared to the number of available lipid 
molecules or droplets. This may cause the precipitation of Fe(III)PPIX as there are not 
enough lipid droplets to keep the Fe(III)PPIX in the suspension and hence to facilitate their 
conversion to β-haematin. While at higher L/H mol ratio above 0.54, there are more than 
enough lipid droplets to maintain Fe(III)PPIX in the dissolved state and also to nucleate β-
haematin crystal growth although it seems likely that small amounts of Fe(III)PPIX might 
still precipitate since a yield of 100% was never obtained. 
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Figure 4.9: Kinetics of β-haematin formation at L/H mol ratios below the 0.54 cut-off of MPG. The kinetics of 
β-haematin formation at 0.46 L/H (∆) gave k = 0.12 ± 0.02 and that at 0.36 L/H () gave a k = 0.11 ± 0.02 
min
1
 which are similar to the rate constants obtained at 0.54 L/H (where k = 0.085  0.006 min1). Reaction 
conditions: Incubation at different times, citric buffer (50 mM, pH 4.8), 37C, MPG (16.06 M). Total 
Fe(III)PPIX concentrations were 35 and 45 μM respectively. Error bars represent SEM (n = 4). 
 
 
4.3.8 Effect of dish diameter on the kinetics of β-haematin formation 
There was a change in the kinetics of β-haematin formation with change in diameter (5 cm) 
of the crystallization vessel used in the kinetic study as shown in Figure 4.10. This 
discrepancy in the rate of β-haematin formation resulting from a change in the diameter of the 
reaction vessel may either be due to the rate of mixing between the lipid solution and the 
citric acid buffer or the rate at which Fe(III)PPIX is efficiently transported to the lipid 
droplets through the solution which might depend on the thickness of the interface where the 
solutions mixed. As a result of this discrepancy in kinetics, all further studies on the effect of 
low molecular weight bio-molecules found in RBC or serum were done in the 9 cm internal 
diameter Schott-Duran crystallization vessel which had been used in all preceding work. 
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Figure 4.10: Kinetics of β-haematin formation with a reaction vessel of 5 cm internal diameter gave k =0.042 ± 
0.005 min
1
 which is half that of a 9 cm internal diameter dish with k = 0.085 ± 0.006 min
1
. Reaction 
conditions: Incubation at different times, citric buffer (50 mM, pH 4.8), 37 C, MPG (16.06 M). Error bars 
represent SEM (n=4). 
 
4.3.9 Fluorescence study of β-haematin formed with MPG 
To determine whether the macroscopic reaction rates described above are commensurate with 
crystal formation, advantage was taken of the exciton fluorescence properties of β-haematin. 
Bellemare et al. (2009) showed Hz to autoflourescence exhibiting excitation and emission 
maxima at 555 nm and 577 nm respectively. This autoflourescence phenomenon is exhibited 
by only the fully hydrated or fully dehydrated β-haematin crystal structures as partially 
hydrated β-haematin crystals were shown not to fluoresce. The fluorescence intensity of β-
haematin crystals is dependent on the ordered nature of the crystals formed. It was therefore 
decided to use confocal microscopy to monitor the appearance of fluorescence from ordered 
β-haematin crystals formed in association with lipids as a function of time. The reaction for 
the formation of β-haematin with MPG at 0.54 L/H mol ratio was allowed to progress for 60 
min and products formed were collected after 10, 20, 30 and 60 min for fluorescence 
measurement. Increase in fluorescence signal was observed from 10 min through 60 min 
(Figure 4.11A, B, C & D) even though there appear not to be any significant changes in the 
fluorescence intensity beyond 30 min (Figure 4.11C & D). The observed increase in 
fluorescence with time confirmed that β-haematin is formed with time in a range that is 
qualitatively in agreement with the kinetics of this process as shown in Figure 4.5 & 4.6A at 
0.54 L/H mol ratio. The fluorescence approach is qualitative since factors such as evaporation 
of solution between the microscope slide and coverslip, aggregation of crystals and 
pathlength between microscopic slide and coverslip which may affect fluorescence, makes it 
unsuitable for quantitative comparison with the kinetic measurement shown in Figure 4.6 and 
4.7A. 
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Figure 4.11: Fluorescence from β-haematin formed during a reaction time course. Confocal laser microscopy 
measurement of autoflourescence arising from wet samples of β-haematin formed with MPG and Fe(III)PPIX at 
different incubation times showed fluorescence signal to increase from products collected at 10 min (A), 20 (B), 
30 (C), through 60 minutes (D). The fluorescence profiles taken along cross-Sections of the images (indicated 
by an arrow in each image) are given below the images as thick red lines. The grey trace (ChD line) represents 
the transmitted light channel. The steady increase in measured fluorescence signal with increasing incubation 
time signifies the steady formation of β-haematin with time during the reaction which qualitatively agrees with 
kinetic measurements with this lipid, showing that the reaction is completed in less than 60 min seen by the 
absence of a significant increase in fluorescence from 30 to 60 min. Excitation was at 516 nm, emission in the 
range 575–630 nm. Reaction mediated by MPG, 0.54 L/H ratio, citric buffer (50 mM, pH 4.8), 37°C.  
 
4.3.10 Effect of buffers on the kinetics of β-haematin formation 
All experiments for the formation β-haematin were done in the presence of buffers. It was 
necessary therefore to investigate their effect on yields and kinetics of this process. Previous 
work by Egan et al. (2006) showed the rate of β-haematin formation at the water-octanol 
interface to be similar in citric acid buffer and MES. It was therefore important to investigate 
A B
C D
A 
C 
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whether the rate of β-haematin formation at the water-lipid interface is also unaffected by 
differences in buffer solutions used. Acetate and MES were found to cause a decrease in the 
rate constant compared to that of citric acid (Figure 4.12). However, overall this seems not to 
be a major effect on the rate of β-haematin formation. 
 
 
 
 
 
 
 
Figure 4.12: Effect of buffers on the kinetics of β-haematin formation. Citric (■), acetic () and MES buffers 
() gave rate constants of 0.080±0.005, 0.047±0.006 and 0.0300.004 min-1 respectively. Reaction conditions: 
Incubation at different times, buffer (50 mM, pH 4.8), 37C, MPG (16.06 M total lipid), constant total 
Fe(III)PPIX concentration of 30 μM. Error bars represent SEM (n = 4). 
  
 
4.3.11 Effect of physiologically relevant ions and other low molecular weight bio-
molecules on the kinetics of β-haematin formation 
 
The membrane of the DV is known to have ion channels through which some ions move in 
and out of the DV depending on the physiological state or activity of the parasite. Also, some 
of the proteins found in DV and parasite cytoplasm require metal ions as co-factors for their 
activity. Some cations and anions from the RBC cytoplasm also may be ingested together 
with haemoglobin during the parasite feeding process and transported to the DV. Although 
the concentration of all these different ions inside the DV is not known, the parasite inside the 
RBC is known to greatly modify the RBC cytoplasm such that its ion content more closely 
resembles that in blood serum (Mauritz et al. 2009). Parasites in RBCs are also known to 
produce proteins that interact with the RBC membrane cytoskeleton thereby resulting in an 
increase in plasma membrane permeability and rigidity of the iRBC (Glenister et al. 2002). 
This further makes ion exchange between RBC cytoplasm and blood very easy as the RBC 
membrane may almost be described as “leaky”. Therefore, the ionic concentrations inside 
RBCs and in blood serum would provide the two extreme possible concentrations that may 
affect Hz formation in the DV. It was for this reason, therefore, that all the major cations and 
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anions present in the RBC cytoplasm and serum were evaluated for their effect on the 
kinetics of β-haematin formation at their different physiological concentrations.  
 
4.3.11.1 Cations at RBC cytoplasmic concentration 
Sodium, potassium and magnesium are some of the relevant cations with known 
concentrations found to be present inside the RBC. Their concentrations inside RBCs are 
smaller compared to their concentrations in blood serum except for potassium which is 
present in larger amount in RBC than in serum. Sodium at 8.0 mM did not show any major 
effect on the kinetics of β-haematin formation. Potassium at 150 mM and magnesium at 1.75 
mM appeared to have a small effect on the kinetics of β-haematin formation as the rate 
constants drop to almost half that of the control without any added ions (Figure 4.13). 
 
 
 
 
 
 
 
 
Figure 4.13: RBC concentration of sodium at 8.0 mM had no major effect on kinetic of β-haematin formation 
with k = 0.067±0.006min
-1
 while that of potassium and magnesium had small effects with k = 0.045±0.005 and 
0.03943± 0.004 and min
-1
 respectively. Reaction conditions: Incubation at different times, citric buffer (50 mM, 
pH 4.8), 37C, MPG (16.06 M total lipid). Error bars represent SEM (n=4 for all ions). 
 
4.3.11.2 Cations at serum concentration 
As the parasite matures to complete its life cycle inside the RBC, the RBC membrane 
becomes increasingly permeable to the external environment (the serum) exposing the 
parasite to cations at concentration levels which exist in the serum. Magnesium at 1.5 mM, 
3.0 mM calcium and 150 mM sodium seem to have a minor effect on the kinetics of β-
haematin formation (Figure 4.14). 
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Figure 4.14: Serum concentration of magnesium (■) at 1.5 mM gave k = 0.050±0.005 min-1, 3.0 mM calcium 
() and 150 mM sodium () had minor effect with decreased rate constants of k= 0.031±0.005 and 0.031±0.004 
min
-1
 respectively. Reaction conditions: Incubation at different times, citric buffer (50 mM, pH 4.8), 37C, MPG 
(16.06 M). Error bars represent SEM (n=4 for all ions). 
 
4.3.11.3 Anions at RBC concentration 
In the case of anions at RBC cytoplasmic concentrations, 1 mM phosphate ions and 15 mM 
carbonate ions which exist as sodium citrate in equilibrium with citric acid buffer in solution 
gave somewhat lower rate constants, half that of the standard reaction conditions with NLB 
or MPG (Figure 4.15). 
  
 
 
 
 
 
 
Figure 4.15: RBC concentrations of 15 mM carbonate () and 1 mM phosphate ions (■) had a small effect with 
k = 0.026±0.004 and 0.033±0.004 min
-1 
respectively. Reaction conditions: Incubation at different times, citric 
buffer (50 mM, pH 4.8), 37 C, MPG (16.06 M). Error bars represent SEM (phosphate, n=4; carbonate, n=5). 
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4.2.12 Effect of Adenosine-5'-triphosphate (ATP)  
ATP, the main energy storage molecule of the cell has only a slight effect on the kinetics of 
β-haematin formation at a concentration of 1.5 mM, comparable to that inside RBC, as the 
rate constant is decreased to a small extent (Figure 4.16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16: Kinetics of 1.5 mM ATP gave k = 0.039±0.005 min
-1
 which is lower than that of the control 
without any added ions. Reaction conditions: incubation at different times, citric buffer (50 mM, pH 4.8), 37C, 
MPG (16.06 M). Error bars represent SEM (n=5). 
 
4.3.13 Effect of 2, 3-diphosphoglycerate  
The yield of β-hematin formation obtained with 4.5 mM 2,3-diphosphoglycerate was 
measured instead of a full kinetic study since it was only available in a limited quantity and is 
also very expensive. The β-haematin yield was 70.7 ± 1.9% at 30 min incubation time which 
is similar to the yield obtained in the control experiment, therefore indicating that this 
molecule is unlikely to affect the overall kinetic process of β-hematin formation to a great 
extent. 
 
4.3.14 Effect of glutathione  
L-Glutathione also had only a minor effect on the kinetics of β-haematin formation with a 
fourfold decrease in rate constant (Figure 4.17) similar to that obtained with some of the other 
ions. The reaction was carried out under argon to prevent glutathione from producing reactive 
oxygen species which can occur under ambient conditions where oxygen is present. The four 
fold decrease in rate constant of β-haematin formation was not surprising as glutathione, a 
known antioxidant, is likely to act by reducing oxidized Fe(III)PPIX to Fe
2+
 thereby 
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preventing it from being incorporated into the growing β-haematin crystal thus resulting in an 
increase available free Fe(III)PPIX in solution and a decrease in the rate of β-haematin 
formed due to precipitation of some of the Fe(III)PPIX in solution as previously described 
(Egan et al. 2001& 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17: Glutathione alone at 2.48 mM RBC concentration decreases the rate constant of β-haematin 
formation about fourfold with k =0.024 ± 0.003 min
-1
. Reaction conditions: incubation at different times, citric 
buffer (50 mM, pH 4.8), 37C, MPG (16.06 M). Error bars represent SEM (n=4). 
 
4.3.15 Effect of all ions present in serum combined at serum concentrations 
Since all ions found inside the RBC are present together rather than individually, it was then 
decided to investigate the combined effect of all these ions (150 mM Na
+
, 1.75 mM Mg
2+
 and 
3 mM Ca
2+
) on the kinetics of β-haematin formation since synergistic effects might be 
present. It was thought that the effect of all the individual ions on the rate of β-haematin 
formation would be additive when combined together. Surprisingly, this was not the case as 
there was no significant change in the rate of formation of β-haematin in the presence of all 
these ions combined compared to the rate constant obtained with some of the individual ions 
as shown in Figure 4.18.  
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Figure 4.18: All ions present in serum combined at their respective serum concentration did not show any 
significant increase in the kinetics of β-haematin formation with k = 0.037 ± 0.003 min-1 compared to kinetics 
with the individual ions. Reaction conditions: incubation at different times, citric buffer (50 mM, pH 4.8), 37C, 
MPG (16.06 M). Error bars represent SEM (n=4). 
 
4.3.16 Effect of all ions combined at RBC concentration 
A combination of all the previously tested individual ions present in RBC (8 mM Na
+
, 150 
mM K
+
, 1 mM H2PO4
-
, 15 mM HCO3
-
 and 1.5 mM ATP), except for 2,3-DPG which was in 
limited quantity, were used to study the kinetics of β-haematin formation. As expected from 
the effects observed at serum concentration, there was no overall major decrease in the 
kinetics of β-haematin formation (Figure 4.19). The effects of all biologically-relevant ions at 
concentrations which they exist individually or combined in RBC or serum on the kinetics of 
β-haematin formation is summarised in Table 4.1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.19: Combination of all ions present in RBC at cytoplasmic concentration showed no significant effect 
compared to the individual ions on the kinetics of β-haematin formation with k = 0.03693 ± 0.006 min-1. 
Reaction conditions: incubation at different times, citric buffer (50 mM, pH 4.8), 37C, MPG (16.06 M). Error 
bars represent SEM (n=4). 
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Table 4.1: Effect of added biomolecules present in RBC or in blood serum on the kinetics of β-haematin 
formation with MPG (0.54 L/H), citric buffer (50 mM, pH 4.8) at 37°C. 
 
 
 a 8 mM Na
+
, 150 mM K
+
, 1 mM H2PO4
-
, 15 mM HCO3
-
 and 1.5 mM ATP 
 b 150 mM Na
+
, 1.75 mM Mg
2+
 and 3 mM Ca
2+
  
 
4.4 CONCLUDING REMARKS 
Lipid was proposed to be the most likely biomolecule responsible for Hz formation in vivo 
from proteomic and lipidomic studies of the Hz crystal in the previous chapter and the 
identified NLB found to be associated with the Hz crystal surface was used to study kinetics 
of β-haematin formation in vitro. The yield of β-haematin formed mediated by NLB and 
MPG, but not MSG, reaches about 80-90% and only starts to decrease when there are more 
than two molecules of Fe(III)PPIX to one molecule of lipid fatty acid chain. The high yield of 
above 80% β-haematin obtained with NLB is in agreement with previous studies by Pisciotta 
Added biomolecules Concentration (mM) k (min-1)
- Control 0.085±0.006
Na+ 8 RBC concentration 0.067±0.006
150 Serum concentration 0.031±0.004
Mg2+ 1.75 RBC concentration 0.039±0.004
1.5 Serum concentration 0.050±0.005
K+ 150 RBC concentration 0.045±0.005
H2PO4
- 1 RBC concentration 0.033±0.004
HCO3
- 15 RBC concentration 0.026±0.004
ATP 1.5 RBC concentration 0.039±0.005
Glutathione 2.48 RBC concentration 0.024±0.003
Ca2+ 3 Serum concentration 0.031±0.005
all ions combined a RBC concentration 0.037±0.006
all ions combined b Serum concentration 0.037±0.003
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et al. (2007). Furthermore, biologically-relevant ions likely to be present either in RBC or in 
serum at physiological concentrations did not have any major effect on the overall reaction of 
β-haematin formation and reaction rates remain adequate to account for Hz formation despite 
an overall drop in yields at physiologically-relevant lipid-to-Fe(III)PPIX ratios. This may 
mean that in a fully mature parasite inside the RBC, ions ingested together with haemoglobin 
from the RBC cytoplasm into the DV compartment where haemoglobin digestion and Hz 
formation takes place, may not have any major effect on the overall process of Fe(III)PPIX 
sequestration into Hz in vivo if the process is purely lipid-mediated as proposed. This further 
supports the process of Hz formation in malaria parasite being lipid-mediated and seems to 
suggest lipid to be the most important factor influencing this process in vivo. CLM studies 
showed autoflourescence arising from β-haematin crystals and clearly demonstrates that β-
haematin formed in situ is in close association with the lipid component of the emulsion. The 
autoflourescence of β-haematin showed potential for use in monitoring the process of β-
haematin formation and to adapt to follow the progress of Hz formation in vivo or to monitor 
the effect of antimalarial drugs that target the Hz formation process. However, a striking 
observation from TEM characterisation of the β-haematin crystals formed with lipid was that 
lipid particle size seems to have an effect on β-haematin crystal size and external morphology 
which would require further investigation. This is described in the next chapter.  
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5. THE NUCLEATION OF SYNTHETIC HAEMOZOIN (β-HAEMATIN) CRYSTALS 
AT THE SURFACE OF NEUTRAL LIPID DROPLETS: CONTROL OF CRYSTAL 
SIZE AND THE EFFECT OF CHLOROQUINE ON HAEMOZOIN CRYSTAL 
GROWTH IN THE MALARIA PARASITE 
 
5.1 INTRODUCTION 
Proteomic and lipid studies in Chapter 3 led to the identification of 
MSG/MPG/DPG/DOG/DLG (NLB) associated with the surface of Hz crystals. Thus lipids 
were suggested as the biomolecules most likely to be responsible for Hz formation in vivo. 
Kinetics studies of the NLB in Chapter 4 showed NLB to be very efficient in mediating β-
haematin formation in vitro which is unlikely to be greatly affected by biologically-relevant 
ions present either in RBC or in serum. However, the crystal formed appeared externally 
distinct from Hz crystals. The β-haematin formed also appeared to fall in a similar size range 
to that of previously reported lipid droplets (Hoang et al. 2010a). Although it was proposed 
that the size of these droplets might control the size of β-haematin formed at the interface, 
this has not yet been fully investigated. Neither has the influence of lipid on shape, crystalline 
nature or localization of β-haematin been investigated.  
Hz and β-haematin crystals have been shown to be chemically, spectroscopically and 
crystallographically identical. They have a triclinic unit cell structure with dimensions a = 
12.2 Å, b = 14.7 Å, c = 8.0 Å, α = 90.2°, β = 96.8°, γ = 97.9° (Pagola et al. 2000). Studies 
have also described the theoretical growth form of β-haematin to be similar in overall shape 
and form to that of Hz as a lath-like structure that extends along the c-axis exhibiting 
dominant {100} and {010} side faces, a less-developed {011} face and a minor {001} face, 
with chloroquine (CQ) proposed to bind to the fastest-growing {001} face to inhibit growth 
(Buller et al. 2002 and Solomonov et al. 2007). However, direct evidence of the effect of this 
drug on Hz crystal habit and form in the parasite is lacking. 
 
In this chapter, β-haematin produced with MPG and NLB emulsions prepared in three 
different ways, as well as at the pentanol-aqueous interface, was characterized and compared 
to Hz crystals isolated from the parasite itself. This was done using TEM and electron 
diffraction. In addition, the location of β-haematin crystals formed with respect to NLB 
particles, the nature and structure of NLB emulsions and the relationship between β-haematin 
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crystal length and NLB particle size was also investigated. Finally, the effect of CQ on Hz 
crystals in the parasite was also investigated. 
 
5.2 METHODS 
 
5.2.1 Preparation of β-haematin crystals with NLB, MPG and Pentanol  
 
5.2.1.1 Experimental procedures 
β-Haematin was prepared as previously described in Section 4.2.2.1 with some slight 
modifications as follows: The 1.5 mL pre-mixed solutions of lipid and Fe(III)PPIX (2.15, 
1.07 and 0.54 lipid/ Fe(III)PPIX mol ratio) in 1:9 v/v acetone/methanol were either vortexed, 
ultrasonicated in a water bath sonicator (Bandelin SONOREX) or micromixed (by passing 
several times through a 10 µm filter using an Avanti
®
 Mini-Extruder system which has been 
heated to about 60°C on a Snijders hot plate magnetic stirrer) before being deposited 
carefully on the surface of citric acid buffer using a 1 mL syringe and this was allowed to 
incubate further at 37°C for different lengths of time for β-haematin formation. In the case of 
β-haematin formation at the pentanol-water interface, 10 mL of pentanol was layered on the 
50 mL citric acid (50 mM, pH 4.8) and pre-incubated for 30 min at 37°C. Pentanol is 
immiscible with water, thus it floats above the buffer solution creating an interface. A 1.5 mL 
solution of 2 mg/mL Fe(III)PPIX was then carefully introduced at this interface and allowed 
to incubate for about 4 h at 37°C in a water bath for β-haematin formation. The entire mixture 
was filtered through Whatman filter paper number 1 and the precipitate washed with 5% 
pyridine solution for TEM imaging using a TECNAI TF20 TEM.  
 
5.2.2 Characterization of β-haematin crystals formed with NLB, MPG and pentanol 
using TEM and TEM-electron diffraction and the indexing of diffraction patterns 
 
5.2.2.1 Experimental procedures 
β-Haematin crystals formed from lipid (NLB or MPG) and Fe(III)PPIX (2.15, 1.07, or 0.54 
L/H mole ratios) mixtures were prepared for TEM imaging as described previously in Section 
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4.2.7.1. Transmission electron microscopy-electron diffraction (TEM-ED) patterns were also 
obtained from some of the cystals using the same TECNAI TF20 TEM. 
The SingleCrystal application of CrystalMaker
®
 Software Version 2.2 was used to index the 
diffraction patterns obtained from β-haematin crystals (CrystalMaker® software Ltd, Oxford, 
2009). The calculated structural data for β-haematin described by Pagola et al. was used to 
build a structural model of the β-haematin crystal using CrystalMaker®. The single crystal 
diffraction software was then used to predict a simulated diffraction pattern based on this 
structure. The Grid tool in SingleCrystal
TM
 was used to index the diffraction pattern obtained 
from β-haematin crystals. Briefly, the observed electron diffraction pattern obtained from the 
β-haematin crystals was opened using the single crystal window of the software. In the same 
window, the CrystalMaker
®
 file for the reported β-haematin crystal structure was loaded. The 
Grid tool was superimposed on the observed diffraction pattern, making sure that all observed 
diffraction spots coincided. The grid was adjusted such that all grid points lay directly over 
the observed points. The command “Calculate Orientation” was launched by selecting it from 
the Grid’s contextual menu and this allowed the software to match the simulated pattern with 
the observed pattern, with the strongest reflections being indexed in this manner.  
 
5.2.3 TEM characterisation of NLB droplet size as a function of time 
 
5.2.3.1 Experimental procedures 
Extruded NLB solution was carefully deposited using a 1 mL syringe (KIMIX) on the surface 
of 50 mL citric acid buffer (50 mM, pH 4.8) that had been pre-incubated for 30 min at 37°C 
in a water bath. This was allowed to incubate further at 37°C in a water bath. Solutions of 
NLB suspension were carefully taken from the NLB-water emulsion layer at 10, 30 and 60 
min incubation time and placed on a glow-discharged grid which was further processed for 
TEM imaging using a TECNAI TF20 TEM as described in Section 4.2.7.1. 
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5.2.4 Confocal laser microscopy characterization of NLB emulsions 
 
5.2.4.1 Experimental procedures 
Solutions of NLB (prepared in 1:9 v/v acetone/methanol) stained with lipophilic 3,3’-
dioctadecyloxacarbocyanine perchlorate fluorescent DiO dye (5 μL/mL ) were carefully 
deposited using a 1 mL syringe (KIMIX) on the surface of 50 mL citric acid buffer (50 mM, 
pH 4.8) that had been pre-incubated for 30 min at 37°C in a water bath. Samples were 
carefully taken from the NLB-water emulsion layer for fluorescence measurement using an 
LSM510-META Zeiss confocal microscope as described in Section 4.2.8.1. Acquisition of 
continuous z-stacked images through NLB droplets were done under the following 
conditions; pin hole diameter of 444 μm, excitation laser at 488 nm, 20% transmission power 
out, detection band pass 500-530 nm (emission) and LD C-Apochromat 40x/1.1 W objective. 
 
5.2.5 Preparation and characterization of liposomes by TEM and cryo-TEM and TEM 
characterization of NLB emulsions  
 
5.2.5.1 Sample preparation 
DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine) lipid solution: 
A 15 mg/mL DMPC lipid solution was prepared in chloroform.  
 
5.2.5.2 Experimental procedures 
A laboratory vacuum pump was used to evaporate the chloroform (lyophilization) for three 
days, leaving behind a dry lipid film or cake. The DMPC lipid film was hydrated with 6.75 
mg/mL aqueous CsCl solution at 70 °C and the suspension was vortexed every 5-10 min for 
about 80 min to form predominantly large multilamellar vesicles (liposomes). The liposome 
suspension was then sonicated for 30 min in a water bath sonicator (Bandelin SONOREX) at 
70°C. It was then extruded using an Avanti
®
 Mini-Extruder by passing it back and forth 23 
times through a 0.1 μm filter. The extruded suspension was placed on a glow-discharged 
carbon-coated grid and processed for TEM imaging as described in Section 4.2.7.1. NLB 
solution prepared in 1:9 v/v acetone/methanol was carefully deposited using a 1 mL syringe 
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on the surface of 50 mL citric acid buffer (50 mM, pH 4.8) containing 6.75 mg/mL CsCl 
which had been pre-incubated for 30 min at 37°C in a water bath. Solution containing 
suspended NLB droplets collected from the emulsion layer was placed on a glow-discharged 
carbon-coated grid and processed further for TEM imaging as described in Section 4.2.7.1. 
Elemental spectroscopic imaging/Electron energy loss spectroscopy (ESI/EELS) analysis of 
Cs distribution in liposome structures and NLB emulsions was carried out on a FEI TECNAI 
20 with GIF 863 Tridiem transmission electron microscope using a slit width of 20 eV. Data 
were processed with Digital micrograph software from Gatan. Two images were recorded at 
energies before the CsM4,5 absorption edge (681 and 711 eV), and a third was centered at 726 
eV. The background images was then extrapolated from the data at 681 and 711 eV and 
subtracted from the image collected at 726 eV.  
Liposomes were also prepared for imaging using Cryo-TEM as follows: A solution of 
suspended liposome preparation was placed on a glow-discharged quantifoil holey carbon-
coated grid and mounted on a PC controlled automated sample preparation machine (Vitrobot 
MkIV). Excess solution on the grid was blotted on filter paper and the grid was immediately 
plunged into liquid ethane (ethane cooled to its melting point with liquid nitrogen). The grid 
was then taken out and mounted in a cryo-holder (Gatan) and imaged at liquid nitrogen 
temperature using the TECNAI TF20 TEM operating at 200kV. 
 
5.2.6 Localization of β-haematin crystals formed with NLB 
 
5.2.6.1 Experimental procedures 
Samples containing product formed using MPG/Fe(III)PPIX or NLB/Fe(III)PPIX solutions 
either “micromixed” or ultrasonicated and then deposited on the buffer surface were carefully 
taken from the lipid-water emulsion layer at 10, 30 and 60 min incubation time and placed on 
a glow-discharged carbon-coated grid. Also, 2 mL citric acid buffer solution (50 mM, pH 7.0) 
was added to a 1 mL solution of NLB/Fe(III)PPIX solution at 1.07 L/H mol ratio which was 
then immediately extruded via a 10 µm filter using a miniextruder at about 60
o
C before 
incubating it at 37°C for β-haematin formation. Samples were also taken from the reaction 
mixture and placed on a glow-discharged carbon-coated grid. Excess liquid on carbon-coated 
grids was carefully blotted with Whatman filter paper number1 and the sample stained with 
uranyl acetate. Excess stain was blotted with Whatman filter paper number1 and the grid was 
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allowed to dry at room temperature. Imaging was done using a TECNAI TF20 TEM 
operating at 200 kV equipped with a Gatan US4000 CCD camera. Electron spectroscopic 
imaging/Electron energy loss spectroscopy (ESI/EELS) analysis of Fe distribution in NLB 
droplets was performed using a FEI TECNAI 20 with GIF 863 Tridiem transmission electron 
microscope with a slit width of 20 eV. Data were processed with Digital micrograph software 
from Gatan. Images were recorded at two energies before the FeL3 absorption edge (650 and 
693 eV), and the third was centered at 708 eV. The background images was then extrapolated 
from the data at 650 and 693 eV and subtracted from the image collected at 708 eV. 
 
5.2.7 Estimation of lipid droplet and crystal sizes  
 
5.2.7.1 Experimental procedures 
The sizes of NLB droplets and β-haematin crystals formed from a minimum of 34 randomly 
selected TEM image fields of NLB and β-haematin preparations in Sections 5.2.4.1 and 
5.2.7.1, respectively, at different incubation times were manually measured. A total of 309 
NLB droplets and 223 β-haematin crystals was measured in the case of the 10 min incubation 
time point and used for statistical analyses using a Kolmogorov-Smirnov test.  
 
5.2.8 Parasite culturing, isolation of haemozoin crystals and TEM of both parasitized 
erythrocytes and isolated Hz crystals 
 
5.2.8.1 Experimental procedures 
Parasites (P. falciparum D10 strain) were maintained in continuous culture as described in 
Section 3.2.1. For TEM, parasites were synchronized with 5% sorbitol. The parasite culture 
was harvested after 24 h by centrifuging at 750 rpm for 5 min. The pellet consisting of 
infected and uninfected red blood cells was washed three times with 10 volumes of 
cacodylate wash buffer. Fixative (paraformaldehyde, glutaraldehyde and 0.1% malachite 
green) was then added to the washed pellet and the sample kept at 4C for 24 h. The pellet 
was then washed again with wash buffer followed by fixation with 1% tannic acid in wash 
buffer while tumbling for 1 h. It was then washed twice with wash buffer and post fixed with 
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1% OsO4 and 0.1% malachite green in wash buffer for 1 h while tumbling. Further washing 
was carried out three times with wash buffer followed by dehydration of cells by sequential 
incubation in 30, 50, 75 and 100% ethanol for 10 min each while tumbling. Further 
dehydration was effected with 100% acetone for 10 min. The dehydrated cells were 
resuspended and incubated in 25:75, 50:50 and 75:25 Spurr’s resin/acetone mixture for 2 h 
each. The cells were finally incubated in 100% Spurr’s resin overnight. They were then 
transferred into freshly prepared 100% Spurr’s resin and tumbled for a day. The cells were 
then again transferred into fresh 100% Spurr’s resin in a microfuge tube and heated at 60C 
in a heating block to solidify. The solid blocks were cut into ultra-thin sections (60 – 80 nm) 
with a REICHERT ultra-microtome using a diamond knife. The cut sections were placed on a 
glow-discharged grid and imaged using a TECNAI TF20 TEM. Hz crystals were also isolated 
from parasites as described in Section 3.2.1 for TEM imaging. 
 
5.2.9 Isolation of haemozoin crystals from chloroquine treated and untreated parasites 
for TEM imaging  
 
5.2.9.1 Experimental procedures 
Parasites (D10 strain) at the ring stage were maintained in culture as described in Section 
3.2.1 in the presence of 30 nM and 60 nM CQ and after 32 h, the parasite cultures were 
harvested and Hz crystals isolated as described in Section 3.2.1 for TEM imaging. Hz crystals 
were also isolated from untreated parasites (D10 strain) maintained in culture for 12 h for 
TEM imaging and were used to compare with Hz crystals isolated from the CQ-treated 
parasites. 
 
5.3 RESULTS AND DISCUSSION 
 
5.3.1 The shape, size distribution and TEM-ED characterization of isolated haemozoin 
crystals 
TEM images of Hz crystals isolated from malaria parasites (Figure 5.1A and B) showed they 
are in the range 177-1386 nm long and about 532 nm long on average (Figure 5.1C). Hz from 
parasites showed a regularly-shaped crystal with no evident defects in the crystal lattice as 
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exhibited by the well-ordered parallel lattice fringes (Figure 5.1D). Indexed TEM-ED 
patterns obtained from isolated Hz crystals showed most of the crystals to lie on their {100} 
or {1¯00} faces, along the a* direction (Figure 5.1E and F) and this was in agreement with the 
interatomic distances of 12.57 Å measured from the visible lattice fringes of the isolated 
hemozoin crystals (Figure 5.1D) corresponding to the {100} or {1¯00} faces of Hz.  
The overall crystal morphology and indexed diffraction pattern exhibited by isolated 
haemozoin therefore showed that it grows along it c-axis, displaying well developed {100} 
faces and {010} side faces, a less developed {011} face and a minor {001}face which is 
consistent with other published data (Buller et al. 2002 and Solomonov et al. 2007). The 
{011} face seen from the indexed diffraction pattern corresponds to the stable end face of the 
theoretical growth form of β-haematin which is seen in other Hz crystals from different 
species (Buller et al. 2002) which showed that the diffraction vector d*(011) is perpendicular 
to the slanted end face as assigned in Figure 5.1E. The calculated average length-to-width 
ratio of isolated Hz crystals was 3.4. This value is consistent with the corresponding length-
to-width ratio of 3.3 previously reported by Buller et al. (2002) calculated based on the ratio 
of attachment energy values (Eatt{001}/Eatt{100}) that were obtained for the theoretical 
growth form of β-haematin. 
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Figure 5.1. TEM imaging showed Hz crystals isolated from P. falciparum have a regular shape (A and B) and 
exhibited very regular lattice fringes with d-spacing of 12.57 Å (D), confirming that the crystals lie on their 
{100} or {1¯00} faces (E). Size range distribution of the isolated Hz crystals showed a majority of them to be 
between 452 and 588 nm long (C). The electron diffraction pattern from the crystals in (E) showed they exhibit 
{010} and {011} crystal faces corresponding to the marked d* and b* directions (F) which are normal to the {1¯
00} face. 
 
5.3.2 The shape and size distribution of β-haematin crystals formed at the pentanol-
water interface  
β-Haematin crystals formed at the pentanol-water interface are in the range 233-2277 nm 
long (Figure 5.2A and B). Some of these crystals are even longer than Hz crystals isolated 
from parasites and appeared to be thinner and more fragile than Hz with some showing signs 
of broken ends marked * (Figure 5.2C). The overall external morphology and size of these 
crystals were similar to that of Hz. The increased lengths of these synthetic Hz crystals 
compared to that of natural isolated Hz might be as result of the long and flat continuous 
pentanol-water interface where the β-haematin crystals grow since the continuous interface 
offers no restriction or limitation to the growing crystal. Indexed TEM-ED patterns obtained 
from some of these β-haematin crystals (Figure 5.2D) showed the crystals to lie on their 
{100} or {1¯00} faces (Figure 5.2E) as seen also with isolated Hz crystals. This is evident by 
measuring the inter-atomic distances of adjacent lattice fringes of some of the crystals (Figure 
ba
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5.2F) which gives a value of 11.93 Å, corresponding to the principal a-axis denoting the 
{100} or { 1¯ 00} faces. β-Haematin crystals formed at the pentanol-water interface are 
therefore similar to that of natural Hz. 
 
 
 
Figure 5.2. TEM imaging showing β-haematin crystals produced at the pentanol-water interface to be very long 
(A and B) with some even longer than Hz. These β-haematin crystals were thinner and seemed more fragile than 
Hz as some appeared to have broken ends marked * (C). TEM-ED of crystals such as that marked* (D) showed 
it forms the {010} crystal faces corresponding to the marked b* directions (E) which are normal to the {1¯00} 
face. Measured d-spacing of 11.93 Å between adjacent lattice fringes, corresponding to {100} or {1¯00} faces 
confirm it lay on this crystal face.  
 
5.3.3 The shape and size distribution of β-haematin crystals formed at MPG-water and 
NLB-water interfaces  
TEM imaging showed most β-haematin crystals formed from a mixture of MPG and 
Fe(III)PPIX solution after vortexing and deposition on citrate buffer had a regular shape but 
were much smaller than Hz (Figure 5.3A) ranging between 17-102 nm and 55 nm long on 
average. A few of the β-haematin crystals formed were irregular in shape (Figure 5.3B) with 
their lattice fringes exhibiting signs of growth defects or a mosaic structure (Figure 5.3C). 
Presumably such complex β-haematin crystal shapes might be the result of an alteration in 
the lipid matrix during the growth process, as it is a phenomenon common for growth of 
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biocrystals mediated by lipid (Collier et al. 2001). Indexed TEM-ED obtained from some of 
these tiny crystals in Figure 5.3D showed they lay in arbitrary orrientations and exposed 
randomly selected diffraction planes to the electron beam as seen from diffraction spots 
arising from higher order Miller indices (Figure 5.3E). Diffraction patterns obtained from 
irregularly-shaped β-haematin crystals with growth defects (Figure 5.3F) gave a ring pattern 
which cannot be easily indexed using the SingleCrystal application of CrystalMaker
®
 
Software Version 2.2. The continuous ring pattern of this diffraction data shows that the 
material was polycrystalline with very small crystallites. Despite the difficulty of not finding 
any of the principal crystallographic axes from these extreamly small crystals even with the 
use of a double tilt goniometer stage, it has previously been confirmed by FT-IR 
characterization of this crystalline product in Section 4.3.7 to be β-haematin. This was also in 
agreement with previous studies in our laboratory using a combination of infrared 
spectroscopy and X-ray powder diffraction to characterize bulk materials produced in this 
system which demonstrated that this crystalline product is indeed -haematin (Hoang et al. 
2010a). The observed size range distribution of these β-haematin crystals formed with MPG 
showed a similar range to the major population of lipid droplets previously reported by 
Hoang et al. (2010a) with a larger population of the crystals in the range 31-70 nm with a 
smaller population below 30 nm and above 97 nm (Figure 5.3H). 
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Figure 5.3. TEM imaging showed β-haematin crystals produced from vortexing mixtures of MPG and 
Fe(III)PPIX were smaller in size (A) than Hz with some having irregular shape (B). Lattice fringes exhibited a 
crystal growth defects (C). TEM-ED of tiny crystals such as those in (D) showed that they lay at an arbitrary 
angle with diffraction from a high index plane {74¯5} (E). The irregular shape crystal (F) gave ring diffraction 
pattern (G). Size range distribution of these crystals showed most of them lay between 31-43 nm (H). 
 
β-Haematin crystals produced by either micromixing MPG and Fe(III)PPIX solution using an 
extruder (Figure 5.4A) or by ultrasonication (Figure 5.4B), followed by deposition on the 
surface of citrate buffer, were identical to one another. The crystals were considerably larger 
than those produced from vortexed mixtures of MPG and Fe(III)PPIX. Indexed TEM-ED 
patterns obtained from long crystals such as those in Figure 5.4C showed the same 
orientation as those produced at the pentanol-water interface and of Hz, exhibiting their 
A CB
D
_ _
{341}
_
{682}
{470}
{262}
_
{341}
_ _
{470}__
{262}
_
_ _
{5101}
E
17-30 31-43 44-56 57-70 71-83 84-96 97-110
Size (nm)
H
F G 2
121 
 
{100} or {1¯00} faces (Figure 5.4D). Most of the β-haematin crystals were, however, found 
associated with visible MPG droplets (Figure 5.4E). The d-spacing of lattice fringes of the 
crystal face directly in contact with MPG lipid droplets was 12.1 Å (Figure 5.4F) which 
corresponds to the {100} or {1¯00} faces of the crystals. This clearly demonstrates that the 
growing β-haematin crystal is in contact with the lipid via its {100} face.  
 
 
Figure 5.4. TEM imaging showed β-haematin crystals prepared by either micromixing (A) or ultrasonication (B) 
of MPG and Fe(III)PPIX are large and similar to Hz in external crystal morphology. TEM-ED of these crystals 
(C) showed that they lay on the principal {100} face (D) which is normal to b*. Most of the β-haematin crystals 
formed remained in contact with lipid droplets (E) and lattice fringes with d-spacing of 12.1 Å showing 
the{100} or {1¯00} of the crystal face was in contact with lipid (F).  
 
TEM imaging showed β-haematin crystals formed from NLB and Fe(III)PPIX solution after 
vortexing have regular shapes and are somewhat bigger than those formed with vortexed 
mixtures of MPG and Fe(III)PPIX (Figure 5.5A). These marginally bigger β-haematin 
crystals were in the range 37-226 nm and 75 nm long on average (Figure 5.5C). The β-
haematin crystals prepared using this method of vortexing generally had a different external 
morphology from Hz, from β-haematin prepared at the pentanol-water interface and even 
those formed from micromixing the NLB and Fe(III)PPIX mixture. However, unlike those 
formed with MPG, indexed TEM-ED patterns of these crystals gave bright spots 
corresponding to higher Miller indices with a clearly visible major crystallographic c-axis 
(Figure 5.5B) as indicated by the c* axis direction on the diffraction pattern. The {005} spot 
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represents diffraction from the c-axis ({001} face) at a higher-order reflection. Clearly visible 
lattice fringes from the crystal in Figure 5.5D with measured interplane distances of 2.87 Å 
(Figure 5.5E) correspond to the {  ̅  ̅  } face, a higher order reflection from the {1¯ 1¯0} crystal 
face. The formation of the {1¯ 1¯0} face of β-haematin seen with NLB is in accordance with the 
attachement energy (Eatt = -52.6 kcal/mol) of this crystal face which is lower than Eatt = -30.6 
and Eatt = -27.7 kcal/mol of {100} and {010} face respectively as predicted by Buller et al. 
(2002). The Eatt of any crystal face controls the crystal growth rate perpendicular to that face 
and the more negative the Eatt the less important that face is in the overall crystal 
morphology. The {001} face with very low Eatt of -101.5 is the most important growing face 
of Hz but is not readily seen in the Hz crystal habit and form. It is reported to be the site to 
which CQ binds to exhibit its haemozoin-inhibiting antimalarial activity (Solomonov et al. 
2007). 
 
 
 
Figure 5.5. TEM imaging showed β-haematin crystals produced by vortexing a mixture of NLB and Fe(III)PPIX 
solution prior to deposition were smaller (A and D) than Hz although slightly larger than those produced with 
MPG using the same method. Indexed TEM-ED of these crystals showed it lay on an unusual {  ̅  ̅  } face (B) 
not seen with Hz or β-haematin formed at pentanol-water interface with lattice spacing of 2.87 Å corresponding 
to {  ̅  ̅  } Miller indices which represent higher order diffraction from the {110} face (E). Size range 
distribution of these crystals mostly lay between 38-70 nm (C).  
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Looking at the very small crystals formed in Figure 5.3 and 5.5 together with polycrystalline 
and mosaic material where lipid and Fe(III)PPIX solutions were vortexed prior to depositing 
on the citrate buffer surface, it was not clear whether these crystals seen here were essentially 
trapped on the pathway from an amorphous precursor to larger crystalline structures. 
However, several previous reports have suggested that this is probably not the case. Firstly, 
Egan et al. (2001) readily observed the conversion of -haematin formed at 60C in 4.5 M 
acetate medium from an amorphous glass-like solid which did not exhibit X-ray diffraction 
peaks, to a microcrystalline solid with a -haematin X-ray diffraction pattern. This kind of 
amorphous structure was not evident in any of the images seen in this study although it could 
be difficult to observe, especially in the presence of lipid. Secondly, the existence of such a 
precursor (if it does exist) must be very short-lived because kinetic studies in the previous 
chapter using MPG under conditions where the reaction was slowed down about seven-fold 
(at 0.54 L/H) exhibited evidence of -haematin fluorescence within 10 min. This 
fluorescence had been shown to arise from an excitation process specific to the -haematin 
crystal lattice (Bellemare et al. 2009). This would translate into appearance of crystals within 
about 90 s of initiation of the process in this study. This rapid rate seems not to be consistent 
with the deposition of an amorphous phase and subsequent conversion to the crystalline 
product. Thirdly, the small crystals seen in Figures 5.3 and 5.5 were not seen in TEM images 
where premixing of lipid and Fe(III)PPIX was thoroughly carried out. However, it is also 
likely that they may not easily be noticed in the presence of many larger crystals or they may 
have all grown larger by the time of measurement. 
β-Haematin crystals produced by either micromixing NLB and Fe(III)PPIX solution using an 
extruder (Figure 5.6A) or by sonication (Figure 5.6B), were identical to one another. The β-
haematin crystals produced were much longer than those produced from a vortexed mixture 
of NLB and Fe(III)PPIX solution and were almost indistinguishable from β-haematin 
produced by either micromixing or sonication of MPG with Fe(III)PPIX solution. Indexed 
TEM-ED patterns obtained from some of the crystals in Figure 5.6C showed similar 
orientation to those produced at the pentanol-water interface and Hz as they also lay on their 
{100} or {1¯00} faces (Figure 5.6D). Most of the β-haematin crystals were found associated 
with visible NLB droplets (Figure 5.6E). The d-spacing of lattice fringes of the crystal face 
directly in contact with NLB lipid droplets was 11.8 Å (Figure 5.6F), corresponding to the 
{100} or {1¯00} faces of β-haematin crystals which again demonstrates that the growing β-
haematin crystal was in contact with the lipid via this face. This is in agreement with earlier 
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reports by Hoang et al. that the NLB surface acts as a template for the growth of β-haematin 
crystals based on a suggestion that was previously made on the basis of findings obtained 
with self-assembled monolayers (de Villiers et al. 2009 and Wang et al. 2010) but was not 
directly demonstrated with lipid droplets. Furthermore, reports in other organisms where lipid 
has been shown to mediate nucleation of biocrystals showed that lipids can act by providing a 
suitable nucleation microenvironment favourable for electrostatic, sterochemical and 
geometric interactions between the nucleating crystal phase and the organic matrix (Young et 
al. 1992 and Collier et al. 2001). This suggests that NLB consistently seen in contact with β-
haematin via its {100} face acts as a nucleation site, inducing the nucleation via this {100} 
face. 
 
 
 
Figure 5.6. Characterization by TEM of β-haematin crystals produced using different methods of mixing NLB 
and Fe(III)PPIX solutions. TEM imaging showed β-haematin crystals prepared by either micromixing (A) or 
sonication (B) of NLB and Fe(III)PPIX solutions were longer and similar to those produced by MPG using the 
same method and also to Hz in external crystal morphology. Indexed TEM-ED of these crystals (C) showed the 
principal crystallographic b-axis indicated by b* (D) which is normal to the {100} face. As with MPG crystals 
produced using the same method, most of the β-haematin crystals formed were also in contact with lipid 
droplets (E) and lattice fringes with d-spacing of 11.8 Å corresponding to the {100} or {1¯00} of the crystal face 
in contact with lipid (F) were observed. This showed again that β-haematin made contact with lipid droplet via 
its {100} face.  
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It is therefore evident that mixing is an important factor that controls the overall crystal habit 
and form of β-haematin produced from lipids and Fe(III)PPIX since β-haematin crystals 
similar to Hz formed in the parasite can only be produced by thoroughly micromixing the two 
solutions of lipid (NLB or MPG) and Fe(III)PPIX either by using an extruder or by 
ultrasonication prior to deposition on aqueous citrate. This was a surprising factor as lipid and 
Fe(III)PPIX solution were expected to mix thoroughly with each other since they were both 
fully dissolved in the same 1:9 v/v acetone/methanol solvent. However, a possible 
explanation for this mixing effect may be that Fe(III)PPIX which bears a 2 charge when 
dissolved in 0.1 M NaOH, may form in a transient colloidal suspension when mixed with 1:9 
v/v acetone/methanol which therefore requires thorough mixing with the lipid solution in 
order to bring Fe(III)PPIX into intimate contact with the lipid molecules. It has also been 
reported that the crystal habit exhibited by crystals grown in the presence of different solvents 
is strongly influenced by the solvent as a result of its interaction with the growing crystal 
surface (Bennema et al. 1992 and Elwenspoek et al. 1987). However, this does not appear to 
be the case here. Pentanol, acetone and methanol used in preparing β-haematin in this study 
appeared not to affect the crystal habit since the external morphology of the crystals produced 
were similar to that of Hz. Nonetheless, visual observation of Hz crystals from TEM images 
showed they appeared to be slightly different in texture compared to their synthetic 
counterparts. This might be due to the presence of lipids or proteins on the Hz crystal surface 
and in the crystal matrix as demonstrated by proteomic studies of the Hz crystals since 
previous studies of other biocrystals have reported clear evidence of the direct effect of 
proteins isolated from the biocrystals on the crystal texture (Berman et al. 1990 and 19993) 
and coherence length (Weissbuch et al. 1995). Finally, given the presence of NLB on the 
surface of Hz crystals in the DV and its proposed involvement in Hz formation in vivo as 
shown with lipidomics and in vitro kinetic studies, in addition to TEM characterization 
confirming NLB to produce synthetic Hz crystals similar to natural Hz when properly mixed 
with Fe(III)PPIX solutions, NLB was chosen for all further studies.  
 
5.3.4 Effect of NLB-to-Fe(III)PPIX ratio on the appearance of β-haematin crystal 
formed at the lipid-water interface 
It was also important to investigate how different amounts of lipid and Fe(III)PPIX present at 
the crystallization site at a particular time would affect the external appearance of the crystals 
formed. TEM images of β-haematin formed with NLB and Fe(III)PPIX at 2.15, 1.07 and 0.54 
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L/H showed no significant change in the overall crystal appearance. Thus, the crystal habit 
does not depend either on the ratio of L/H present or on the kinetics of the crystal growth 
process (Figure 5.7). This was important as it suggests that the shape of Hz crystals formed 
inside the parasite is unlikely to be affected by the amount of Fe(III)PPIX released from 
digested haemoglobin at the site where Hz crystal growth takes place. This phenomenon of 
the overall crystal shape not being affected by the amount of Fe(III)PPIX present or by 
kinetics of the crystal growth process can also be exploited to investigate the effect of some 
antimalarial drugs on Hz crystal growth in vivo, as any change in crystal morphology 
resulting from such treatment would be likely to be a direct effect or action of the antimalarial 
drug on the Hz crystallization process. 
 
 
 
Figure 5.7. TEM characterization of β-haemtin crystal morphology formed at different lipid-to-Fe(III)PPIX mol 
ratios. TEM imaging of β-haematin crystals formed with NLB and Fe(III)PPIX at 2.15, 1.07 and 0.54 L/H 
showed no change in overal appearance of either the smaller or bigger crystals formed, despite changes in the 
amount of Fe(III)PPIX present and different incubation time points. 
 
5.3.5 Characterization of the sizes and structures of NLB droplets formed at the lipid-
water interface 
Since the observed size range distribution of β-haematin crystals formed from vortexing 
MPG lipid with Fe(III)PPIX was similar to the major population of lipid droplets previously 
reported by Hoang et al. it was decided to investigate the sizes and structures of lipid droplets 
formed at the lipid-water interface to see how they compare to the sizes of β-haematin 
2.15 L/H 1.07 L/H 0.54 L/H
10 min 30 min 60 min
127 
 
produced at this inteface by the method of micromixing. Lipid droplets formed at the 
interface as during the β-haematin formation process were investigated at 10, 30 and 60 min 
incubation time using TEM. TEM images showed an increase in the population of small 
particle sized lipid droplets with increase in incubation time from 10 to 60 min (Figure 5.8). 
The measured diameter of the lipid droplets formed (assuming lipid droplets are spherical) at 
this interface showed the majority of them to be in the range 21-120 nm as shown in the 
population size distribution plot in Figure 5.8D. These smaller droplets may possibly be 
formed as a result of aggregation of even smaller droplets which could not be resolved in 
TEM images taken at earlier times, or more likely from dispersed lipid molecules which took 
a longer time to aggregate. Whatever the case, it is evident that these smaller droplets came to 
dominate the emulsion over time. However, since they appeared to form more slowly than β-
haematin, they seemingly play little or no role in β-haematin formation. 
 
 
 
 
Figure 5.8: TEM characterization of NLB droplet sizes formed at the NLB-water interface. TEM imaging 
showed the population of smaller NLB droplets formed increases with increased in incubation time from 10 to 
60 min. Scale bar represents 0.2 µm at 10 min and 0.5 µm at 30 and 60 min. 
 
To investigate the nature and structure of NLB droplets formed, NLB solution stained with 
DiO dye and deposited on citric acid buffer was carefully taken from the NLB-water 
emulsion region for florescence imaging using confocal laser microscopy. Continuous z-stack 
images taken through NLB droplets using confocal microscopy showed continuous 
fluorescence right through the interior of the NLB droplets as shown in the resultant z-
stacked image in Figure 5.9A. This showed that the interior portion of the lipid droplets 
10 min 30 min10 min 30 min
60 min60 min
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formed was hydrophobic. This is in agreement with previous studies which showed 
orthogonal projections of spontaneously formed NLB droplets stained with Nile Red 
(lipophilic dye) had a hydrophobic non-hollow and continuous interior (Hoang et al. 2010b). 
 
Further characterization using TEM of NLB droplets prepared in the presence of aqueous 
CsCl was done. TEM images showed the interior portion of NLB droplets to have low 
electron density (Figure 5.9B and C) while liposomes prepared in the presence of aqueous 
CsCl (to serve as control structures) showed the inside of the vesicle to be darker. The dark 
area means it is electron dense thereby indicating the presence of aqueous Cs
+
 as expected. 
Multilamellar (MLV), small unilamellar (SUV) and large unilamellar (LUV) vesicle 
structures could also be seen from the liposome preparation by TEM (Figure 5.9D and E); 
meanwhile, no such structure was seen with NLB droplets formed at the interface. Cryo-TEM 
of the liposome preparation clearly confirmed the presence these structures in suspension 
(Figure 5.9F).  
ESI/EELS analysis of Cs
+ 
distribution in NLB and liposome structures showed Cs
+
 was 
present inside the liposome vesicle (Figure 5.9H) as expected and completely absent inside 
NLB (Figure 5.9G). In summary, these studies unequivocally demonstrated that NLB 
droplets consist of lipid throughout their interiors which are non-hollow and hydrophobic.  
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Figure 5.9: Confocal laser microscopy of Z-stacked images of DiO stained NLB droplets shows fluorescence 
right through the interior part of lipid droplets (A). TEM imaging showed aqueous Cs-treated NLB droplets to 
have a clear whitish interior (B and C) while liposome structures had a darker interior (D and E) and showed the 
presence of multilamellar (M), small unilamellar (S) and large unilamellar (L) structures formed which was 
confirmed using cryo-TEM imaging (F) while no such structures were seen with NLB. ESI/EELS analysis 
showed the interior of NLB to be devoid of Cs
+
 (G) confirming it was completely hydrophobic while liposome 
structures were filled with aqueous Cs
 
containing solution (H) indicating it was hydrophilic. This confirmed the 
lipid droplets have a non-hollow continuous hydrophobic interior. 
 
5.3.6 Visualization of β-haematin crystals formed at NLB-water interface  
Samples carefully collected from the NLB-water emulsion during the β-haematin formation 
process at different incubation time points of 10, 30 and 60 min were visualized using the 
TECNAI TF20 TEM. Interestingly, small crystalline structures (β-haematin) were 
consistently seen in association with lipid droplets (Figure 5.10A and B) and this was the case 
with all the products at the different incubation time points. In addition, a few longer crystals 
were seen not directly associated with NLB droplets (Figure 5.10C) but which may have 
grown from lipid-associated crystals. ESI/EELS analyzes of iron distribution in these images 
of products formed at the NLB-water interface (Figure 5.10B) confirmed these crystalline 
structures associated with NLB droplets corresponded to β-haematin (Figure 5.10D). Looking 
at some of the TEM images, it was difficult to tell the precise location of β-haematin crystals 
with respect to NLB droplets. However, close inspection of these associated structures 
showed clearly that β-haematin lay on the surface of NLB as seen in Figure 5.10E, F and G. 
Extruded NLB and Fe(III)PPIX in citric acid buffer unequivocally confirmed the growing β-
haematin crystal to lie on the surface of lipid droplet (Figure 5.10H). Another striking 
observation was that the population of these crystals produced appeared to match the sizes of 
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the lipid droplets they were associated with. The lattice fringes of crystals in association with 
lipid droplets has shown that it is it {100} or {1¯00} face which is in contact with the lipid 
droplets (Figure 5.6F), an observation also made with droplets from MPG lipid (Figure 5.4F). 
The appearance of these β-haematin crystals associated with NLB droplets is very similar to 
that in S. mansoni where hemozoin crystals have also been reported to be associated with 
lipid droplets (Corrêa and Egan et al., 2007). 
 
 
Figure 5.10: Visualization by TEM of β-haematin formed with NLB at the lipid-water interface.TEM imaging 
showed many crystalline structures to be associated with NLB droplets (A and B), which upon ESI/EELS 
analysis of iron distribution (D) confirmed clearly that they were iron containing. Some of the longer crystals 
were found already grown out from the lipid droplets (C). Careful examination of β-haematin crystals in contact 
with lipid droplets showed these crystals lie on the surface of the lipid droplets (E, F, G). TEM imaging of β-
haematin prepared by extruding both NLB and Fe(III)PPIX together with citric acid buffer unequivocally 
confirmed the growing β-haematin crystal to be located on the surface of lipid droplet (H) at the lipid-water 
interface. Scale bar = 50 nm in A, C and H. 
 
5.3.7 Relationship between size distribution of NLB droplets and β-haematin crystals 
formed at the NLB-water interface 
The sizes of β-haematin crystals formed with NLB and that of NLB droplets were measured 
at different incubation times. Kinetic studies showed the reaction of β-haematin with NLB 
was completed within 10 min and so the relative numbers of β-haematin crystals and NLB 
particles formed at 10 min incubation time were examined. Their measured sizes were 
arranged into various size ranges as shown in Figure 5.11A and B. The distribution plot 
showed they both fell into similar size ranges with two distinct population maxima. The size 
distribution of NLB showed two maxima with one between 74-146 nm and the other between 
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366-438 nm representing a large population of small droplets and smaller population of larger 
NLB droplets respectively. The size distribution of β-haematin crystals also showed two 
maxima between 94-140 nm and between 188-234 nm representing a larger population of 
smaller β-haematin and smaller population of larger β-haematin crystals respectively. The 
average measured length of β-haematin crystals (206 nm) was found to be 0.62 times the 
average diameter of lipid particle droplets (331 nm). To check if there was any relationship 
between the sizes of both β-haematin crystals mediated by NLB and that of the NLB droplets 
themselves, a non-parametric Kolmogorov-Smirnov (K-S) test was conducted (Massey, 
1951). This determines if the distribution of two populations are significantly different.  
 
The null hypothesis (H0) for this test was that the cumulative distribution of β-haematin 
crystal sizes are the same as that of 0.62 times diameter of NLB particle droplets, while the 
alternate hypothesis (HA) was that their cumulative distributions are not the same at a given 
significance level. So H0 is rejected if the inequality in Equation 2 holds, and vice versa. 
 
√
   
    
        -------------------- 2  
        |   ( )     ( 
 )| 
Dnn′ = absolute supremum difference between the cumulative distributions of the sizes of β-haematin and 0.62 times NLB 
diameter 
Kα = critical value at a given confidence level  
n = number of β-haematin crystals measured  
n′ = number of lipid droplets measured 
F1,n(x) = Empirical distribution function of β-haematin  
F2,n(x′) = Empirical distribution function of lipid droplets 
 
Using an available free online version of K-S statistical analysis software 
(http://www.physics.csbsju.edu/stats/KS-test.n.plot_form.html), the computed Dnn’ obtained 
was 0.1124 (Figure 5.11C) giving a value for the left hand side (LHS) of Equation 2 of 1.28. 
The Kα on the right hand side (RHS) of Equation 2 was 1.36 at  = 0.05. Thus, since the LHS 
was less than the RHS (1.28 versus 1.36), H0 holds at the  = 0.05 significance level which 
means that the distribution of β-haematin crystal sizes and lipid droplet diameters ( 0.62) 
was statistically indistinguishable at 10 min incubation time. However, the distributions of 
sizes between β-haematin crystals and NLB droplet diameters were found to be statistically 
different at 30 and 60 min incubation time. This may be due to the very large number of 
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small lipid droplets that appeared at these longer times which were not associated with 
smaller β-haematin crystals as can be seen in Figure 5.10A. However, this is not unexpected 
since the kinetic studies in Chapter 4 showed that the β-haematin formation process was 
completed with 10 min. Since these smaller droplets formed later (30 and 60 min) they could 
not contribute to the β-haematin formation process. Thus a size correlation would not be 
expected. 
 
 
Figure 5.11: Plots showing the size distributions of NLB particles and -haematin crystals. The plot showing the 
size range distribution of measured diameters of approximately 309 NLB particle droplets formed at the lipid-
water interface at 10 min incubation time (A) showed larger populations of the droplets between 74-146 and 
366-438 nm while a plot of the measured length of 223 -haematin crystals formed at this lipid-water interface 
at 10 min incubation also showed maxima at 94-140 and 188-234 nm (B). The average length of β-haematin 
crystals was found to be 0.62 times the average diameter of lipid droplets and K-S statistical analysis of these 
two data sets, assuming β-haematin crystal grow to about 0.62 times the diameter of lipid droplet, showed there 
is no significant difference between these two data sets based on the cumulative size distribution of the lipid 
droplets normalized to 0.62 times their diameters (solid line) and that of -haematin crystals (dotted line) (C) at 
 = 0.05. 
 
These findings suggest that β-haematin crystals grew to about 0.62 times the diameter of the 
lipid droplets, implying crystals at the lipid surfaces, which acts as a nucleator (Figure 
5.12A), stop growing when the angle made between the growing crystal and lipid surface is 
38 (Figure 5.12C). This is most probably because the surface tension exceeds the interaction 
between β-haematin and lipid droplets after this point and contact between the crystal and 
lipid can no longer be sustained, thereby preventing further growth as shown in the schematic 
representation in Figure 5.12B.  
 
The strong correlation of the sizes of NLB droplets to that of β-haematin formed at NLB-
water interface coupled with the location of β-haematin on the surface of lipid both in vitro 
(Figure 5.10E, F, G and H), and in vivo as seen in S. mansoni (Oliveira et al. 2005), 
convincingly suggest that the size of β-haematin/Hz crystals is controlled by the size of NLB 
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droplets. This is further supported by the evidence of extremely long β-haematin crystals 
formed at the flat continuous pentanol-water interface which offers no restriction or limit to 
β-haematin crystal growth length. However, β-haematin or Hz crystal growth in such an 
environment or compartment may also be limited by the growth inhibition effect of small 
amounts of the non-centrosymmetric isomer of -propionato dimer of Fe(III)PPIX present as 
was previously suggested (Buller et al. 2002). 
 
 
Figure 5.12. (A) A molecular graphics representation of nucleation and growth of the -haematin at the surface 
of an MPG droplet. The MPG surface structure was based on the 2D unit cell of a monomyristoylglycerol 
(MMG) monolayer observed by de Villiers et al. (2009) at the air-water interface using grazing incidence x-ray 
diffraction and specular x-ray reflectivity. (B) shows the near match between positions of -haematin propionic 
acid groups at the {100} surface of the crystal (rendered in gold) and every third glycerol –OH group of MPG 
(red). (C) shows the size of -haematin crystals relative to lipid droplets as found in this study. The angle 
formed by -haematin crystal with the surface of the droplet (assuming it is spherical) was 38 which is close to 
the angles observed in several TEM images such as in Figure 5.10H. 
 
Lattice fringes and diffraction patterns of -haematin crystals formed seen in association with 
both MPG and NLB droplets in Figures 5.4 and 5.6, respectively, showed that it makes 
contact with lipid via its prominent {100} or {1¯00} faces. This observation, however, does 
not necessarily imply that the crystals nucleated from these faces or that they grew with these 
faces in contact with the lipid. Indeed, it is quite possible that the crystals could have 
nucleated from a different face and then subsequently interacted with the lipid on this face 
since this is the largest face in the crystal morphology. Even the match between crystal and 
lipid droplet sizes seen in Figures 5.6 and 5.10 could have arisen from lipid associating with 
these large crystal faces after formation of -haematin. However, the observation that crystal 
lengths correlate with the diameters of lipid droplets formed independently of Fe(III)PPIX 
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(Figure 5.11) is difficult to explain unless one of the faces incorporating the long axis of the 
crystal ({100}, {1¯00}, {010} or {01¯0}) was in contact with the lipid face during crystal 
growth. In view of the suitable complementary interaction between -haematin propionic 
acid groups and glycerol head groups in Figure 5.12 as well as the previous observation of 
nucleation from the {100} face in the case of self-assembled monolayers (SAMs) with –OH 
head groups (de Villiers et al. 2009), it was suspected that this would more likely be the 
{100} face, although this still needs to be proven experimentally. This idea is consistent with 
the proposal that the neutral lipid surface acts as a template for the growth of -haematin (de 
Villiers et al. 2009 and Hoang et al. 2010a), a suggestion that has been made previously on 
the basis of findings obtained with self-assembled monolayers (de Villiers et al. 2009, 
Solomonov et al. 2007 and Wang et al. 2010).  
 
5.3.8 Haemozoin crystals imaged within the DV in P. falciparum  
Malachite green, which is known to stain lipids in biological samples, was used to stain 
parasites during the fixation process for TEM imaging. Hz crystals seen by TEM seemed not 
to be associated with any visible stained lipid droplets inside the DV (Figure 5.13A, C and D) 
in contrast to what was clearly seen in the case of TEM images of β-haematin formed with 
NLB (Figure 5.10). Instead, the Hz crystals in the DV appeared to be aligned along the inner 
walls of the DV (Figure 5.13A and C), probably in association with the DV inner membrane. 
This observation is in agreement with recent reports by Kapishnikov et al. that showed with 
the use of 5.3D serial surface view microscopy and cryo-SEM smaller Hz crystals align with 
their {100} face along the inner membrane surface of DV which probably acts as the 
nucleation site of this crystal face. Some of the measured angles of the crystals marked * in 
Figure 5.12A and C are close to 120
o
 thereby indicating the crystal exposes it {100} as seen 
with β-haematin crystals formed with NLB. Measured inter-atomic distances of 12.6 Å and 
12.37 Å in some of these crystals inside the DV (Figure 5.13B and E respectively), all 
corresponding to {100} or {1¯00} faces, also confirmed that Hz crystals inside the parasite 
predominantly lie on their {100} or {1¯00} faces in this image. The predominance of this 
crystal face in the morphology of Hz crystals aligned with the DV inner membrane surface in 
the parasite and also in β-haematin crystals in contact with lipid droplets at the lipid-water 
interface, suggest that the {100} face is actually the crystal face at which nucleation of Hz 
crystal growth occurs, as argued above. 
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Figure 5.13: TEM imaging of Hz crystals inside the DV. Hz crystals appeard to align with the inner membrane 
surface of the DV (A and B) and d-spacing measurement of 12.6 Å (B) and 12.37 Ǻ (E) for lattice fringes of 
some of these crystals inside parasite corresponding to the{100} or {1¯00} faces showed this is the predominant 
face on which the crystals lie in the parasite. 
 
5.3.9 The effect of the antimalarial drug chloroquine on Hz crystal growth in vivo 
The β-haematin and Hz formation process has been shown to be the major target for many 
antimalarial drugs like CQ (Egan et al. 1994, Chou et al. 1980, Sullivan et al. 1996 and 
Sandlin et al. 2011). CQ has also been proposed to act by binding to the fastest growing 
{001} face of the theoretical growth form of β-haematin (Buller et al. 2002 and Solomonov et 
al. 2007). However, direct evidence of the effect of this drug on Hz crystal morphology in 
vivo has not been shown. TEM was therefore used to characterize Hz crystals isolated from 
parasites grown in the presence of 30 and 60 nM CQ at 32 h. Hz crystals isolated from 30 and 
60 nM CQ-treated parasites showed significant decrease in the crystal length at 32 h with 
diffraction fringes exhibiting signs of growth defects at 60 nM (Figure 5.14A & B 
respectively) compared to a well-formed Hz crystals isolated from untreated parasites at 32 h 
(Figure 5.14C), exhibiting parallel straight lattice fringes (Figure 5.14F) with no signs of 
growth defects. The size of hemozoin crystals decreased from an average of 500 nm 
(untreated parasites) to about 250 nm and further down to 5 nm in the presence of 30 and 60 
nM CQ concentrations respectively. The degree of crystal growth inhibition appeared to 
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increase with increase in the drug concentration (inhibition effect was concentration 
dependent). 
It was also thought that the very tiny sizes of Hz isolated from parasite cultures grown in the 
presence of 60 nM CQ at 32 h might be similar to the sizes of Hz crystals at a very early 
stage of the parasite growth when the crystals just start growing. In this respect Hz crystals 
were also isolated from parasites grown in the absence of drug at 12 h (Figure 5.14D) and 
their lattice fringes were compared to those isolated from 60 nM CQ-treated parasites at 32 h. 
Interestingly, lattice fringes from 12 h parasites showed no defects in crystal growth (Figure 
5.14E). Evidence in this study showed that besides the inhibition of Hz crystal growth by CQ, 
the crystal growth process is also affected as seen with lattice fringes exhibiting signs of 
growth defects. This unequivocally shows that CQ inhibits Hz crystal growth in vivo in a 
concentration-dependent manner.  
 
Figure 5.14: Effect of CQ on Hz crystal morphology. Hz isolated from parasite cultures grown in the presence 
of 30 (A) and 60 nM (B) CQ at 32 h caused a significant decrease in Hz crystal length from about 500 nm in 
untreated parasites (C) to about 250 and further down to 5 nm respectively. The sizes of Hz from 60 nM CQ 
treated parasite was superficially similar to Hz isolated from untreated parasites at 12 h (D); however, crystal 
lattice fringes from 60 nM treated parasites showed signs of growth defects while that of untreated parasites at 
12 h (E) and 32 h (F) showed no defects in crystal growth. 
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5.4 CONCLUDING REMARKS 
This study has shown that, under physiological conditions, MSG/MPG/DPG/DOG/DLG 
(NLB) lipids found associated with the surface of Hz crystals mediate the formation of β-
haematin crystals which are identical in overall crystal habit and form to Hz crystals from the 
malaria parasite itself and also to β-haematin formed at the pentanol-water interface. The 
morphology of the β-haematin crystals formed with NLB was neither affected by the ratio of 
lipid-to-Fe(III)PPIX present at any given time nor by the kinetics of the crystal growth 
process, thus this may imply that the shape of Hz crystals formed in vivo might not be 
affected by either the amount of Fe(III)PPIX released into the crystallization compartment 
where crystal growth occurs or by the rate at which the Hz crystals grow. Nucleation of 
crystal growth mediated by lipids seems to occur via the prominent {100} face which is 
always seen in contact with the lipid droplet. It has also been demonstrated for the first time 
that the size of the lipid particle apparently controls the size of β-haematin crystals formed at 
short incubation times. The β-haematin crystals maintain contact with lipid particle until they 
stop growing when the angle of contact between them reaches 38
o
. β-Haematin crystals have 
been shown to be located on the surface of lipid droplets which have a continuous non-
hollow hydrophobic interior with no surrounding lipid bilayer membrane. NLB therefore acts 
as a nucleation site for β-haematin crystal growth by providing a suitable microenvironment 
for electrostatic, stereochemical and geometric complementarity between the lipid and 
nucleating {100} face of the growing crystal. Finally, CQ has been shown to unequivocally 
inhibit Hz crystal growth in a concentration-dependent manner in the parasite. This whole 
study points strongly to the nucleation of Hz crystals in vivo being aided by lipid and also 
gives new insight into the shape and sizes of the crystals formed during this process. 
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6. OVERALL CONCLUSIONS AND FUTURE WORK 
 
6.1 OVERALL CONCLUSIONS 
Malaria, a disease caused by a parasite belonging to the genus Plasmodium, affects about 3.3 
billion people worldwide, the majority of whom live in Sub-Saharan Africa (WHO, 2011). 
Plasmodium falciparum is the most deadly species of this genus and pregnant women and 
children under the age of five are the most affected group. With little indication of a vaccine 
against malaria being developed in the near future, chemotherapy remains the most reliable 
method to successfully treat the disease. However, there is increasing evidence of resistance 
by parasites to many of the existing antimalarial drugs such as the artemisinin-based 
combination therapies (Alker et al. 2007 & Denis et al. 2006); therefore, there is an urgent 
need to development new antimalarial agents.  
The biomineralization of Fe(III)PPIX into haemozoin (Hz) is a known target for many 
antimalarial drugs such as chloroquine (CQ), artesunate, amodiaquine, lumefantrine, 
mefloquine and quinine (Egan et al. 1994, Chou et al. 1980, Sullivan et al. 1996, Sandlin et 
al. 2011 & Combrinck et al. 2012). However, the widespread occurrence of parasitic 
resistance to this drug and other similar antimalarials means that many are no longer suitable 
for treating the disease. Therefore, elucidating the mechanism by which this 
biomineralization process occurs in the parasite would assist in the design and development 
of new antimalarial agents and could potentially identify new targets related to this process.  
Proteins such as HDP (Jani et al. 2008) and HRPII (Sullivan et al. 1996) and lipids (Fitch et 
al. 1999 & Pisciotta et al. 2007) have been proposed to be responsible for this 
biomineralization process in vivo. However, evidence of the presence of any of these 
biomolecules interacting with the Hz crystal itself is lacking in contrast to what has been 
invariably shown with other biominerals (Alves et al. 2011, Mann et al. 2008, Arakaki et al. 
2008, Marie et al. 2011, Nemoto et al. 2012 & Mann et al. 2006) where proteins are involved 
in the biomineralization process. In this current study, SDS-PAGE and LC-MS/MS used to 
study the proteome of the Hz crystal did not identify any of the proteins previously 
implicated in Hz crystal formation such as HDP and HRPII on either the Hz crystal surface or 
in the matrix proteome. Since about 40% of the P. falciparum genome is uncharacterized, it 
was also thought that by studying the proteome of the Hz crystal, new-uncharacterized 
putative proteins that could be implicated in the biomineralization process of Hz formation 
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could be identified. Surprisingly, no “stand-out” proteins that could be implicated in 
mediating this process were identified on either the Hz crystal surface or in the matrix 
proteome, even after using two different algorithms (MASCOT and X!Tandem) to interrogate 
both the P. falciparum and H. sapiens databank. On the other hand, the 
MSG/MPG/DPG/DOG/DLG blend (NLB) reported by Pisciotta et al. (2007) to be associated 
with Hz inside the parasite was easily identified associated with the surface of the Hz crystal. 
Lipids have been reported to be in an abundance 180 000-360 000 times greater than the 
detection limit of protein present in the Hz crystal. The absence, therefore, of any of the 
proteins previously implicated in Hz formation in the Hz crystal associated proteome coupled 
with the massive abundance of lipid over protein in the crystal shown in this study 
presumably points to lipids as the most likely biomolecules responsible for mediating the 
biomineralization of Hz formation in vivo. 
The NLB identified associated with the Hz crystal surface in this study and some of its 
constituent lipids have previously been shown to efficiently mediate Hz formation in vitro 
(Picsiotta et al. 2007, Egan et al. 2006, Hoang et al. 2010a & Hoang et al. 2010b). However, 
information on the detailed kinetics of this process in vitro under conditions mimicking the 
DV is lacking. The effects of biologically-relevant ions on this process had not yet been 
investigated. Neither had the effects of Fe(III)PPIX and lipid concentrations on this process. 
This study has shown that NLB found associated with the surface of the Hz crystal is very 
efficient in mediating β-haematin formation giving a yield of about 90% and the reaction was 
completed in under 10 min at a NLB-to-Fe(III)PPIX mole ratio of about 1:1. The reaction 
rate only slowed down when there were about two molecules of Fe(III)PPIX to one molecule 
of the lipid fatty acid chain and still gave a high yield of about 90% in under 30 min. 
However, despite the decrease in reaction rates observed with a decrease in lipid 
concentrations, rates still remain adequate to account for Hz formation despite an overall drop 
in yields at physiologically-relevant lipid-to-Fe(III)PPIX ratios. The reaction rates of β-
haematin formation with lipid were not greatly affected by the presence of physiologically-
relevant ions. This seems to suggest that the process of Hz formation in vivo is greatly 
affected by lipid only and not by the presence of surrounding biological ions, if indeed the 
process is solely mediated by lipid as was suggested based on findings from proteomic and 
lipid studies of the Hz crystals in this current work. CLM measurement of autoflorescence 
arising from materials collected during the reaction process of β-haematin formation over 
time confirmed the formation of well-ordered crystalline β-haematin in situ in close 
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association with lipid emulsions. This method showed potential application to monitor β-
haematin formation in vitro, Hz formation in vivo and the effects of antimalarial drugs that 
exploit this process as their target, in real time. 
The average size of β-haematin crystals formed in the reaction mediated by NLB or MPG in 
this study appeared to be smaller than Hz in vivo and exhibited a different external 
morphology. The small size of β-haematin crystals formed with MPG fell in a similar range 
to that reported for NLB particles (Hoang et al. 2010a). However, detailed crystallographic 
characterization of the β-haematin crystals formed with NLB or MPG was not previously 
available. Neither was there any information on how the lipid droplet might influence the size 
of the crystals grown at the lipid-water interface and there was no clear evidence of the effect 
of CQ on the Hz formation process in vivo. This study explicitly showed by TEM and TEM-
ED characterization that β-haematin produced under physiological conditions with the NLB 
found to be associated with the Hz surface is identical in overall crystal form and habit to that 
of Hz itself. Although there appears to be a minor difference in the texture of the two crystals, 
this may be due the presence of lipid and proteins present in the Hz crystal matrix as was 
clearly demonstrated in this study. The external morphology of the β-haematin formed was 
not affected by either a change in lipid-to-Fe(III)PPIX ratio or by the kinetics of the crystal 
growth process which may suggest that the morphology of the Hz crystal formed in vivo is 
not affected by the rate and amount of Fe(III)PPIX sequestered into the growing crystal 
inside the DV. This, again, is a very important finding as it may be exploited to investigate 
the direct effect of drugs on the morphology of the Hz crystal formed in vivo in the DV in the 
case of malaria parasites and also in other organisms such as S. mansoni (Oliveira et al. 
2000), H. columbae (Chen et al. 2001) and R. prolixus (Oliveira et al. 1999) where Hz crystal 
formation is thought to be a lipid-mediated process. This is because any changes in the crystal 
morphology resulting from such treatment would be a direct effect of the drug on the Hz 
formation process. The β-haematin formed at lipid-water interface was consistently seen with 
its {100} face in contact with lipid droplets which were shown to have non-hollow lipid-
filled interiors. Importantly, analysis of the distribution of sizes of independently-formed 
NLB droplets without Fe(III)PPIX (assuming droplets are spherical and their diameter 
normalized to 0.62 times that of the crystals) and that of β-haematin formed at the lipid-water 
interface at 10 min incubation time by the Kolmogorov-Smirnov test showed a very strong 
correlation between them. This suggest that the lipid droplets always seen in contact with the 
{100} face of crystals controls the size of the crystal grown at the lipid-water interface and 
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the crystal stops growing when the angle of contact made with the lipid droplet is 38
o
. This 
major finding provides new insight into the role of lipid in Hz crystal formation. The 
consistent observations of lipid droplets in contact with the {100} face of β-haematin 
crystals, coupled with direct evidence that the lipid droplet controls the size of crystals 
grown, strongly suggest that lipid interacting with Fe(III)PPIX provides a suitable 
microenvironment for electrostatic, stereochemical and geometric complementarity between 
the lipid and the propionate group (nucleating face) of Fe(III)PPIX (as shown Figure 5.12) 
representing the {100} face for crystal growth. Thus, it is evident that the lipid nucleates the 
β-haematin crystal growth from its {100} face. Finally, this study unequivocally showed that 
CQ interferes with the Hz lattice in the cell. 
 
6.2 FUTURE WORK 
This study has shown that neither the proteins HDP or HRPII previously implicated in the 
biomineralization of Hz formation in vivo is present on the Hz crystal surface or matrix based 
on proteomic studies of the Hz crystal. In addition, no “stand-out” proteins were identified 
that could be implicated in the Hz crystal formation in vivo. However, lipids constituting the 
NLB found to be associated with the Hz crystal were proposed to be the most likely 
biomolecules responsible for Hz crystal formation. These lipids were shown to be very 
efficient in mediating β-haematin formation under biomimetic conditions similar to the DV 
and producing crystals that are identical in overall external morphology and form to that of 
Hz itself. Therefore, to completely support the hypothesis of this work that Hz formation in 
vivo is most likely to be purely a lipid-mediated process, further investigation needs to be 
done. In this regard, the following studies are proposed: 
1. To use β-haematin produced from pentanol that has no associated lipid to pack a β-
haematin column, run extract from the DV through the column followed by an SDS-
PAGE gel to identify proteins which will possibly bind to β-haematin and therefore 
Hz. 
2. To treat malaria parasites with drugs known to inhibit Hz formation, e.g. CQ, isolate 
the DV and, if possible, Hz to study their proteome to see if new proteins can be 
identified which are recruited during stress conditions to bind free haem. 
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3. To isolate Hz and treat the crystals with 1% (v/v) NaOCl at 4-6°C to completely 
destroy organic material located at the surface of Hz, leaving intact the intracrystalline 
proteins only. The crystals are then dissolved and run on an SDS-PAGE gel. The 
entire gel lane would be cut out for protein identification by LC-MS to detect only 
proteins found in the matrix for further characterization. This approach is commonly 
used to identify biomineral matrix proteins. 
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Appendix 1 
All P. falciparum (Pf) and human proteins identified from the respective gel sections in Figure 3.4 
Bands on 15% 
SDS PAGE 
Coomassie (C) 
and silver (S) 
stained gels 
Protein name Predicted 
protein 
mass 
(KDa) 
Location 
(compartment and/or 
subcellular location) 
Intact,I 
or 
digested
,D 
C1  (P13830) Ring-infected erythrocyte surface antigen precursor RESA_PLAFF 124.907 Cell membrane  I 
  (P13819) Merozoite surface protein 1 precursor PMMSA) MSP1_PLAFF 193.72 Cell membrane D 
  (P04932) Merozoite surface protein 1 precursor (PMMSA) (P190) 187.291 Cell membrane  D 
  (Q8I4V5) Probable U3 small nucleolar RNA-associated protein 11 (U3 
snoRNA-associated protein 11)  
25.668 Nucleus  
  (Q8IBS5) Calcium-dependent protein kinase 4 CDPK4_PLAF7 60.780 Unknown  
  (P40282) Histone H2A H2A_PLAFA 14.122 Nucleus  
  (O97231) 60S ribosomal protein L44 RL44_PLAFA 12.157 Ribosome  
  (Q9NJU9) Calcium-dependent protein kinase 3 CDPK3_PLAF7 65.288 Unknown  
  (P21421) DNA-directed RNA polymerase beta chain RPOB_PLAFA 122.186 Plastid, apicoplast I 
  (Q02595) Probable serine/threonine-protein kinase 2 (EC 2.7.1.37) 
 KPK2_PLAFK 
59.006 Membrane of young 
trophs&schizonts 
 
  (P68875) Transmission-blocking target antigen S230 precursor S230_PLAFO 363.218 Cell membrane   
  (Q05866) 78 kDa glucose-regulated protein homolog precursor (GRP 78) 
 GRP78_PLAFO 
72.776 ER Lumen  
  (O97249) 40S ribosomal protein S12 RS12_PLAFA 15.396 Ribosome  
  (P30315) DNA polymerase delta catalytic subunit DPOD_PLAFK 126.884 Nucleus I 
      
C1 Human None    
      
C2 Pf (P33948) ER lumen protein retaining receptor ERD2_PLAFA 26.447 ER membrane  
  (P13819) Merozoite surface protein 1 precursorMSP1_PLAFF 193.72  D 
  (P04932) Merozoite surface protein 1 precursor  (PMMSA) (P190) 187.291  D 
ii 
 
 MSP1_PLAFK 
  (Q04956) Probable cation-transporting ATPase 1 ATX1_PLAFA 230.286 Membrane  D 
  (P40282) Histone H2A H2A_PLAFA 14.122  D 
  (P34940) Chaperonin CPN60, mitochondrial precursor CH60_PLAFG 79.445 Mitochondria D 
  (P21421) DNA-directed RNA polymerase beta chain RPOB_PLAFA 122.186  D 
  (P13830) Ring-infected erythrocyte surface antigen precursor RESA_PLAFF 124.907  D 
  (P27625) DNA-directed RNA polymerase III largest subunitRPC1_PLAFA 272.832 Nucleus D 
  (P02895) Glycophorin-binding protein (GBP-130) GBP_PLAFG 90.018 Cytoplasm D 
  (P05691) Circumsporozoite protein (CS) (Fragment) CSP_PLAFL 33.649 Cell membrane  
  (P14643) Tubulin beta chain (Beta tubulin) TBB_PLAFK 49.751 Cytoskeleton   
  (P12078) Heat shock 70 kDa protein PPF203 (fragment) HSP73_PLAFA 23.058 DV  
  (P41001) DNA topoisomerase II (EC 5.99.1.3) TOP2_PLAFK 161.029 Nucleus D 
  (P13922) Bifunctionaldihydrofolate DRTS_PLAFK 71.817 Unknown D 
  (Q08210) Dihydroorotate dehydrogenase homolog, mitochondrial precursor 
PYRD_PLAFA 
65.558 Mitochondrion inner 
membrane 
I 
  (P30315) DNA polymerase delta catalytic subunit DPOD_PLAFK 126.884  D 
      
C2 Human (P68871) Haemoglobin beta chain HBB_HUMAN 15.998 Cytoplasm  
  (P11166) Solute carrier family 2, facilitated glucose transporter, member 1 
(Glucose transporter type 1, RBC/brain) GTR1_HUMAN 
54.084 Cell membrane I 
  (P02768) Serum albumin precursor ALBU_HUMAN 69.367 Plasma(secreted) I 
  (P69905) Haemoglobin alpha chain HBA_HUMAN 15.258 Cytoplasm  
  (P02730) Band 3 anion transport protein B3AT_HUMAN 101.792  Membrane protein D 
  (P11678) Eosinophil peroxidase precursor PERE_HUMAN 81.040 Cytoplasmic  
granules of 
eosinophil 
D 
  (P62988) Ubiquitin UBIQ_HUMAN; demerged into P0CG47 
(UBB_HUMAN), 
P0CG48 (UBC_HUMAN, 
 P62979 (RS27A_HUMAN),  
P62987 (RL40_HUMAN) 
25.762, 
77.039, 
17.965, 
14.728 
Nucleus  
D 
iii 
 
  (Q99569) Plakophilin 4 (p0071) PKP4_HUMAN 131.868 Cytoskeleton D 
  (P27105) Erythrocyte band 7 integral membrane protein (Stomatin) (Protein 
7.2b)  STOM_HUMAN 
31.731 Inner surface of 
plasma membrane, 
binds cytoskeleton 
 
  (Q05996) Zonapellucida sperm-binding protein 2 precursor ZP2_HUMAN 82.357 Cell  membrane D 
  (P12273) Prolactin-inducible protein precursor PIP_HUMAN 16.572 Secreted  
      
C3 Pf (P40282) Histone H2A H2A_PLAFA 14.112   
  (P13830) Ring-infected erythrocyte surface antigen precursor RESA_PLAFF 124.907  D 
  (P13819) Merozoite surface protein 1 precursor MSP1_PLAFF 193.72  D 
  (P04932) Merozoite surface protein 1 precursor (P190)  MSP1_PLAFK 187.291  D 
  (O96935) M1-family aminopeptidase AMP1_PLAFQ 126.062 Cytosol, DV D 
  (P05691) Circumsporozoite protein (CS) (Fragment) CSP_PLAFL 33.649   
  (P13922) Bifunctionaldihydrofolatereductase-thymidylate synthase 
DRTS_PLAFK 
71.817 Unknown D 
  (P34940) Chaperonin CPN60, mitochondrial precursor CH60_PLAFG 79.445  D 
      
C3 Human (P68871) Haemoglobin beta chain HBB_HUMAN 15.998   
  (P69905) Haemoglobin alpha chain HBA_HUMAN 15.258   
  (P14136) Glial fibrillary acidic protein, astrocyte GFAP_HUMAN 49.880 Cytoplasm D 
  (P11166) Solute carrier family 2, facilitated glucose transporter, member 1 
GTR1_HUMAN 
54.084  D 
  (P02261) Histone H2A.c/d/i/n/p (H2A.1) (H2A/c) (H2A/d) (H2A/i) (H2A/n) 
(H2A/p) (H2A.1b)  H2AC_HUMAN; Demerged into P0C0S8 
(H2A1_HUMAN) 
14.09 Nucleus  
  (P02730) Band 3 anion transport protein B3AT_HUMAN 101.792  D 
      
C4 Pf (P13819) Merozoite surface protein 1 precursor MSP1_PLAFF 193.72  D 
  (P04932) Merozoitesurface protein 1 precursor (P190)  MSP1_PLAFK 193.72  D 
  (P40282) Histone H2A H2A_PLAFA 14.112   
  (P13830) Ring-infected erythrocyte surface antigen precursorRESA_PLAFF 124.907  D 
iv 
 
  (P13922) Bifunctionaldihydrofolatereductase-thymidylate synthase 
DRTS_PLAFK 
71.817  D 
  (P41001) DNA topoisomerase II TOP2_PLAFK 161.029  D 
  (P27625) DNA-directed RNA polymerase III largest subunitRPC1_PLAFA 272.832  D 
  (P38545) GTP-binding nuclear protein Ran RAN_PLAFA 24.875 Nucleus  
  (P14248) DNA-directed RNA polymerase II largest subunitRPB1_PLAFD 278.168 Nucleus D 
  (P33948) ER lumen protein retaining receptor ERD2_PLAFA 26.447   
  (P62343) Calcium-dependent protein kinase 1 CDPK1_PLAFK 60.800 Membrane D 
  (P34940) Chaperonin CPN60, mitochondrial precursor CH60_PLAFG 79.445  D 
  (P39898) Plasmepsin 1 precursor (PFAPG) 51.461 DV D 
  (P30315) DNA polymerase delta catalytic subunit DPOD_PLAFK 126.884  D 
  (Q08210) Dihydroorotate dehydrogenase homolog, mitochondrial precursor 
PYRD_PLAFA 
65.558  D 
  (P13824) Clustered-asparagine-rich protein ARP2_PLAFA 51.176 Unknown D 
  (Q27743) L-lactate dehydrogenase LDH1_PLAFD 34.108 DV I 
  (Q08853) Calcium-transporting ATPase (EC 3.6.3.8) (Calcium pump) 139.415 Membrane D 
  (P25407) Hypothetical protein in calmodulin 5'region (Fragment) 29.324   
  (P13568) Multidrug resistance protein (Chloroquine resistance protein) 
 MDR_PLAFF 
162.252 DV D 
  (P05691) Circumsporozoite protein (CS) (Fragment) CSP_PLAFL 33.649  I 
  (P61076) ThioredoxinreductaseTRXR_PLAF7 68.698 Cytoplasm I(mon) 
  (P50647) Ribonucleoside-diphosphatereductase large chain RIR1_PLAFG 92.403 Unknown D 
  (Q00080) Elongation factor 1-alpha (EF-1-alpha) EF1A_PLAFK 49.041 Cytoplasm D 
  (P25805) Trophozoite cysteine proteinase precursor CYSP_PLAFA 66.880  D 
  (P16405) Octapeptide-repeat antigen (ORA) (Fragment) ORA_PLAFN 79.049 PV D 
  (P11144) Heat shock 70 kDa protein (HSP70) HSP70_PLAFA 74.287 DV D 
  (Q02155) Hexokinase (EC 2.7.1.1) HXK_PLAFA 55.346 Unknown D 
  (P69193) Serine-repeat antigen protein precursor SERA_PLAFD 111.095  D 
  (P46468) Putative cell division cycle ATPase CDAT_PLAF7 142.080 Unknown D 
  (Q05866) 78 kDa glucose-regulated protein homolog precursor 
GRP78_PLAFO 
72.776  D 
v 
 
  (O96935) M1-family aminopeptidaseAMP1_PLAFQ 126.062  D 
  (P22620) 101 kDa malaria antigen (P101) (Acidic basic repeat antigen) 
 ABRA_PLAFC 
86.622 PV membrane D 
  (P34787) Tubulin gamma chain (Gamma tubulin) TBG_PLAFO 51.538 Cytoskeleton D 
      
C4 Human (P68871) Haemoglobin beta chain HBB_HUMAN 15.998   
  (P02730) Band 3 anion transport protein B3AT_HUMAN 101.972  D 
  (P11166) Solute carrier family 2, facilitated glucose transporter, member 1 
GTR1_HUMAN 
54.084  D 
  (P69905) Haemoglobin alpha chain HBA_HUMAN 15.258   
  (P62805) Histone H4 H4_HUMAN 11.367 Nucleus  
  (P02261) Histone H2A.c/d/i/n/p (H2A.1) (H2A/c) (H2A/d) (H2A/i) (H2A/n) 
(H2A/p) (H2A.1b)  H2AC_HUMAN 
14.09   
  (P02768) Serum albumin precursor ALBU_HUMAN 69.367  D 
  (Q01543) Friend leukemia integration 1 transcription factorFLI1_HUMAN 50.982 Nucleus  D 
  (Q13683) Integrin alpha-7 precursor ITA7_HUMAN 128.948 Membrane  D 
  (P27105) Erythrocyte band 7 integral membrane protein (Stomatin) (Protein 
7.2b) STOM_HUMAN 
31.731   
  (Q8N511) Protein C17orf32 CQ032_HUMAN 23.130 Membrane  
  (Q9H293) Interleukin-17E precursor (IL-17E) IL17E_HUMAN 20.330 Secreted  
  (Q02094) Rhesus blood group-associated glycoprotein RHAG_HUMAN 44.198 Membrane D 
  (Q9Y5I4) Protocadherin alpha C2 precursor PCDC2_HUMAN 109.450 Membrane D 
  (P62988) Ubiquitin UBIQ_HUMAN; demerged into  P0CG47 
(UBB_HUMAN), P0CG48 (UBC_HUMAN) 
                              P62979 (RS27A_HUMAN) 
                              P62987 (RL40_HUMAN) 
25.762, 
77.039, 
17.965, 
14.728 
  
  (Q92844) TRAF family member-associated NF-kappa-B activator 
TANK_HUMAN 
47.816 Cytoplasm 
(Ubiquitous) 
D 
  (P14778) Interleukin-1 receptor, type I precursor IL1R1_HUMAN 65.402 Cell membrane 
(secreted) 
D 
  (Q9BXS1) Isopentenyl-diphosphate delta-isomerase 2 IDI2_HUMAN 26.753 Peroxisome  
vi 
 
(detected in skeletal 
muscle) 
  (O94973) Adapter-related protein complex 2 alpha 2 subunit 
AP2A2_HUMAN 
103.960 Membrane  D 
  (Q96NR8) Retinol dehydrogenase 12 RDH12_HUMAN 35.094 Unknown (Widely 
expressed, mostly in 
eye, kidney, brain, 
skeletal muscle and 
stomach) 
I 
  (Q9C0E2) Exportin 4 (Exp4) XPO4_HUMAN 130.139 Nucleus D 
  (Q9NQT8) Kinesin-like protein KIF13B KI13B_HUMAN 202.666 (cytoskeleton D 
  (P25100) Alpha-1D adrenergic receptor ADA1D_HUMAN 60.463 Membrane D 
  (O43150) Development and differentiation-enhancing factor 2 
DDEF2_HUMAN 
111.651 Golgi apparatus D 
  (Q15124) Phosphoglucomutase-like protein 5PGM5_HUMAN 62.225 Cytoskeleton 
(detected in cardiac 
& skeletal muscle, 
liver, kidney, skin & 
brain) 
D 
  (Q92545) RW1 protein (Fragment) RW1_HUMAN 205.138 Membrane D 
  (Q05682) Caldesmon (CDM) CALD1_HUMAN 93.231 Cytoskeleton D 
      
C5 Pf (P13819) Merozoite surface protein 1 precursor  MSP1_PLAFF 193.72  D 
  (P19598) Merozoite surface protein 1 precursor (P190)  MSP1_PLAF3 192.463 Cell membrane D 
  (P40282) Histone H2A H2A_PLAFA 14.122   
      
C5 Human (P33948) ER lumen protein retaining receptor ERD2_PLAFA 26.447   
  (P13830) Ring-infected erythrocyte surface antigen precursor RESA_PLAFF 124.907  D 
  (P05691) Circumsporozoite protein CSP_PLAFL 33.649   
  (P61076) Thioredoxinreductase TRXR_PLAF7 68.698  D 
  (P69193) Serine-repeat antigen protein precursor SERA_PLAFD 111.095  D 
vii 
 
  (P38545) GTP-binding nuclear protein Ran (GTPase Ran) (Ras-like protein 
TC4)  RAN_PLAFA 
24.875   
  (P68871) Haemoglobin beta chain HBB_HUMAN 15.998   
  (P11166) Solute carrier family 2, facilitated glucose transporter, member 1  
GTR1_HUMAN 
54.084  D 
  (P69905) Haemoglobin alpha chain HBA_HUMAN 15.258   
  (P02768) Serum albumin precursor ALBU_HUMAN 69.367  D 
  (P02261) Histone H2A.c/d/i/n/p (H2A.1) (H2A/c) (H2A/d) (H2A/i) (H2A/n) 
(H2A/p) (H2A.1b)  H2AC_HUMAN 
14.09   
  (P62988) Ubiquitin UBIQ_HUMAN demerged into  P0CG47 
(UBB_HUMAN) P0CG48 (UBC_HUMAN) 
 P62979 (RS27A_HUMAN) 
 P62987 (RL40_HUMAN) 
25.762, 
77.039, 
17.965, 
14.728 
  
  (Q92844) TRAF family member-associated NF-kappa-B activator 
TANK_HUMAN 
47.816  D 
      
C6 Pf (P13819) Merozoite surface protein 1 precursor MSP1_PLAFF 193.72  D 
  (P19598) Merozoite surface protein 1 precursor  (P190) 192.463  D 
  (P13830) Ring-infected erythrocyte surface antigen precursor RESA_PLAFF 124.907  D 
  (P40282) Histone H2A H2A_PLAFA 14.122   
  (P27625) DNA-directed RNA polymerase III largest subunitRPC1_PLAFA 272.832  D 
  (P14248) DNA-directed RNA polymerase II largest subunitRPB1_PLAFD 278.168  D 
  (P34940) Chaperonin CPN60, mitochondrial precursor CH60_PLAFG 79.445  D 
  (P13922) Bifunctionaldihydrofolatereductase-thymidylate synthase 
DRTS_PLAFK 
71.817  D 
  (P30315) DNA polymerase delta catalytic subunit DPOD_PLAFK 126.884  D 
  (Q08210) Dihydroorotate dehydrogenase homolog, mitochondrial precursor 
PYRD_PLAFA 
65.558  D 
  (P13824) Clustered-asparagine-rich protein ARP2_PLAFA 51.176  D 
  (Q08853) Calcium-transporting ATPase (EC 3.6.3.8) (Calcium pump) 
 ATC_PLAFK 
139.415  D 
viii 
 
  (P25407) Hypothetical protein in calmodulin 5'region (Fragment) 
YCA1_PLAFA 
29.324   
  (P05691) Circumsporozoite protein (CS) (Fragment) CSP_PLAFL 33.649   
  (P16405) Octapeptide-repeat antigen (ORA) (Fragment) ORA_PLAFN 79.049  D 
  (P38545) GTP-binding nuclear protein Ran (GTPase Ran) (Ras-like protein 
TC4)  RAN_PLAFA 
24.875   
  (P41001) DNA topoisomerase II (EC 5.99.1.3) TOP2_PLAFK 161.029  D 
  (Q02155) Hexokinase (EC 2.7.1.1) HXK_PLAFA 55.346  D 
  (Q05866) 78 kDa glucose-regulated protein homolog precursor 
GRP78_PLAFO 
72.776  D 
      
C6 Human (P27105) Erythrocyte band 7 integral membrane protein (Stomatin) (Protein 
7.2b)  STOM_HUMAN 
31.731   
  (P68871) Haemoglobin beta chain HBB_HUMAN 15.998   
  (P11166) Solute carrier family 2, facilitated glucose transporter, member 1 
GTR1_HUMAN 
54.084  D 
  (P69905) Haemoglobin alpha chain HBA_HUMAN 15.258   
  (P02768) Serum albumin precursor ALBU_HUMAN 69.367  D 
  (P02261) Histone H2A.c/d/i/n/p (H2A.1) (H2A/c) (H2A/d) (H2A/i) (H2A/n) 
(H2A/p) (H2A.1b)  H2AC_HUMAN 
14.09   
  (Q16352) Alpha-internexin (Alpha-Inx) AINX_HUMAN 55.391 Intermediate 
filament 
D 
  (Q8WWR8) Sialidase 4  NEUR4_HUMAN 51.572 Membrane & 
Lysosome lumen 
D 
      
C7 Pf (P11144) Heat shock 70 kDa protein (HSP70) HSP70_PLAFA 74.287  D 
  (P39898) Plasmepsin 1 precursor PLM1_PLAFA 51.461  D 
  (Q07805) Ornithine aminotransferase (EC 2.6.1.13) (Ornithine--oxo-acid 
aminotransferase)  OAT_PLAFD 
46.055 Cytoplasm, DV D 
  (P38545) GTP-binding nuclear protein Ran (GTPase Ran) (Ras-like protein 
TC4)  RAN_PLAFA 
24.875  D 
ix 
 
  (Q94650) ADP-ribosylation factor ARF_PLAFA 20.912 Golgi apparatus, DV D 
  (Q00080) Elongation factor 1-alpha (EF-1-alpha) EF1A_PLAFK 49.041  D 
  (P13568) Multidrug resistance protein MDR_PLAFF 162.252  D 
  (P10988) Actin I ACT1_PLAFA 41.843 Cytoskeleton & DV D 
      
  (P14883) Actin II ACT2_PLAFA 42.679 Cytoskeleton & DV D 
  (P33948) ER lumen protein retaining receptor ERD2_PLAFA 26.447  D 
  (P14643) Tubulin beta chain (Beta tubulin) TBB_PLAFK 49.751  D 
  (Q8I3H7) T-cell immunomodulatory protein homolog precursor TIP_PLAF7 82.905 Membrane D 
  (P40282) Histone H2A H2A_PLAFA 14.122  I 
  (Q04956) Probable cation-transporting ATPase 1  ATX1_PLAFA 230.286  D 
  (P13830) Ring-infected erythrocyte surface antigen precursor 
 RESA_PLAFF 
124.907  D 
  (P20147) Heat shock 90 kDa protein homolog (Fragment) 
 HSP90_PLAFP 
21.968 Cytoplasm D 
  (Q07785) Cell division control protein 2 homolog CDC2H_PLAFK 32.996 Cytoplasm D 
  (P13819) Merozoite surface protein 1 precursor MSP1_PLAFF 193.72  D 
  (P04932) Merozoite surface protein 1 precursor (P190)  MSP1_PLAFK 187.291  D 
  (P13825) Aspartic acid-rich protein precursor ASP_PLAFS 30.248 Nucleus D 
  (Q27727) Enolase ENO_PLAFA 48.702 Cytoplasm D 
  (P50489) Apical membrane antigen 1 precursor AMA1_PLAFC 71.944 Membrane D 
  (Q02155) Hexokinase  HXK_PLAFA 55.346  D 
  (P34940) Chaperonin CPN60, mitochondrial precursor CH60_PLAFG 79.445  D 
  (O15865) Calcium-dependent protein kinase 2   CDPK2_PLAFK 59.048 Myristoylation may 
target it to different 
subcellular 
compartments 
D 
  (P50647) Ribonucleoside-diphosphatereductase large chainRIR1_PLAFG 92.403  D 
  (P34787) Tubulin gamma chain (Gamma tubulin) TBG_PLAFO 51.538  D 
  (P30315) DNA polymerase delta catalytic subunit  DPOD_PLAFK 126.884  D 
  (Q05866) 78 kDa glucose-regulated protein homolog precursor 72.776  D 
x 
 
 GRP78_PLAFO 
  (P09593) S-antigen protein precursor SANT_PLAFV 35.500 PV D 
  (Q08853) Calcium-transporting ATPase (Calcium pump) ATC_PLAFK 139.415  D 
  (P68875) Transmission-blocking target antigen S230 precursor 
 S230_PLAFO 
363.218  D 
  (P12078) Heat shock 70 kDa protein PPF203 (Fragment) 
 HSP73_PLAFA 
23.058  D 
  (P13922) Bifunctionaldihydrofolatereductase-thymidylate synthase 
DRTS_PLAFK 
71.817  D 
  (P21422) DNA-directed RNA polymerase beta' chain (EC 2.7.7.6) 
 RPOC_PLAFA 
69.406 Plastid, apicoplast D 
  (P27625) DNA-directed RNA polymerase III largest subunit (EC 2.7.7.6) 
 RPC1_PLAFA 
272.832  D 
  (P04928) S-antigen protein precursor SANT_PLAFN 33.695 PV D 
      
C7 Human (P68871) Haemoglobin beta chain HBB_HUMAN 15.998  I 
  (P62805) Histone H4 H4_HUMAN 11.367  I 
  (P11166) Solute carrier family 2, facilitated glucose transporter, member 1 
GTR1_HUMAN 
54.084  D 
  (P11171) Protein 4.1 (Band 4.1) (P4.1) (EPB4.1) (4.1R) 41_HUMAN 97.017 Cytoskeleton & 
Nucleus 
D 
  (P69905) Haemoglobin alpha chain HBA_HUMAN 15.258  I 
  (P62241) 40S ribosomal protein S8 RS8_HUMAN 24.205 Cytoplasm D 
  (P63261) Actin, cytoplasmic 2 (Gamma-actin) ACTG_HUMAN 41.793 Cytoplasm 
(cytoskeleton) 
D 
  (P02768) Serum albumin precursor ALBU_HUMAN 69.367  D 
  (Q8WUD1) Ras-related protein Rab-2B RAB2B_HUMAN 24.214 ER membrane D 
  (Q15907) Ras-related protein Rab-11B (GTP-binding protein YPT3) 
RB11B_HUMAN 
24.489 Cytoplasmic vesicle 
membrane  
D 
  (Q9NP58) ATP-binding cassette, sub-family B, member 6, mitochondrial 
precursor  ABCB6_HUMAN 
93.886 Mitochondria outer 
membrane,ER,Golgi 
D 
xi 
 
apparatus 
  (P59190) Ras-related protein Rab-15 RAB15_HUMAN 24.391 Membrane D 
  (Q9H082) Ras-related protein Rab-33B RB33B_HUMAN 25.718 Golgi apparatus 
membrane 
D 
  (O95716) Ras-related protein Rab-3D RAB3D_HUMAN 24.267 Cell membrane D 
  (Q9NRW1) Ras-related protein Rab-6B RAB6B_HUMAN 23.462 Golgi apparatus 
membrane 
D 
  (P62826) GTP-binding nuclear protein Ran (GTPase Ran) (Ras-like protein 
TC4) RAN_HUMAN 
24.423 Nucleus D 
  (P02730) Band 3 anion transport protein B3AT_HUMAN 101.792  D 
  (P39023) 60S ribosomal protein L3 (HIV-1 TAR RNA binding protein 
B)RL3_HUMAN 
46.109 Cytoplasm 
(nucleus,nucleolus) 
D 
  (P62988) Ubiquitin UBIQ_HUMAN demerged into  P0CG47 
(UBB_HUMAN), P0CG48 (UBC_HUMAN) 
P62979 (RS27A_HUMAN) 
P62987 (RL40_HUMAN) 
25.762, 
77.039, 
17.965, 
14.728 
 D 
  (P62280) 40S ribosomal protein S11 RS11_HUMAN 18.431 Cytoplasm 
(ribosome) 
D 
  (P42330) Aldo-ketoreductase family 1 member C3 (EC 1.1.1.-) (Trans-1,2-
dihydrobenzene-1,2-diol deh AK1C3_HUMAN 
36.853 Cytoplasm D 
  (P08107) Heat shock 70 kDa protein 1 (HSP70.1) (HSP70-1/HSP70-2) 
 HSP71_HUMAN 
70.052 Cytoplasm D 
  (Q9Y6X8) Zinc fingers and homeoboxes protein 2 ZHX2_HUMAN 92.307 Nucleus D 
      
  (P27105) Erythrocyte band 7 integral membrane protein (Stomatin) (Protein 
7.2b)  STOM_HUMAN 
31.731  D 
  (P04406) Glyceraldehyde-3-phosphate dehydrogenase, liver G3P2_HUMAN 36.053 Cytosol, Nucleus, 
&cytoskeleton 
D 
  (P02261) Histone H2A.c/d/i/n/p (H2A.1) (H2A/c) (H2A/d) (H2A/i) (H2A/n) 
(H2A/p) (H2A.1b)  H2AC_HUMAN 
14.09  I 
      
xii 
 
C25k Pf (P13819) Merozoite surface protein 1 precursor MSP1_PLAFF 193.72  D 
  (P04932) Merozoite surface protein 1 precursor (P190)  MSP1_PLAFK 187.291  D 
  (P11144) Heat shock 70 kDa protein (HSP70) HSP70_PLAFA 74.287  D 
  (Q08853) Calcium-transporting ATPase (Calcium pump) ATC_PLAFK 139.415  D 
  (P13830) Ring-infected erythrocyte surface antigen precursor 
 RESA_PLAFF 
124.907  D 
  (Q07805) Ornithine aminotransferase OAT_PLAFD 46.055  D 
  (P33948) ER lumen protein retaining receptor ERD2_PLAFA 26.447  I 
  (P40282) Histone H2A H2A_PLAFA 14.122   
  (Q8I3H7) T-cell immunomodulatory protein homolog precursor 
 TIP_PLAF7 
82.905  D 
  (P14248) DNA-directed RNA polymerase II largest subunit RPB1_PLAFD 278.168  D 
  (Q94660) 60S acidic ribosomal protein P0 RLA0_PLAF8 34.998 Ribosome D 
  (Q04956) Probable cation-transporting ATPase 1 ATX1_PLAFA 230.286  D 
  (P16405) Octapeptide-repeat antigen (ORA) (Fragment) ORA_PLAFN 79.049  D 
  (Q03400) S-antigen protein precursor SANT_PLAF7 62.947 PV D 
      
C25k Human (P68871) Haemoglobin beta chain HBB_HUMAN 15.998   
  (P27105) Erythrocyte band 7 integral membrane protein (Stomatin) (Protein 
7.2b)  STOM_HUMAN 
31.731  D 
  (P11166) Solute carrier family 2, facilitated glucose transporter, member 1 
 GTR1_HUMAN 
54.084  D 
  (P02768) Serum albumin precursor ALBU_HUMAN 69.367  D 
  (P11678) Eosinophil peroxidase precursor PERE_HUMAN 81.040  D 
  (P04004) Vitronectin precursor (Serum spreading factor) VTNC_HUMAN 54.306 In plasma (secreted) D 
  (P69905) Haemoglobin alpha chain HBA_HUMAN 15.258   
  (P62988) Ubiquitin UBIQ_HUMAN demerged into  P0CG47 
(UBB_HUMAN), P0CG48 (UBC_HUMAN) 
                               P62979 (RS27A_HUMAN) 
                               P62987 (RL40_HUMAN) 
25.762, 
77.039, 
17.965, 
14.728 
 I 
  (Q9NR81) Rho guanine nucleotide exchange factor 3 ARHG3_HUMAN 59.783 Cytoplasm D 
xiii 
 
  (P39023) 60S ribosomal protein L3 RL3_HUMAN 46.109  D 
  (P02730) Band 3 anion transport protein B3AT_HUMAN 101.792  D 
  (P55268) Laminin beta-2 chain precursor  LAMB2_HUMAN 195.981 Extracellular space 
& matrix (secreted)  
D 
  (P08311) Cathepsin G precursor CATG_HUMAN 28.837 Cell membrane I 
  (P62805) Histone H4 H4_HUMAN 11.367   
  (O75131) Copine III CPNE3_HUMAN 60.131 Cytosol D 
      
S1 Pf None    
      
S1 Human (Q8WXH0) Nesprin 2 (Nuclear envelope spectrin repeat protein 2)
 SYNE2_HUMAN 
796.442 Nucleus outer 
membrane 
D 
  (P99999) Cytochrome c CYC_HUMAN 11.749 Mitochondria 
intermembrane space 
 
  (Q15746) Myosin light chain kinase, smooth muscle and non-muscle 
isozymes MYLK_HUMAN 
210.715 Cytoskeleton D 
  (Q92616) GCN1-like protein 1 (HsGCN1) GCN1L_HUMAN 
(Translational activator GCN1) 
292.758  Ribosome 
(Ubiquitously 
expressed)  
D 
  (Q9NQ29) Putative RNA-binding protein Luc7-like 1 LUC7L_HUMAN 43.728 (Ubiquitous.) 
Nucleus 
D 
  (P51956) Serine/threonine-protein kinase Nek3 NEK3_HUMAN 57.705 Cytoplasm D 
      
S2 Pf (P19214) Erythrocyte-binding antigen EBA-175  EBA1_PLAFC 167.390 Membrane D 
  (P04933) Merozoite surface protein 1 precursor (P195)  MSP1_PLAFW 187.619  D 
      
S2 Human None    
      
S4 Pf (Q9UAR6) Myosin A (PfM-A) MYOA_PLAFB 92.277  D 
  (P13814) Circumsporozoite protein precursor (CS) CSP_PLAFT 45.611 Cell membrane D 
      
xiv 
 
S4 Human (Q14980) Nuclear mitotic apparatus protein 1  NUMA1_HUMAN 238.260 Nucleus  D 
  (Q9Y3Y4) Pygopus homolog 1 PYGO1_HUMAN 45.116 Nucleus D 
  (P13727) Eosinophil granule major basic protein precursor EMBP_HUMAN 25.206  I 
  (O14830) Serine/threonine protein phosphatase with EF-hands-
2PPE2_HUMAN 
86.518 Cytoplasm D 
  (Q9UIF7) A/G-specific adenine DNA glycosylaseMUTYH_HUMAN 60.069 Nucleus D 
  (Q9NRI5) Disrupted in schizophrenia 1 protein DISC1_HUMAN 93.611 Cytoskeleton D 
      
S5 Pf (P14140) Tubulin beta chain (Beta tubulin) TBB_PLAFA 49.814 Cytoskeleton, DV D 
  (P24044) Calmodulin (CaM) CALM_PLAFA 16.931 Unknown D 
  (Q25998) DNA primase small subunit PRI1_PLAFK 53.489 Replisome D 
  (P22621) Apical membrane antigen 1 precursor  72.010 Membrane D 
      
S5 Human (Q9BXT6) Potential helicase Mov10l1  M10L1_HUMAN 135.293 Unknown D 
  (P05164) Myeloperoxidase precursor  PERM_HUMAN 83.869 Lysosome  D 
  (P02748) Complement component C9 precursor CO9_HUMAN 63.173 Cell membrane D 
      
CHz Pf (Q00080) Elongation factor 1-alpha (EF-1-alpha) EF1A_PLAFK 49.041  D 
  (P11144) Heat shock 70 kDa protein (HSP70) HSP70_PLAFA 74.287  D 
  (P39898) Plasmepsin 1 precursor PLM1_PLAFA 51.461  D 
  (P04934) Merozoite surface protein 1 precursor  (P195)  MSP1_PLAFC 196.198 Cell membrane D 
  (P04933) Merozoite surface protein 1 precursor (P195)  MSP1_PLAFW 187.619 Cell membrane D 
  (P38545) GTP-binding nuclear protein Ran (GTPase Ran) (Ras-like protein 
TC4)  RAN_PLAFA 
24.874  I 
  (Q07805) Ornithine aminotransferase OAT_PLAFD 46.055  D 
  (P10988) Actin I ACT1_PLAFA 41.843  D 
  (P14643) Tubulin beta chain (Beta tubulin) TBB_PLAFK 49.751  D 
  (Q04956) Probable cation-transporting ATPase 1 ATX1_PLAFA 230.286  D 
  (P40282) Histone H2A H2A_PLAFA 14.112   
  (P50647) Ribonucleoside-diphosphatereductase large chainRIR1_PLAFG 92.403  D 
  (P13830) Ring-infected erythrocyte surface antigen  RESA_PLAFF 124.907  D 
xv 
 
  (P14883) Actin II ACT2_PLAFA 42.679  D 
  (P13922) Bifunctionaldihydrofolatereductase-thymidylate synthase 
DRTS_PLAFK 
71.817  D 
  (P25805) Trophozoite cysteine proteinase precursor CYSP_PLAFA 66.880  D 
  (Q8I3H7) T-cell immunomodulatory protein homolog precursor TIP_PLAF7 82.905  D 
  (P25408) Hypothetical protein in calmodulin 3'region (Fragment) 28.100 Unknown I 
  (Q9UAR6) Myosin A (PfM-A) MYOA_PLAFB 92.277 Cell membrane D 
  (P16405) Octapeptide-repeat antigen (ORA) (Fragment) ORA_PLAFN 79.049  D 
  (Q08210) Dihydroorotate dehydrogenase homolog, mitochondrial precursor 
PYRD_PLAFA 
65.558  D 
  (P34787) Tubulin gamma chain (Gamma tubulin) TBG_PLAFO 51.538  D 
  (P16893) Thrombospondin related anonymous protein precursor 
 TRAP_PLAFA 
63.300 Cell membrane D 
  (P50250) Adenosylhomocysteinase SAHH_PLAF7 53.839 Cytoplasm, DV D 
      
CHz Human (P68871) Haemoglobin beta chain HBB_HUMAN 15.998  D 
  (P27105) Erythrocyte band 7 integral membrane protein (Stomatin) (Protein 
7.2b)  STOM_HUMAN 
31.731  D 
  (P62805) Histone H4 H4_HUMAN 11.367   
  (P02768) Serum albumin precursor ALBU_HUMAN 69.367  D 
  (P11166) Solute carrier family 2, facilitated glucose transporter, member 1
 GTR1_HUMAN 
58.084  D 
  (P69905) Haemoglobin alpha chain HBA_HUMAN 15.258   
  (P02730) Band 3 anion transport protein B3AT_HUMAN 101.792  D 
  (P13727) Eosinophil granule major basic protein precursor EMBP_HUMAN 25.206 Eosinophil granule  I 
  (Q9Y6X8) Zinc fingers and homeoboxes protein 2 ZHX2_HUMAN 92.307  D 
  (P62241) 40S ribosomal protein S8 RS8_HUMAN 24.205  I 
  (P39023) 60S ribosomal protein L3      RL3_HUMAN 46.109  D 
  (P62988) Ubiquitin UBIQ_HUMAN demerged into  P0CG47 
(UBB_HUMAN), P0CG48 (UBC_HUMAN) 
                               P62979 (RS27A_HUMAN) 
25.762, 
77.039, 
17.965, 
 I 
xvi 
 
                               P62987 (RL40_HUMAN) 14.728 
  (P08107) Heat shock 70 kDa protein 1 (HSP70.1) (HSP70-1/HSP70-
2)HSP71_HUMAN 
70.052  D 
  (P59190) Ras-related protein Rab-15 RAB15_HUMAN 24.391  I 
  (Q9H082) Ras-related protein Rab-33B RB33B_HUMAN 25.718  I 
      
  (P61106) Ras-related protein Rab-14 RAB14_HUMAN 23.897 Early endosome 
membrane, golgi 
apparatus membrane 
I 
  (Q9NRW1) Ras-related protein Rab-6B RAB6B_HUMAN 23.462  I 
  (P08311) Cathepsin G precursor  CATG_HUMAN 28.837  I 
  (P02261) Histone H2A.c/d/i/n/p (H2A.1) (H2A/c) (H2A/d) (H2A/i) (H2A/n) 
(H2A/p) (H2A.1b)  H2AC_HUMAN 
14.09   
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Appendix 2 
All 73 human proteins identified from sample Hs 
Protein name No. of unique 
peptide 
fragments 
Subcellular 
location 
Compartment 
(P11166) Solute carrier family 2, facilitated glucose transporter, member 1 GTR1_HUMAN 4 Cell membrane  
(P02730) Band 3 anion transport protein (Anion exchange protein 1) B3AT_HUMAN 6  
(Q99569) Plakophilin 4 (p0071) PKP4_HUMAN 1  
(P27105) Erythrocyte band 7 integral membrane protein (Stomatin)STOM_HUMAN 5  
(O75131) Copine III CPNE3_HUMAN 1  
(Q13683) Integrin alpha-7 precursor (UNQ406/PRO768)  ITA7_HUMAN 1  
(Q02094) Rhesus blood group-associated glycoprotein RHAG_HUMAN 1  
(O94973) Adapter-related protein complex 2 alpha 2 subunit AP2A2_HUMAN 1  
(Q8WUD1) Ras-related protein Rab-2B RAB2B_HUMAN 1  
(P59190) Ras-related protein Rab-15 RAB15_HUMAN 1  
(Q15907) Ras-related protein Rab-11B (GTP-binding protein YPT3) 1  
(P02768) Serum albumin precursor ALBU_HUMAN 2  
(Q9Y5I4) Protocadherin alpha C2 precursor (PCDH-alpha-C2)  PCDC2_HUMAN 1  
(P25100) Alpha-1D adrenergic receptor (Alpha 1D-adrenoceptor ADA1D_HUMAN 1  
(Q8N511) Protein C17orf32 (transmembrane 199) CQ032_HUMAN  1  
(P08311) Cathepsin G precursor (EC 3.4.21.20) (CG) CATG_HUMAN 1  
O95716) Ras-related protein Rab-3D RAB3D_HUMAN  2  
(Q05996) Zonapellucida sperm-binding protein 2 precursor ZP2_HUMAN   
(P51956) Serine/threonine-protein kinase Nek3 (EC 2.7.1.37) (HSPK 3 NEK3_HUMAN 1  
(P02748) Complement component C9 precursor CO9_HUMAN 1  
(Q92545) RW1 protein (Transmembrane protein 131) RW1_HUMAN   
(P68871) Haemoglobin beta chain HBB_HUMAN 10 Cytosol 
 
 
 
(P69905) Haemoglobin alpha chain HBA_HUMAN 1  
(Q9H293) Interleukin-17E precursor (IL-17E) IL17E_HUMAN 1  
xviii 
 
(P14778) Interleukin-1 receptor, type I precursor IL1R1_HUMAN 1  
 
Cytosol 
 
(P42330) Aldo-ketoreductase family 1 member C3 (EC 1.1.1) AK1C3_HUMAN 1  
(P04406) Glyceraldehyde-3-phosphate dehydrogenase, liver (EC 1.2.1.12) (GAPDH) 
G3P2_HUMAN 
1  
(P08107) Heat shock 70 kDa protein 1 (HSP70.1) HSP71_HUMAN 1  
(P13727) Eosinophil granule major basic protein precursor 2  
(Q9BXS1) Isopentenyl-diphosphate delta-isomerase 2 DI2_HUMAN 1  
(P63261) Actin, cytoplasmic 2 (Gamma-actin) ACTG_HUMAN  1  
(P11678) Eosinophil peroxidase precursor (EC 1.11.1.7) PERE_HUMAN 4  
(P14136) Glial fibrillary acidic protein, astrocyte GFAP_HUMAN 1  
(Q92844) TRAF family member-associated NF-kappa-B activator (TRAF-interacting protein) 
(I-TRAF)  TANK_HUMAN 
1  
(Q9NR81) Rho guanine nucleotide exchange factor 3  ARHG3_HUMAN 1  
(Q9NQ29) Putative RNA-binding protein Luc7-like 1 (SR+89) (Putative SR protein LUC7B1) 
LUC7L_HUMAN 
1  
(P62241) 40S ribosomal protein S8 RS8_HUMAN 2  
(P62988) Ubiquitin (P0CG47,P0CG48,P62979,P62987) 1 Nucleus  
(P02261) Histone H2A.c/d/i/n/p (H2A.1) (H2A/c) (H2A/d) (H2A/i) (H2A/n) (H2A/p) 
(H2A.1b)  H2AC_HUMAN; Demerged into P0C0S8 (H2A1_HUMAN) 
1  
(P62805) Histone H4 H4_HUMAN 3  
(Q01543) Friend leukemia integration 1 transcription factor FLI1_HUMAN 1  
(P62826) GTP-binding nuclear protein Ran (GTPase Ran) (Ras-like protein TC4) 
RAN_HUMAN 
1  
(O14830) Serine/threonine protein phosphatase with EF-hands-2 (EC 3.1.3.16) (PPEF-2) 
PPE2_HUMAN 
1  
(Q9Y6X8) Zinc fingers and homeoboxes protein 2 ZHX2_HUMAN 1  
(Q9C0E2) Exportin 4 (Exp4) XPO4_HUMAN  1  
(P39023) 60S ribosomal protein L3 (HIV-1 TAR RNA binding protein B) (TARBP-B) 
(OK/SW-cl.32)  
1  
(Q8WXH0) Nesprin 2 (Nuclear envelope spectrin repeat protein 2) SYNE2_ 1  
(Q9Y3Y4) Pygopus homolog 1 PYGO1_HUMAN  1  
xix 
 
(Q9UIF7) A/G-specific adenine DNA glycosylase (EC 3.2.2.-) (MutY homolog) (hMYH) 
MUTYH_HUMAN 
  
(Q8WWR8) Sialidase 4 (EC 3.2.1.18) NEUR4_HUMAN 1 Lysosome  
(P05164) Myeloperoxidase precursor (EC 1.11.1.7) (MPO) PERM_HUMAN   
(Q8WUD1) Ras-related protein Rab-2B RAB2B_HUMAN 1 ER  
(Q9H082) Ras-related protein Rab-33B RB33B_HUMAN 1 Golgi  
(Q9NRW1) Ras-related protein Rab-6B RAB6B_HUMAN 1  
(P61106)Ras-related protein Rab-14 RAB14_HUMAN 2  
(Q9NP58) ATP-binding cassette, sub-family B, member 6, mitochondrial precursor 
ABCB6_HUMAN 
1 Mitochondria  
(P99999) Cytochrome c CYC_HUMAN 1  
(Q99569) Plakophilin 4 (p0071) PKP4_HUMAN 1 Cytoskeleton  
(P27105) Erythrocyte band 7 integral membrane protein (Stomatin) (Protein 7.2b) 
STOM_HUMAN 
5  
(P11171) Protein 4.1 (Band 4.1) (P4.1) (EPB4.1) (4.1R) 2  
(Q15124) Phosphoglucomutase-like protein 5 PGM5_HUMAN 1  
(Q05682) Caldesmon (CDM) CALD1_HUMAN   
(Q9NQT8) Kinesin-like protein KIF13B (Kinesin-like protein GAKIN) KI13B_HUMAN   
(Q15746) Myosin light chain kinase, smooth muscle and non-muscle isozymes (EC 2.7.1.117) 
MYLK_HUMAN  
1  
(Q9NRI5) Disrupted in schizophrenia 1 protein DISC1_HUMAN   
(Q16352) Alpha-internexin (Alpha-Inx) (Neurofilament-66) (NF-66)  AINX_HUMAN 1 Intermediate 
filament 
 
(P62280) 40S ribosomal protein S11 RS11_HUMAN   Ribosome  
(P12273) Prolactin-inducible protein precursor (Secretory actin-binding protein) PIP_HUMAN 1 Unknown  
(P04004) Vitronectin precursor (Serum spreading factor) (S-protein) (V75) VTNC_HUMAN 1  
(P55268) Laminin beta-2 chain precursor (S-laminin) LAMB2_HUMAN 1  
(Q92616) GCN1-like protein 1 (HsGCN1) GCN1L_HUMAN  1  
(Q9BXT6) Potential helicase Mov10l1 (EC 3.6.1) M10L1_HUMAN   
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Appendix 3 
P. falciparum proteins identified using X! Tandem search algorithm 
Protein name  No. of unique peptides 
identified 
Total no. of 
independent spectra 
HSP70_PLAFA Heat shock 70 kDa protein 3 6 
PLM1_PLAFA Plasmepsin-1 6 7 
B0M0V9_PLAFA RhopH2 6 8 
B3L435_PLAKH 40s ribosomal protein s11, putative 3 8 
B3L4K2_PLAKH Histone H4 10 21 
B3L4K3_PLAKH Histone H2B 2 2 
B3LBQ3_PLAKH 60S ribosomal protein L24, putative 2 2 
O77389_PLAF7 Formate-nitrate transporter, putative 7 23 
Q4XSB6_PLACH 40S ribosomal protein S16 2 3 
Q6T755_PLAFA Phosphoethanolamine N-methyltransferase 3 3 
Q8I2Q0_PLAF7 Putative uncharacterized protein 2 3 
Q8I488_PLAF7  PIESP2 erythrocyte surface protein 2 2 
Q8IE85_PLAF7 60S ribosomal protein L6, putative 2 3 
Q8IEJ0_PLAF7 Uncharacterized protein 4 9 
Q8II36_PLAF7 Aquaglyceroporin OS 3 19 
Q8ILE3_PLAF7 Putative uncharacterized protein 2 4 
Q8IM15_PLAF7 HAP protein 3 4 
ERD2_PLAFA  ER lumen protein retaining receptor 2 3 
RAN_PLAFA  GTP-binding nuclear protein Ran 2 3 
Q8I0P6_PLAF7  Elongation factor 1-alpha 3 5 
OAT_PLAFD Ornithine aminotransferase 4 5 
ARF1_PLAFO ADP-ribosylation factor 1 2 2 
CRT_PLAF7 Putative chloroquine resistance transporter 5 18 
Q9BHT6_PLAFA Small GTPase Rab2, putative 3 3 
B3L7Q9_PLAKH 60S ribosomal protein L19 2 4 
xxi 
 
B3L9A1_PLAKH Ribosomal protein S3, putative 4 6 
Q8I2X3_PLAF7 Acid phosphatase 7 9 
C6KT11_PLAF7 Mitochondrial import receptor subunit tom40 3 4 
Q8IKC8_PLAF7 Exp-2 protein 3 4 
O97250_PLAF7 60S ribosomal protein L7, putative 3 11 
Q8IJ34_PLAF7 Adenine nucleotide translocase 3 4 
Q4YP98_PLABA Ribosomal protein L10, putative 4 9 
Q8I305_PLAF7 Transporter, putative 2 3 
Q8I431_PLAF7 60S ribosomal protein L4, putative 3 7 
Q8I4R5_PLAF7 Rhoptry neck protein 3, putative 3 3 
Q8I546_PLAF7 Conserved Plasmodium membrane protein 2 14 
Q8IDH5_PLAF7 Thioredoxin-related protein, putative 5 22 
Q8IFP2_PLAF7 40S ribosomal protein S19, putative 3 5 
Q9NFS5_PLAFA Spermidine synthase 5 14 
Q8IIU8_PLAF7 40S ribosomal protein S4, putative 3 4 
Q8IJC6_PLAF7 60S ribosomal protein L3, putative 4 16 
Q8ILE8_PLAF7 60S ribosomal protein L14, putative 3 5 
Q8ILM8_PLAF7 Putative uncharacterized protein 3 3 
Q8ILY8_PLAF7 Putative uncharacterized protein 4 7 
Q8IBQ5_PLAF7 40S ribosomal protein S10, putative 2 2 
Q8IBN5_PLAF7 40S ribosomal protein S5, putative 2 3 
Q8IJR6_PLAF7 Putative uncharacterized protein 2 4 
C0H4A6_PLAF7 Ribosomal protein L15 OS 3 9 
Q8IDV0_PLAF7  Elongation factor 1-gamma, putative 2 2 
Q8IM26_PLAF7 Putative uncharacterized protein 2 7 
B3KZ74_PLAKH  Rab18 GTPase, putative 2 2 
P13568|MDR_PLAFF Multidrug resistance protein 2 2 
Q9GRI2_PLAFA Protein disulfide isomerase 2 2 
Q9TZT4_PLAFA Merozoite surface protein 1 OS 3 14 
Q8IE80_PLAF7 Uncharacterized protein 3 4 
Q4YNS1_PLABA Putative uncharacterized protein (Fragment) 2 4 
xxii 
 
Q8I502_PLAF7 40S ribosomal protein S17, putative 2 2 
Q9U445_PLAFA  P-type ATPase 2 2 
Q9NIH9_PLAFA  Nucleoside transporter 1 2 12 
O77395_PLAF7 40S ribosomal protein S15A, putative 2 2 
Q8IBY4_PLAF7 60S ribosomal protein L34-A, putative 2 2 
Q8IJH8_PLAF7  Phospholipid scramblase 1, putative 2 3 
Q8T6B1_PLAFA Glyceraldehyde-3-phosphate dehydrogenase (Fragment) 1 1 
Q9GVA9_PLAFA Conserved Plasmodium protein 1 1 
Q8IDR9_PLAF7 40S ribosomal protein S6, putative 1 1 
Q4YSE1_PLABA 40S ribosomal protein S3a 1 3 
Q8II62_PLAF7 60S ribosomal protein L38e, putative 1 1 
B3L086_PLAKH 60S ribosomal protein L11a 1 2 
B3LAS9_PLAKH 40S ribosomal protein S8 1 2 
Q8I490_PLAF7 Putative uncharacterized protein 1 2 
Q8IJU2_PLAF7 Conserved Plasmodium protein 1 1 
Q8IJK8_PLAF7 60S ribosomal protein L30e, putative 1 1 
B3L8I9_PLAKH GTP-binding protein, putative 1 1 
Q8II93_PLAF7 Protein phosphatase, putative 1 3 
Q8IDB0_PLAF7 40S ribosomal protein S13, putative 1 1 
P40282|H2A_PLAFA Histone H2A 1 8 
B3L9U8_PLAKH Ribosomal protein S2, putative 1 1 
B3L6W2_PLAKH Ubiquitin/ribosomal fusion protein uba52 homologue, 
putative 
1 2 
B3L3J3_PLAKH DNA/RNA-binding protein, putative 1 1 
Q8I433_PLAF7 Rhomboid protease ROM4 1 1 
B3L2Q6_PLAKH RNA-binding protein, putative 1 1 
TIP_PLAF7 T-cell immunomodulatory protein homolog 1 1 
Q8IAU7_PLAF7 Putative uncharacterized protein 1 1 
B3L9V6_PLAKH Leucineaminopeptidase, putative 1 1 
C6KSQ7_PLAF7 Long chain polyunsaturated fatty acid elongation enzyme, 
putative 
1 2 
xxiii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B3L567_PLAKH Ribosomal protein s18, putative 1 2 
Q8I0U9_PLAF7 Triose phosphate transporter 1 1 
B3L2G4_PLAKH Major facilitator, transporter protein,putative 1 1 
K6ULC9_9APIC Protein transport protein Sec61 alpha subunit (Fragment) 1 1 
Q8IDF7_PLAF7  V-type ATPase, putative 1 1 
xxiv 
 
Appendix 4 
P. falciparum proteins identified from sample Hd 
Protein name No. of unique 
peptide fragments 
Subcellular 
location 
(P25408) Hypothetical protein in calmodulin 3'region (Fragment)                    
( QueuinetRNA-ribosyltransferase-like protein) 
1 unknown 
(P16893) Thrombospondin related anonymous protein 1 Cell membrane 
(P50250) Adenosylhomocysteinase  1 Cytoplasm and DV 
(Q8I3H7) T-cell immunomodulatory protein homolog precursor  3 Cell membrane 
(Q00080) Elongation factor 1-alpha  5 Cytoplasm 
(P11144) Heat shock 70 kDa protein  8 DV 
(P39898) Plasmepsin 1 precursor  5 DV 
(P04932) Merozoite surface protein 1  5 Cell membrane,DV 
(P38545) GTP-binding nuclear protein Ran (GTPase Ran)  4 Nucleus & DV 
(Q07805) Ornithine aminotransferase  4 Cytosol & DV 
(P10988) Actin I  2 Cytoskeleton  DV 
(P14643) Tubulin beta chain (Beta tubulin)  2 Cytoskeleton,DV 
(Q04956) Probable cation-transporting ATPase 1  3 Cell membrane 
(P40282) Histone H2A  3 Nucleus 
(P50647) Ribonucleoside-diphosphatereductase large chain  2 Unknown 
(P13830) Ring-infected erythrocyte surface antigen   5 Cell membrane,DV 
(P14883) Actin II  1 Cytoskeleton, DV 
(P13922) Bifunctionaldihydrofolatereductase-thymidylate synthase  3 Unknown 
(P25805) Trophozoite cysteine proteinase precursor  2 Unknown 
(Q8I3H7) T-cell immunomodulatory protein homolog precursor  3 Cell membrane 
(Q9UAR6) Myosin A  2 Cell membrane 
(P16405) Octapeptide-repeat antigen  2 PV 
(Q08210) Dihydroorotate dehydrogenase homolog, mitochondrial precursor  2 Mitochondria 
(P34787) Tubulin gamma chain (Gamma tubulin) TBG_PLAFO 2 Cytoskeleton 
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Human Proteins identified from sample Hd 
Human proteins No. of unique 
peptide fragments 
Subcellular 
location 
(P13727) Eosinophil granule major basic protein precursor  2 Cell membrane 
(P61106) Ras-related protein Rab-14  2 Golgi apparatus  
(P68871) Haemoglobin beta chain  10 Gytosol 
(P27105) Erythrocyte band 7 integral membrane protein (Stomatin)  5 Cytoskeleton  
(P62805) Histone H4  3 Nucleus 
(P02768) Serum albumin precursor  2 Cell membrane 
(P11166) Solute carrier family 2, facilitated glucose transporter,  4 Cell membrane 
(P69905) Haemoglobin alpha chain  1 Cytosol 
(P02730) Band 3 anion transport protein  6 Cell membrane 
(Q9Y6X8) Zinc fingers and homeoboxes protein 2  1 Nucleus 
(P62241) 40S ribosomal protein S8   2 Nucleus 
(P39023) 60S ribosomal protein L3 (HIV-1 TAR RNA binding protein B)  1 Nucleus 
(P62988) Ubiquitin (P0CG47) 
(UBB_HUMAN),P0CG48(UBC_HUMAN),P62979 (RS27A_HUMAN)                                         
P62987 (RL40_HUMAN) 
1 Nucleus 
(P08107) Heat shock 70 kDa protein 1  1 Cytosol 
(P59190) Ras-related protein Rab-15 1 Cell membrane 
(Q9H082) Ras-related protein Rab-33B  1 Golgi apparatus 
(Q9NRW1) Ras-related protein Rab-6B  1 Golgi apparatus 
(P08311) Cathepsin G precursor  1 Cell membrane 
(P02261) Histone H2A.c/d/i/n/p (H2A.1) (H2A/c) (H2A/d) (H2A/i) (H2A/n) 
(H2A/p) (H2A.1b) H2AC_HUMAN 
1 Nucleus 
 
 
